AGE|AGE_ADJUSTED_CI_LOWER|AGE_ADJUSTED_CI_UPPER|AGE_ADJUSTED_RATE|COUNT|ICCC_GROUP|POPULATION|YEAR
0-14|142.4|148.6|145.4|8502|All ICCC Groups Combined|58588724|1999
0-14|43.6|47.1|45.3|2651|I Leukemias, myeloproliferative & myelodysplastic diseases|58588724|1999
0-14|34.0|37.1|35.5|2081|I(a) Lymphoid leukemias|58588724|1999
0-14|6.9|8.3|7.6|441|I(b) Acute myeloid leukemias|58588724|1999
0-14|0.4|0.9|0.6|36|I(c) Chronic myeloproliferative diseases|58588724|1999
0-14|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|58588724|1999
0-14|1.1|1.7|1.4|82|I(e) Unspecified and other specified leukemias|58588724|1999
0-14|14.3|16.4|15.3|897|II Lymphomas and reticuloendothelial neoplasms|58588724|1999
0-14|4.9|6.1|5.5|320|II(a) Hodgkin lymphomas|58588724|1999
0-14|5.4|6.6|6.0|349|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|58588724|1999
0-14|2.1|3.0|2.5|148|II(c) Burkitt lymphoma|58588724|1999
0-14|0.7|1.2|0.9|52|II(d) Miscellaneous lymphoreticular neoplasms|58588724|1999
0-14|0.3|0.7|0.5|28|II(e) Unspecified lymphomas|58588724|1999
0-14|30.3|33.2|31.7|1857|III CNS and misc intracranial and intraspinal neoplasms|58588724|1999
0-14|2.6|3.5|3.0|176|III(a) Ependymomas and choroid plexus tumor|58588724|1999
0-14|13.5|15.5|14.5|848|III(b) Astrocytomas|58588724|1999
0-14|7.1|8.6|7.8|460|III(c) Intracranial and intraspinal embryonal tumors|58588724|1999
0-14|4.6|5.8|5.1|302|III(d) Other gliomas|58588724|1999
0-14|0.3|0.7|0.5|30|III(e) Other specified intracranial & intraspinal neoplasms|58588724|1999
0-14|0.5|1.0|0.7|41|III(f) Unspecified intracranial and intraspinal neoplasms|58588724|1999
0-14|9.8|11.5|10.6|617|IV Neuroblastoma and other peripheral nervous cell tumors|58588724|1999
0-14|9.6|11.3|10.4|607|IV(a) Neuroblastoma and ganglioneuroblastoma|58588724|1999
0-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|58588724|1999
0-14|8.7|10.3|9.5|553|IX Soft tissue and other extraosseous sarcomas|58588724|1999
0-14|4.4|5.5|4.9|288|IX(a) Rhabdomyosarcomas|58588724|1999
0-14|0.7|1.2|0.9|55|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|58588724|1999
0-14|~|~|~|~|IX(c) Kaposi sarcoma|58588724|1999
0-14|2.3|3.1|2.7|156|IX(d) Other specified soft tissue sarcomas|58588724|1999
0-14|0.7|1.2|0.9|53|IX(e) Unspecified soft tissue sarcomas|58588724|1999
0-14|0.2|0.4|0.3|16|Not classified by ICCC|58588724|1999
0-14|3.7|4.8|4.2|245|V Retinoblastoma|58588724|1999
0-14|7.3|8.8|8.0|467|VI Renal tumors|58588724|1999
0-14|6.9|8.3|7.6|442|VI(a) Nephroblastoma and other nonepithelial renal tumors|58588724|1999
0-14|0.2|0.6|0.4|22|VI(b) Renal carcinomas|58588724|1999
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|58588724|1999
0-14|1.7|2.5|2.1|122|VII Hepatic tumors|58588724|1999
0-14|1.4|2.1|1.7|101|VII(a) Hepatoblastoma|58588724|1999
0-14|0.2|0.5|0.4|21|VII(b) Hepatic carcinomas|58588724|1999
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|58588724|1999
0-14|6.5|7.9|7.2|419|VIII Malignant bone tumors|58588724|1999
0-14|3.7|4.8|4.2|246|VIII(a) Osteosarcomas|58588724|1999
0-14|~|~|~|~|VIII(b) Chondrosarcomas|58588724|1999
0-14|2.0|2.8|2.3|136|VIII(c) Ewing tumor and related sarcomas of bone|58588724|1999
0-14|0.2|0.5|0.3|19|VIII(d) Other specified malignant bone tumors|58588724|1999
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|58588724|1999
0-14|4.4|5.6|5.0|289|X Germ cell, trophoblastic tumors & neoplasms of gonads|58588724|1999
0-14|1.0|1.6|1.3|75|X(a) Intracranial & intraspinal germ cell tumors|58588724|1999
0-14|1.1|1.7|1.3|78|X(b) Malignant extracranial & extragonadal germ cell tumors|58588724|1999
0-14|1.8|2.5|2.1|124|X(c) Malignant gonadal germ cell tumors|58588724|1999
0-14|~|~|~|~|X(d) Gonadal carcinomas|58588724|1999
0-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|58588724|1999
0-14|5.2|6.5|5.8|339|XI Other malignant epithelial neoplasms and malignant melanomas|58588724|1999
0-14|~|~|~|~|XI(a) Adrenocortical carcinomas|58588724|1999
0-14|1.5|2.2|1.9|109|XI(b) Thyroid carcinomas|58588724|1999
0-14|0.2|0.6|0.4|22|XI(c) Nasopharyngeal carcinomas|58588724|1999
0-14|1.4|2.1|1.8|102|XI(d) Malignant melanomas|58588724|1999
0-14|~|~|~|~|XI(e) Skin carcinomas|58588724|1999
0-14|1.2|1.9|1.5|89|XI(f) Other and unspecified carcinomas|58588724|1999
0-14|0.3|0.7|0.5|30|XII Other and unspecified malignant neoplasms|58588724|1999
0-14|~|~|~|~|XII(a) Other specified malignant tumors|58588724|1999
0-14|0.2|0.5|0.3|19|XII(b) Other unspecified malignant tumors|58588724|1999
0-19|155.8|161.4|158.6|12377|All ICCC Groups Combined|78174581|1999
0-19|39.3|42.1|40.7|3176|I Leukemias, myeloproliferative & myelodysplastic diseases|78174581|1999
0-19|28.9|31.3|30.1|2354|I(a) Lymphoid leukemias|78174581|1999
0-19|7.4|8.7|8.0|625|I(b) Acute myeloid leukemias|78174581|1999
0-19|0.8|1.3|1.0|80|I(c) Chronic myeloproliferative diseases|78174581|1999
0-19|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|78174581|1999
0-19|1.1|1.6|1.3|105|I(e) Unspecified and other specified leukemias|78174581|1999
0-19|22.2|24.3|23.2|1812|II Lymphomas and reticuloendothelial neoplasms|78174581|1999
0-19|11.1|12.6|11.9|924|II(a) Hodgkin lymphomas|78174581|1999
0-19|7.0|8.3|7.6|597|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|78174581|1999
0-19|2.1|2.8|2.4|188|II(c) Burkitt lymphoma|78174581|1999
0-19|0.5|0.9|0.7|54|II(d) Miscellaneous lymphoreticular neoplasms|78174581|1999
0-19|0.5|0.8|0.6|49|II(e) Unspecified lymphomas|78174581|1999
0-19|27.5|29.9|28.7|2244|III CNS and misc intracranial and intraspinal neoplasms|78174581|1999
0-19|2.3|3.0|2.6|206|III(a) Ependymomas and choroid plexus tumor|78174581|1999
0-19|12.8|14.5|13.6|1067|III(b) Astrocytomas|78174581|1999
0-19|6.1|7.2|6.6|519|III(c) Intracranial and intraspinal embryonal tumors|78174581|1999
0-19|4.2|5.2|4.7|365|III(d) Other gliomas|78174581|1999
0-19|0.4|0.7|0.5|40|III(e) Other specified intracranial & intraspinal neoplasms|78174581|1999
0-19|0.4|0.8|0.6|47|III(f) Unspecified intracranial and intraspinal neoplasms|78174581|1999
0-19|7.6|8.9|8.2|638|IV Neuroblastoma and other peripheral nervous cell tumors|78174581|1999
0-19|7.3|8.6|7.9|616|IV(a) Neuroblastoma and ganglioneuroblastoma|78174581|1999
0-19|0.2|0.4|0.3|22|IV(b) Other peripheral nervous cell tumors|78174581|1999
0-19|10.2|11.7|10.9|854|IX Soft tissue and other extraosseous sarcomas|78174581|1999
0-19|4.1|5.0|4.5|355|IX(a) Rhabdomyosarcomas|78174581|1999
0-19|0.9|1.4|1.1|88|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|78174581|1999
0-19|~|~|~|~|IX(c) Kaposi sarcoma|78174581|1999
0-19|3.6|4.5|4.0|311|IX(d) Other specified soft tissue sarcomas|78174581|1999
0-19|1.0|1.5|1.2|97|IX(e) Unspecified soft tissue sarcomas|78174581|1999
0-19|0.2|0.4|0.3|22|Not classified by ICCC|78174581|1999
0-19|2.8|3.6|3.2|246|V Retinoblastoma|78174581|1999
0-19|5.8|6.9|6.3|494|VI Renal tumors|78174581|1999
0-19|5.3|6.3|5.8|451|VI(a) Nephroblastoma and other nonepithelial renal tumors|78174581|1999
0-19|0.4|0.7|0.5|39|VI(b) Renal carcinomas|78174581|1999
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|78174581|1999
0-19|1.7|2.3|2.0|154|VII Hepatic tumors|78174581|1999
0-19|1.1|1.6|1.3|102|VII(a) Hepatoblastoma|78174581|1999
0-19|0.5|0.9|0.7|51|VII(b) Hepatic carcinomas|78174581|1999
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|78174581|1999
0-19|8.2|9.6|8.9|692|VIII Malignant bone tumors|78174581|1999
0-19|4.6|5.7|5.1|400|VIII(a) Osteosarcomas|78174581|1999
0-19|0.2|0.5|0.4|28|VIII(b) Chondrosarcomas|78174581|1999
0-19|2.4|3.1|2.7|212|VIII(c) Ewing tumor and related sarcomas of bone|78174581|1999
0-19|0.4|0.7|0.5|40|VIII(d) Other specified malignant bone tumors|78174581|1999
0-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|78174581|1999
0-19|9.4|10.9|10.1|788|X Germ cell, trophoblastic tumors & neoplasms of gonads|78174581|1999
0-19|1.1|1.7|1.4|109|X(a) Intracranial & intraspinal germ cell tumors|78174581|1999
0-19|1.1|1.7|1.4|106|X(b) Malignant extracranial & extragonadal germ cell tumors|78174581|1999
0-19|6.1|7.3|6.7|522|X(c) Malignant gonadal germ cell tumors|78174581|1999
0-19|0.3|0.6|0.4|32|X(d) Gonadal carcinomas|78174581|1999
0-19|0.1|0.4|0.2|19|X(e) Other and unspecified malignant gonadal tumors|78174581|1999
0-19|14.5|16.2|15.3|1193|XI Other malignant epithelial neoplasms and malignant melanomas|78174581|1999
0-19|0.1|0.4|0.2|18|XI(a) Adrenocortical carcinomas|78174581|1999
0-19|5.3|6.4|5.9|456|XI(b) Thyroid carcinomas|78174581|1999
0-19|0.4|0.7|0.5|41|XI(c) Nasopharyngeal carcinomas|78174581|1999
0-19|4.3|5.3|4.8|370|XI(d) Malignant melanomas|78174581|1999
0-19|~|~|~|~|XI(e) Skin carcinomas|78174581|1999
0-19|3.4|4.3|3.9|301|XI(f) Other and unspecified carcinomas|78174581|1999
0-19|0.6|1.0|0.8|64|XII Other and unspecified malignant neoplasms|78174581|1999
0-19|0.1|0.3|0.2|17|XII(a) Other specified malignant tumors|78174581|1999
0-19|0.4|0.8|0.6|47|XII(b) Other unspecified malignant tumors|78174581|1999
0-14|146.8|153.1|150.0|8814|All ICCC Groups Combined|58914904|2000
0-14|44.2|47.7|46.0|2696|I Leukemias, myeloproliferative & myelodysplastic diseases|58914904|2000
0-14|35.5|38.7|37.1|2175|I(a) Lymphoid leukemias|58914904|2000
0-14|5.9|7.3|6.6|387|I(b) Acute myeloid leukemias|58914904|2000
0-14|0.5|1.0|0.7|44|I(c) Chronic myeloproliferative diseases|58914904|2000
0-14|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|58914904|2000
0-14|1.1|1.7|1.4|81|I(e) Unspecified and other specified leukemias|58914904|2000
0-14|15.5|17.6|16.5|976|II Lymphomas and reticuloendothelial neoplasms|58914904|2000
0-14|5.2|6.5|5.8|345|II(a) Hodgkin lymphomas|58914904|2000
0-14|5.4|6.6|6.0|353|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|58914904|2000
0-14|2.4|3.3|2.8|166|II(c) Burkitt lymphoma|58914904|2000
0-14|1.0|1.6|1.3|75|II(d) Miscellaneous lymphoreticular neoplasms|58914904|2000
0-14|0.4|0.9|0.6|37|II(e) Unspecified lymphomas|58914904|2000
0-14|31.8|34.8|33.3|1957|III CNS and misc intracranial and intraspinal neoplasms|58914904|2000
0-14|2.3|3.1|2.7|157|III(a) Ependymomas and choroid plexus tumor|58914904|2000
0-14|16.1|18.3|17.2|1012|III(b) Astrocytomas|58914904|2000
0-14|6.8|8.3|7.5|443|III(c) Intracranial and intraspinal embryonal tumors|58914904|2000
0-14|4.1|5.3|4.7|275|III(d) Other gliomas|58914904|2000
0-14|0.3|0.7|0.5|28|III(e) Other specified intracranial & intraspinal neoplasms|58914904|2000
0-14|0.5|1.0|0.7|42|III(f) Unspecified intracranial and intraspinal neoplasms|58914904|2000
0-14|9.3|10.9|10.1|588|IV Neuroblastoma and other peripheral nervous cell tumors|58914904|2000
0-14|9.1|10.8|9.9|580|IV(a) Neuroblastoma and ganglioneuroblastoma|58914904|2000
0-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|58914904|2000
0-14|9.7|11.3|10.5|616|IX Soft tissue and other extraosseous sarcomas|58914904|2000
0-14|4.7|5.9|5.3|309|IX(a) Rhabdomyosarcomas|58914904|2000
0-14|0.7|1.2|1.0|56|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|58914904|2000
0-14|~|~|~|~|IX(c) Kaposi sarcoma|58914904|2000
0-14|2.8|3.7|3.2|189|IX(d) Other specified soft tissue sarcomas|58914904|2000
0-14|0.8|1.3|1.0|61|IX(e) Unspecified soft tissue sarcomas|58914904|2000
0-14|~|~|~|~|Not classified by ICCC|58914904|2000
0-14|3.9|5.0|4.4|257|V Retinoblastoma|58914904|2000
0-14|8.1|9.6|8.8|515|VI Renal tumors|58914904|2000
0-14|7.7|9.2|8.4|492|VI(a) Nephroblastoma and other nonepithelial renal tumors|58914904|2000
0-14|0.2|0.6|0.4|22|VI(b) Renal carcinomas|58914904|2000
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|58914904|2000
0-14|1.8|2.6|2.2|129|VII Hepatic tumors|58914904|2000
0-14|1.6|2.3|1.9|113|VII(a) Hepatoblastoma|58914904|2000
0-14|~|~|~|~|VII(b) Hepatic carcinomas|58914904|2000
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|58914904|2000
0-14|5.9|7.2|6.5|387|VIII Malignant bone tumors|58914904|2000
0-14|3.1|4.1|3.6|211|VIII(a) Osteosarcomas|58914904|2000
0-14|~|~|~|~|VIII(b) Chondrosarcomas|58914904|2000
0-14|2.2|3.1|2.6|156|VIII(c) Ewing tumor and related sarcomas of bone|58914904|2000
0-14|~|~|~|~|VIII(d) Other specified malignant bone tumors|58914904|2000
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|58914904|2000
0-14|4.4|5.5|4.9|291|X Germ cell, trophoblastic tumors & neoplasms of gonads|58914904|2000
0-14|1.2|1.8|1.5|87|X(a) Intracranial & intraspinal germ cell tumors|58914904|2000
0-14|0.9|1.4|1.1|66|X(b) Malignant extracranial & extragonadal germ cell tumors|58914904|2000
0-14|1.8|2.6|2.2|128|X(c) Malignant gonadal germ cell tumors|58914904|2000
0-14|~|~|~|~|X(d) Gonadal carcinomas|58914904|2000
0-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|58914904|2000
0-14|5.2|6.5|5.8|344|XI Other malignant epithelial neoplasms and malignant melanomas|58914904|2000
0-14|0.2|0.5|0.3|18|XI(a) Adrenocortical carcinomas|58914904|2000
0-14|1.6|2.3|1.9|114|XI(b) Thyroid carcinomas|58914904|2000
0-14|0.2|0.5|0.3|19|XI(c) Nasopharyngeal carcinomas|58914904|2000
0-14|1.5|2.2|1.8|105|XI(d) Malignant melanomas|58914904|2000
0-14|~|~|~|~|XI(e) Skin carcinomas|58914904|2000
0-14|1.1|1.8|1.4|85|XI(f) Other and unspecified carcinomas|58914904|2000
0-14|0.5|1.0|0.7|44|XII Other and unspecified malignant neoplasms|58914904|2000
0-14|~|~|~|~|XII(a) Other specified malignant tumors|58914904|2000
0-14|0.4|0.7|0.5|31|XII(b) Other unspecified malignant tumors|58914904|2000
0-19|161.2|166.8|164.0|12887|All ICCC Groups Combined|78714159|2000
0-19|40.0|42.8|41.4|3246|I Leukemias, myeloproliferative & myelodysplastic diseases|78714159|2000
0-19|30.6|33.1|31.8|2496|I(a) Lymphoid leukemias|78714159|2000
0-19|6.6|7.8|7.1|561|I(b) Acute myeloid leukemias|78714159|2000
0-19|0.7|1.2|0.9|72|I(c) Chronic myeloproliferative diseases|78714159|2000
0-19|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|78714159|2000
0-19|1.1|1.6|1.4|106|I(e) Unspecified and other specified leukemias|78714159|2000
0-19|23.7|25.9|24.8|1956|II Lymphomas and reticuloendothelial neoplasms|78714159|2000
0-19|11.5|13.1|12.3|970|II(a) Hodgkin lymphomas|78714159|2000
0-19|7.6|8.8|8.2|645|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|78714159|2000
0-19|2.3|3.1|2.7|211|II(c) Burkitt lymphoma|78714159|2000
0-19|0.8|1.2|1.0|78|II(d) Miscellaneous lymphoreticular neoplasms|78714159|2000
0-19|0.5|0.9|0.7|52|II(e) Unspecified lymphomas|78714159|2000
0-19|29.1|31.5|30.3|2383|III CNS and misc intracranial and intraspinal neoplasms|78714159|2000
0-19|2.0|2.7|2.3|183|III(a) Ependymomas and choroid plexus tumor|78714159|2000
0-19|15.0|16.7|15.8|1245|III(b) Astrocytomas|78714159|2000
0-19|5.9|7.0|6.4|506|III(c) Intracranial and intraspinal embryonal tumors|78714159|2000
0-19|4.1|5.1|4.6|360|III(d) Other gliomas|78714159|2000
0-19|0.3|0.6|0.5|37|III(e) Other specified intracranial & intraspinal neoplasms|78714159|2000
0-19|0.5|0.9|0.7|52|III(f) Unspecified intracranial and intraspinal neoplasms|78714159|2000
0-19|7.1|8.3|7.7|599|IV Neuroblastoma and other peripheral nervous cell tumors|78714159|2000
0-19|6.9|8.2|7.5|588|IV(a) Neuroblastoma and ganglioneuroblastoma|78714159|2000
0-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|78714159|2000
0-19|11.2|12.7|12.0|941|IX Soft tissue and other extraosseous sarcomas|78714159|2000
0-19|4.4|5.4|4.9|383|IX(a) Rhabdomyosarcomas|78714159|2000
0-19|1.0|1.5|1.2|94|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|78714159|2000
0-19|~|~|~|~|IX(c) Kaposi sarcoma|78714159|2000
0-19|4.0|5.0|4.5|355|IX(d) Other specified soft tissue sarcomas|78714159|2000
0-19|1.1|1.6|1.3|105|IX(e) Unspecified soft tissue sarcomas|78714159|2000
0-19|0.1|0.3|0.2|17|Not classified by ICCC|78714159|2000
0-19|2.9|3.7|3.3|258|V Retinoblastoma|78714159|2000
0-19|6.3|7.5|6.9|538|VI Renal tumors|78714159|2000
0-19|5.8|7.0|6.4|499|VI(a) Nephroblastoma and other nonepithelial renal tumors|78714159|2000
0-19|0.3|0.6|0.5|37|VI(b) Renal carcinomas|78714159|2000
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|78714159|2000
0-19|1.6|2.2|1.8|144|VII Hepatic tumors|78714159|2000
0-19|1.2|1.7|1.4|113|VII(a) Hepatoblastoma|78714159|2000
0-19|0.2|0.5|0.4|29|VII(b) Hepatic carcinomas|78714159|2000
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|78714159|2000
0-19|7.7|9.0|8.4|661|VIII Malignant bone tumors|78714159|2000
0-19|4.2|5.2|4.7|371|VIII(a) Osteosarcomas|78714159|2000
0-19|~|~|~|~|VIII(b) Chondrosarcomas|78714159|2000
0-19|2.7|3.5|3.1|241|VIII(c) Ewing tumor and related sarcomas of bone|78714159|2000
0-19|0.1|0.4|0.2|19|VIII(d) Other specified malignant bone tumors|78714159|2000
0-19|0.1|0.3|0.2|16|VIII(e) Unspecified malignant bone tumors|78714159|2000
0-19|10.0|11.5|10.7|845|X Germ cell, trophoblastic tumors & neoplasms of gonads|78714159|2000
0-19|1.4|2.0|1.7|131|X(a) Intracranial & intraspinal germ cell tumors|78714159|2000
0-19|1.1|1.7|1.4|109|X(b) Malignant extracranial & extragonadal germ cell tumors|78714159|2000
0-19|6.4|7.6|7.0|553|X(c) Malignant gonadal germ cell tumors|78714159|2000
0-19|0.3|0.6|0.4|34|X(d) Gonadal carcinomas|78714159|2000
0-19|0.1|0.4|0.2|18|X(e) Other and unspecified malignant gonadal tumors|78714159|2000
0-19|14.8|16.5|15.6|1233|XI Other malignant epithelial neoplasms and malignant melanomas|78714159|2000
0-19|0.2|0.5|0.3|25|XI(a) Adrenocortical carcinomas|78714159|2000
0-19|5.1|6.2|5.7|446|XI(b) Thyroid carcinomas|78714159|2000
0-19|0.4|0.7|0.5|40|XI(c) Nasopharyngeal carcinomas|78714159|2000
0-19|4.7|5.8|5.2|412|XI(d) Malignant melanomas|78714159|2000
0-19|~|~|~|~|XI(e) Skin carcinomas|78714159|2000
0-19|3.4|4.3|3.9|304|XI(f) Other and unspecified carcinomas|78714159|2000
0-19|0.6|1.1|0.8|66|XII Other and unspecified malignant neoplasms|78714159|2000
0-19|~|~|~|~|XII(a) Other specified malignant tumors|78714159|2000
0-19|0.5|0.9|0.6|51|XII(b) Other unspecified malignant tumors|78714159|2000
0-14|153.0|159.3|156.1|9331|All ICCC Groups Combined|59815030|2001
0-14|48.7|52.3|50.5|3003|I Leukemias, myeloproliferative & myelodysplastic diseases|59815030|2001
0-14|37.1|40.3|38.7|2295|I(a) Lymphoid leukemias|59815030|2001
0-14|6.6|8.0|7.3|437|I(b) Acute myeloid leukemias|59815030|2001
0-14|1.3|2.0|1.7|100|I(c) Chronic myeloproliferative diseases|59815030|2001
0-14|1.3|2.0|1.6|96|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|59815030|2001
0-14|1.0|1.6|1.3|75|I(e) Unspecified and other specified leukemias|59815030|2001
0-14|15.0|17.1|16.0|965|II Lymphomas and reticuloendothelial neoplasms|59815030|2001
0-14|5.3|6.6|5.9|357|II(a) Hodgkin lymphomas|59815030|2001
0-14|5.8|7.1|6.4|387|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|59815030|2001
0-14|1.9|2.7|2.3|135|II(c) Burkitt lymphoma|59815030|2001
0-14|0.8|1.3|1.0|62|II(d) Miscellaneous lymphoreticular neoplasms|59815030|2001
0-14|0.3|0.6|0.4|24|II(e) Unspecified lymphomas|59815030|2001
0-14|31.4|34.3|32.8|1959|III CNS and misc intracranial and intraspinal neoplasms|59815030|2001
0-14|2.4|3.2|2.8|166|III(a) Ependymomas and choroid plexus tumor|59815030|2001
0-14|15.3|17.4|16.3|975|III(b) Astrocytomas|59815030|2001
0-14|6.6|8.0|7.3|435|III(c) Intracranial and intraspinal embryonal tumors|59815030|2001
0-14|4.8|6.0|5.4|320|III(d) Other gliomas|59815030|2001
0-14|0.5|0.9|0.7|42|III(e) Other specified intracranial & intraspinal neoplasms|59815030|2001
0-14|0.2|0.5|0.3|21|III(f) Unspecified intracranial and intraspinal neoplasms|59815030|2001
0-14|10.7|12.5|11.6|693|IV Neuroblastoma and other peripheral nervous cell tumors|59815030|2001
0-14|10.6|12.3|11.4|685|IV(a) Neuroblastoma and ganglioneuroblastoma|59815030|2001
0-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|59815030|2001
0-14|9.7|11.3|10.5|629|IX Soft tissue and other extraosseous sarcomas|59815030|2001
0-14|4.6|5.8|5.2|308|IX(a) Rhabdomyosarcomas|59815030|2001
0-14|1.0|1.6|1.3|76|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|59815030|2001
0-14|~|~|~|~|IX(c) Kaposi sarcoma|59815030|2001
0-14|2.6|3.5|3.1|185|IX(d) Other specified soft tissue sarcomas|59815030|2001
0-14|0.8|1.3|1.0|60|IX(e) Unspecified soft tissue sarcomas|59815030|2001
0-14|~|~|~|~|Not classified by ICCC|59815030|2001
0-14|3.9|5.0|4.4|266|V Retinoblastoma|59815030|2001
0-14|7.9|9.4|8.6|510|VI Renal tumors|59815030|2001
0-14|7.5|9.0|8.2|488|VI(a) Nephroblastoma and other nonepithelial renal tumors|59815030|2001
0-14|0.2|0.5|0.3|20|VI(b) Renal carcinomas|59815030|2001
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|59815030|2001
0-14|1.8|2.5|2.1|126|VII Hepatic tumors|59815030|2001
0-14|1.4|2.0|1.7|100|VII(a) Hepatoblastoma|59815030|2001
0-14|0.3|0.6|0.4|25|VII(b) Hepatic carcinomas|59815030|2001
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|59815030|2001
0-14|6.3|7.7|7.0|421|VIII Malignant bone tumors|59815030|2001
0-14|3.3|4.3|3.8|231|VIII(a) Osteosarcomas|59815030|2001
0-14|~|~|~|~|VIII(b) Chondrosarcomas|59815030|2001
0-14|2.2|3.1|2.6|159|VIII(c) Ewing tumor and related sarcomas of bone|59815030|2001
0-14|~|~|~|~|VIII(d) Other specified malignant bone tumors|59815030|2001
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|59815030|2001
0-14|4.5|5.6|5.0|303|X Germ cell, trophoblastic tumors & neoplasms of gonads|59815030|2001
0-14|1.0|1.6|1.3|79|X(a) Intracranial & intraspinal germ cell tumors|59815030|2001
0-14|1.1|1.7|1.4|84|X(b) Malignant extracranial & extragonadal germ cell tumors|59815030|2001
0-14|1.7|2.4|2.0|121|X(c) Malignant gonadal germ cell tumors|59815030|2001
0-14|~|~|~|~|X(d) Gonadal carcinomas|59815030|2001
0-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|59815030|2001
0-14|6.0|7.3|6.6|400|XI Other malignant epithelial neoplasms and malignant melanomas|59815030|2001
0-14|0.2|0.5|0.3|17|XI(a) Adrenocortical carcinomas|59815030|2001
0-14|1.9|2.7|2.3|140|XI(b) Thyroid carcinomas|59815030|2001
0-14|0.2|0.5|0.3|19|XI(c) Nasopharyngeal carcinomas|59815030|2001
0-14|1.7|2.4|2.0|121|XI(d) Malignant melanomas|59815030|2001
0-14|~|~|~|~|XI(e) Skin carcinomas|59815030|2001
0-14|1.3|2.0|1.7|100|XI(f) Other and unspecified carcinomas|59815030|2001
0-14|0.5|1.0|0.7|43|XII Other and unspecified malignant neoplasms|59815030|2001
0-14|0.2|0.6|0.4|22|XII(a) Other specified malignant tumors|59815030|2001
0-14|0.2|0.5|0.4|21|XII(b) Other unspecified malignant tumors|59815030|2001
0-19|167.6|173.3|170.4|13641|All ICCC Groups Combined|80042731|2001
0-19|44.2|47.2|45.7|3635|I Leukemias, myeloproliferative & myelodysplastic diseases|80042731|2001
0-19|31.6|34.2|32.9|2611|I(a) Lymphoid leukemias|80042731|2001
0-19|7.1|8.4|7.7|620|I(b) Acute myeloid leukemias|80042731|2001
0-19|1.9|2.6|2.3|182|I(c) Chronic myeloproliferative diseases|80042731|2001
0-19|1.2|1.8|1.5|118|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|80042731|2001
0-19|1.1|1.6|1.3|104|I(e) Unspecified and other specified leukemias|80042731|2001
0-19|23.6|25.7|24.6|1980|II Lymphomas and reticuloendothelial neoplasms|80042731|2001
0-19|11.7|13.3|12.5|1007|II(a) Hodgkin lymphomas|80042731|2001
0-19|8.0|9.3|8.6|694|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|80042731|2001
0-19|1.9|2.5|2.2|174|II(c) Burkitt lymphoma|80042731|2001
0-19|0.6|1.0|0.8|66|II(d) Miscellaneous lymphoreticular neoplasms|80042731|2001
0-19|0.3|0.7|0.5|39|II(e) Unspecified lymphomas|80042731|2001
0-19|28.8|31.2|30.0|2397|III CNS and misc intracranial and intraspinal neoplasms|80042731|2001
0-19|2.1|2.8|2.5|196|III(a) Ependymomas and choroid plexus tumor|80042731|2001
0-19|14.2|15.9|15.1|1203|III(b) Astrocytomas|80042731|2001
0-19|6.0|7.1|6.5|518|III(c) Intracranial and intraspinal embryonal tumors|80042731|2001
0-19|4.5|5.5|5.0|402|III(d) Other gliomas|80042731|2001
0-19|0.5|0.8|0.6|49|III(e) Other specified intracranial & intraspinal neoplasms|80042731|2001
0-19|0.2|0.5|0.4|29|III(f) Unspecified intracranial and intraspinal neoplasms|80042731|2001
0-19|8.2|9.5|8.9|708|IV Neuroblastoma and other peripheral nervous cell tumors|80042731|2001
0-19|8.0|9.3|8.7|693|IV(a) Neuroblastoma and ganglioneuroblastoma|80042731|2001
0-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|80042731|2001
0-19|11.2|12.7|11.9|956|IX Soft tissue and other extraosseous sarcomas|80042731|2001
0-19|4.6|5.6|5.0|401|IX(a) Rhabdomyosarcomas|80042731|2001
0-19|1.2|1.7|1.4|116|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|80042731|2001
0-19|~|~|~|~|IX(c) Kaposi sarcoma|80042731|2001
0-19|3.7|4.6|4.1|333|IX(d) Other specified soft tissue sarcomas|80042731|2001
0-19|1.0|1.5|1.3|103|IX(e) Unspecified soft tissue sarcomas|80042731|2001
0-19|0.2|0.4|0.2|20|Not classified by ICCC|80042731|2001
0-19|2.9|3.7|3.3|266|V Retinoblastoma|80042731|2001
0-19|6.2|7.4|6.8|539|VI Renal tumors|80042731|2001
0-19|5.7|6.8|6.2|493|VI(a) Nephroblastoma and other nonepithelial renal tumors|80042731|2001
0-19|0.4|0.7|0.5|43|VI(b) Renal carcinomas|80042731|2001
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|80042731|2001
0-19|1.5|2.1|1.8|145|VII Hepatic tumors|80042731|2001
0-19|1.0|1.5|1.3|101|VII(a) Hepatoblastoma|80042731|2001
0-19|0.4|0.7|0.5|43|VII(b) Hepatic carcinomas|80042731|2001
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|80042731|2001
0-19|8.8|10.2|9.5|766|VIII Malignant bone tumors|80042731|2001
0-19|4.7|5.7|5.2|418|VIII(a) Osteosarcomas|80042731|2001
0-19|0.2|0.5|0.4|29|VIII(b) Chondrosarcomas|80042731|2001
0-19|3.0|3.8|3.4|272|VIII(c) Ewing tumor and related sarcomas of bone|80042731|2001
0-19|0.3|0.6|0.4|36|VIII(d) Other specified malignant bone tumors|80042731|2001
0-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|80042731|2001
0-19|9.7|11.1|10.4|835|X Germ cell, trophoblastic tumors & neoplasms of gonads|80042731|2001
0-19|1.3|1.9|1.6|128|X(a) Intracranial & intraspinal germ cell tumors|80042731|2001
0-19|1.3|1.9|1.6|128|X(b) Malignant extracranial & extragonadal germ cell tumors|80042731|2001
0-19|6.0|7.1|6.6|528|X(c) Malignant gonadal germ cell tumors|80042731|2001
0-19|0.2|0.5|0.3|27|X(d) Gonadal carcinomas|80042731|2001
0-19|0.2|0.4|0.3|24|X(e) Other and unspecified malignant gonadal tumors|80042731|2001
0-19|15.6|17.3|16.4|1323|XI Other malignant epithelial neoplasms and malignant melanomas|80042731|2001
0-19|0.1|0.4|0.2|18|XI(a) Adrenocortical carcinomas|80042731|2001
0-19|5.3|6.3|5.8|466|XI(b) Thyroid carcinomas|80042731|2001
0-19|0.4|0.7|0.5|43|XI(c) Nasopharyngeal carcinomas|80042731|2001
0-19|5.3|6.3|5.8|466|XI(d) Malignant melanomas|80042731|2001
0-19|~|~|~|~|XI(e) Skin carcinomas|80042731|2001
0-19|3.6|4.5|4.0|325|XI(f) Other and unspecified carcinomas|80042731|2001
0-19|0.7|1.1|0.9|71|XII Other and unspecified malignant neoplasms|80042731|2001
0-19|0.3|0.5|0.4|30|XII(a) Other specified malignant tumors|80042731|2001
0-19|0.4|0.7|0.5|41|XII(b) Other unspecified malignant tumors|80042731|2001
0-14|152.1|158.4|155.2|9300|All ICCC Groups Combined|59931314|2002
0-14|47.7|51.3|49.5|2952|I Leukemias, myeloproliferative & myelodysplastic diseases|59931314|2002
0-14|35.5|38.6|37.1|2206|I(a) Lymphoid leukemias|59931314|2002
0-14|7.2|8.6|7.9|475|I(b) Acute myeloid leukemias|59931314|2002
0-14|1.3|1.9|1.6|96|I(c) Chronic myeloproliferative diseases|59931314|2002
0-14|1.3|1.9|1.6|95|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|59931314|2002
0-14|1.1|1.7|1.3|80|I(e) Unspecified and other specified leukemias|59931314|2002
0-14|14.7|16.7|15.7|947|II Lymphomas and reticuloendothelial neoplasms|59931314|2002
0-14|4.9|6.1|5.5|336|II(a) Hodgkin lymphomas|59931314|2002
0-14|5.5|6.7|6.1|366|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|59931314|2002
0-14|2.3|3.2|2.7|164|II(c) Burkitt lymphoma|59931314|2002
0-14|0.9|1.5|1.1|69|II(d) Miscellaneous lymphoreticular neoplasms|59931314|2002
0-14|~|~|~|~|II(e) Unspecified lymphomas|59931314|2002
0-14|33.1|36.1|34.6|2065|III CNS and misc intracranial and intraspinal neoplasms|59931314|2002
0-14|3.1|4.1|3.6|215|III(a) Ependymomas and choroid plexus tumor|59931314|2002
0-14|15.5|17.5|16.5|984|III(b) Astrocytomas|59931314|2002
0-14|6.8|8.2|7.4|443|III(c) Intracranial and intraspinal embryonal tumors|59931314|2002
0-14|5.4|6.6|6.0|355|III(d) Other gliomas|59931314|2002
0-14|0.5|1.0|0.7|43|III(e) Other specified intracranial & intraspinal neoplasms|59931314|2002
0-14|0.3|0.6|0.4|25|III(f) Unspecified intracranial and intraspinal neoplasms|59931314|2002
0-14|10.2|11.9|11.1|662|IV Neuroblastoma and other peripheral nervous cell tumors|59931314|2002
0-14|10.1|11.8|10.9|654|IV(a) Neuroblastoma and ganglioneuroblastoma|59931314|2002
0-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|59931314|2002
0-14|10.0|11.7|10.8|650|IX Soft tissue and other extraosseous sarcomas|59931314|2002
0-14|4.8|6.0|5.3|319|IX(a) Rhabdomyosarcomas|59931314|2002
0-14|0.9|1.4|1.1|69|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|59931314|2002
0-14|~|~|~|~|IX(c) Kaposi sarcoma|59931314|2002
0-14|3.0|3.9|3.4|208|IX(d) Other specified soft tissue sarcomas|59931314|2002
0-14|0.7|1.2|0.9|54|IX(e) Unspecified soft tissue sarcomas|59931314|2002
0-14|0.2|0.5|0.4|21|Not classified by ICCC|59931314|2002
0-14|3.3|4.3|3.8|225|V Retinoblastoma|59931314|2002
0-14|7.6|9.1|8.3|493|VI Renal tumors|59931314|2002
0-14|7.3|8.8|8.1|479|VI(a) Nephroblastoma and other nonepithelial renal tumors|59931314|2002
0-14|~|~|~|~|VI(b) Renal carcinomas|59931314|2002
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|59931314|2002
0-14|1.6|2.3|1.9|114|VII Hepatic tumors|59931314|2002
0-14|1.2|1.9|1.5|92|VII(a) Hepatoblastoma|59931314|2002
0-14|0.2|0.5|0.3|21|VII(b) Hepatic carcinomas|59931314|2002
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|59931314|2002
0-14|6.2|7.5|6.8|415|VIII Malignant bone tumors|59931314|2002
0-14|3.2|4.2|3.6|222|VIII(a) Osteosarcomas|59931314|2002
0-14|~|~|~|~|VIII(b) Chondrosarcomas|59931314|2002
0-14|2.2|3.0|2.6|157|VIII(c) Ewing tumor and related sarcomas of bone|59931314|2002
0-14|0.2|0.5|0.3|21|VIII(d) Other specified malignant bone tumors|59931314|2002
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|59931314|2002
0-14|4.7|5.9|5.2|318|X Germ cell, trophoblastic tumors & neoplasms of gonads|59931314|2002
0-14|1.1|1.7|1.4|85|X(a) Intracranial & intraspinal germ cell tumors|59931314|2002
0-14|1.2|1.8|1.5|88|X(b) Malignant extracranial & extragonadal germ cell tumors|59931314|2002
0-14|1.9|2.6|2.2|134|X(c) Malignant gonadal germ cell tumors|59931314|2002
0-14|~|~|~|~|X(d) Gonadal carcinomas|59931314|2002
0-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|59931314|2002
0-14|6.0|7.3|6.6|401|XI Other malignant epithelial neoplasms and malignant melanomas|59931314|2002
0-14|~|~|~|~|XI(a) Adrenocortical carcinomas|59931314|2002
0-14|1.7|2.4|2.0|123|XI(b) Thyroid carcinomas|59931314|2002
0-14|~|~|~|~|XI(c) Nasopharyngeal carcinomas|59931314|2002
0-14|2.0|2.7|2.3|141|XI(d) Malignant melanomas|59931314|2002
0-14|~|~|~|~|XI(e) Skin carcinomas|59931314|2002
0-14|1.4|2.0|1.7|103|XI(f) Other and unspecified carcinomas|59931314|2002
0-14|0.4|0.8|0.6|37|XII Other and unspecified malignant neoplasms|59931314|2002
0-14|0.2|0.6|0.4|22|XII(a) Other specified malignant tumors|59931314|2002
0-14|~|~|~|~|XII(b) Other unspecified malignant tumors|59931314|2002
0-19|168.0|173.7|170.8|13730|All ICCC Groups Combined|80317363|2002
0-19|43.3|46.3|44.8|3582|I Leukemias, myeloproliferative & myelodysplastic diseases|80317363|2002
0-19|30.6|33.1|31.9|2540|I(a) Lymphoid leukemias|80317363|2002
0-19|7.5|8.8|8.1|655|I(b) Acute myeloid leukemias|80317363|2002
0-19|1.8|2.4|2.1|169|I(c) Chronic myeloproliferative diseases|80317363|2002
0-19|1.2|1.8|1.5|120|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|80317363|2002
0-19|1.0|1.5|1.2|98|I(e) Unspecified and other specified leukemias|80317363|2002
0-19|23.5|25.7|24.6|1989|II Lymphomas and reticuloendothelial neoplasms|80317363|2002
0-19|11.6|13.2|12.4|1005|II(a) Hodgkin lymphomas|80317363|2002
0-19|7.6|8.9|8.2|665|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|80317363|2002
0-19|2.4|3.1|2.7|220|II(c) Burkitt lymphoma|80317363|2002
0-19|0.7|1.1|0.9|71|II(d) Miscellaneous lymphoreticular neoplasms|80317363|2002
0-19|0.2|0.5|0.3|28|II(e) Unspecified lymphomas|80317363|2002
0-19|30.2|32.7|31.4|2516|III CNS and misc intracranial and intraspinal neoplasms|80317363|2002
0-19|2.6|3.3|2.9|236|III(a) Ependymomas and choroid plexus tumor|80317363|2002
0-19|14.6|16.3|15.4|1235|III(b) Astrocytomas|80317363|2002
0-19|5.8|6.9|6.4|508|III(c) Intracranial and intraspinal embryonal tumors|80317363|2002
0-19|5.1|6.1|5.6|444|III(d) Other gliomas|80317363|2002
0-19|0.6|0.9|0.7|59|III(e) Other specified intracranial & intraspinal neoplasms|80317363|2002
0-19|0.3|0.6|0.4|34|III(f) Unspecified intracranial and intraspinal neoplasms|80317363|2002
0-19|7.8|9.1|8.5|678|IV Neuroblastoma and other peripheral nervous cell tumors|80317363|2002
0-19|7.6|8.9|8.2|659|IV(a) Neuroblastoma and ganglioneuroblastoma|80317363|2002
0-19|0.1|0.4|0.2|19|IV(b) Other peripheral nervous cell tumors|80317363|2002
0-19|11.0|12.6|11.8|948|IX Soft tissue and other extraosseous sarcomas|80317363|2002
0-19|4.4|5.4|4.9|390|IX(a) Rhabdomyosarcomas|80317363|2002
0-19|0.9|1.4|1.2|94|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|80317363|2002
0-19|~|~|~|~|IX(c) Kaposi sarcoma|80317363|2002
0-19|4.3|5.3|4.8|386|IX(d) Other specified soft tissue sarcomas|80317363|2002
0-19|0.8|1.2|1.0|78|IX(e) Unspecified soft tissue sarcomas|80317363|2002
0-19|0.2|0.5|0.3|26|Not classified by ICCC|80317363|2002
0-19|2.5|3.2|2.8|225|V Retinoblastoma|80317363|2002
0-19|6.0|7.1|6.5|520|VI Renal tumors|80317363|2002
0-19|5.5|6.6|6.1|482|VI(a) Nephroblastoma and other nonepithelial renal tumors|80317363|2002
0-19|0.3|0.6|0.5|37|VI(b) Renal carcinomas|80317363|2002
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|80317363|2002
0-19|1.4|2.0|1.7|136|VII Hepatic tumors|80317363|2002
0-19|0.9|1.4|1.2|93|VII(a) Hepatoblastoma|80317363|2002
0-19|0.4|0.7|0.5|42|VII(b) Hepatic carcinomas|80317363|2002
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|80317363|2002
0-19|8.5|9.8|9.1|740|VIII Malignant bone tumors|80317363|2002
0-19|4.4|5.4|4.9|398|VIII(a) Osteosarcomas|80317363|2002
0-19|0.3|0.6|0.5|38|VIII(b) Chondrosarcomas|80317363|2002
0-19|2.7|3.5|3.1|250|VIII(c) Ewing tumor and related sarcomas of bone|80317363|2002
0-19|0.4|0.7|0.5|42|VIII(d) Other specified malignant bone tumors|80317363|2002
0-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|80317363|2002
0-19|10.3|11.8|11.0|892|X Germ cell, trophoblastic tumors & neoplasms of gonads|80317363|2002
0-19|1.4|1.9|1.6|132|X(a) Intracranial & intraspinal germ cell tumors|80317363|2002
0-19|1.3|1.8|1.5|125|X(b) Malignant extracranial & extragonadal germ cell tumors|80317363|2002
0-19|6.6|7.8|7.2|582|X(c) Malignant gonadal germ cell tumors|80317363|2002
0-19|0.2|0.5|0.4|29|X(d) Gonadal carcinomas|80317363|2002
0-19|0.2|0.4|0.3|24|X(e) Other and unspecified malignant gonadal tumors|80317363|2002
0-19|16.4|18.2|17.3|1404|XI Other malignant epithelial neoplasms and malignant melanomas|80317363|2002
0-19|0.1|0.4|0.2|19|XI(a) Adrenocortical carcinomas|80317363|2002
0-19|5.3|6.4|5.8|472|XI(b) Thyroid carcinomas|80317363|2002
0-19|0.4|0.8|0.6|49|XI(c) Nasopharyngeal carcinomas|80317363|2002
0-19|6.0|7.1|6.5|528|XI(d) Malignant melanomas|80317363|2002
0-19|~|~|~|~|XI(e) Skin carcinomas|80317363|2002
0-19|3.6|4.5|4.0|328|XI(f) Other and unspecified carcinomas|80317363|2002
0-19|0.7|1.2|0.9|74|XII Other and unspecified malignant neoplasms|80317363|2002
0-19|0.3|0.6|0.5|38|XII(a) Other specified malignant tumors|80317363|2002
0-19|0.3|0.6|0.4|36|XII(b) Other unspecified malignant tumors|80317363|2002
0-14|149.2|155.4|152.3|9251|All ICCC Groups Combined|60628650|2003
0-14|46.0|49.5|47.7|2884|I Leukemias, myeloproliferative & myelodysplastic diseases|60628650|2003
0-14|34.5|37.5|36.0|2168|I(a) Lymphoid leukemias|60628650|2003
0-14|6.8|8.2|7.5|457|I(b) Acute myeloid leukemias|60628650|2003
0-14|1.2|1.8|1.5|90|I(c) Chronic myeloproliferative diseases|60628650|2003
0-14|1.5|2.2|1.8|111|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60628650|2003
0-14|0.7|1.2|1.0|58|I(e) Unspecified and other specified leukemias|60628650|2003
0-14|15.2|17.2|16.2|986|II Lymphomas and reticuloendothelial neoplasms|60628650|2003
0-14|5.3|6.5|5.9|362|II(a) Hodgkin lymphomas|60628650|2003
0-14|5.7|7.0|6.3|385|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60628650|2003
0-14|2.3|3.2|2.7|163|II(c) Burkitt lymphoma|60628650|2003
0-14|0.9|1.5|1.2|70|II(d) Miscellaneous lymphoreticular neoplasms|60628650|2003
0-14|~|~|~|~|II(e) Unspecified lymphomas|60628650|2003
0-14|31.5|34.4|32.9|1990|III CNS and misc intracranial and intraspinal neoplasms|60628650|2003
0-14|2.1|2.9|2.5|151|III(a) Ependymomas and choroid plexus tumor|60628650|2003
0-14|15.4|17.5|16.4|993|III(b) Astrocytomas|60628650|2003
0-14|6.5|7.9|7.2|434|III(c) Intracranial and intraspinal embryonal tumors|60628650|2003
0-14|5.0|6.2|5.6|339|III(d) Other gliomas|60628650|2003
0-14|0.6|1.1|0.9|52|III(e) Other specified intracranial & intraspinal neoplasms|60628650|2003
0-14|0.2|0.5|0.3|21|III(f) Unspecified intracranial and intraspinal neoplasms|60628650|2003
0-14|9.9|11.6|10.7|652|IV Neuroblastoma and other peripheral nervous cell tumors|60628650|2003
0-14|9.7|11.4|10.5|642|IV(a) Neuroblastoma and ganglioneuroblastoma|60628650|2003
0-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|60628650|2003
0-14|9.9|11.5|10.7|650|IX Soft tissue and other extraosseous sarcomas|60628650|2003
0-14|4.5|5.7|5.1|306|IX(a) Rhabdomyosarcomas|60628650|2003
0-14|0.8|1.3|1.1|64|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60628650|2003
0-14|~|~|~|~|IX(c) Kaposi sarcoma|60628650|2003
0-14|3.1|4.1|3.6|220|IX(d) Other specified soft tissue sarcomas|60628650|2003
0-14|0.7|1.2|0.9|58|IX(e) Unspecified soft tissue sarcomas|60628650|2003
0-14|~|~|~|~|Not classified by ICCC|60628650|2003
0-14|3.6|4.6|4.1|250|V Retinoblastoma|60628650|2003
0-14|7.8|9.3|8.6|517|VI Renal tumors|60628650|2003
0-14|7.4|8.9|8.2|492|VI(a) Nephroblastoma and other nonepithelial renal tumors|60628650|2003
0-14|0.2|0.5|0.3|21|VI(b) Renal carcinomas|60628650|2003
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|60628650|2003
0-14|2.1|2.9|2.5|152|VII Hepatic tumors|60628650|2003
0-14|1.7|2.4|2.0|124|VII(a) Hepatoblastoma|60628650|2003
0-14|0.3|0.7|0.5|28|VII(b) Hepatic carcinomas|60628650|2003
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60628650|2003
0-14|6.0|7.3|6.6|408|VIII Malignant bone tumors|60628650|2003
0-14|3.2|4.2|3.7|227|VIII(a) Osteosarcomas|60628650|2003
0-14|~|~|~|~|VIII(b) Chondrosarcomas|60628650|2003
0-14|1.9|2.6|2.2|137|VIII(c) Ewing tumor and related sarcomas of bone|60628650|2003
0-14|0.2|0.4|0.3|17|VIII(d) Other specified malignant bone tumors|60628650|2003
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|60628650|2003
0-14|4.5|5.7|5.1|312|X Germ cell, trophoblastic tumors & neoplasms of gonads|60628650|2003
0-14|0.9|1.5|1.2|72|X(a) Intracranial & intraspinal germ cell tumors|60628650|2003
0-14|1.2|1.8|1.4|88|X(b) Malignant extracranial & extragonadal germ cell tumors|60628650|2003
0-14|1.8|2.6|2.2|136|X(c) Malignant gonadal germ cell tumors|60628650|2003
0-14|~|~|~|~|X(d) Gonadal carcinomas|60628650|2003
0-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60628650|2003
0-14|5.7|6.9|6.3|390|XI Other malignant epithelial neoplasms and malignant melanomas|60628650|2003
0-14|~|~|~|~|XI(a) Adrenocortical carcinomas|60628650|2003
0-14|1.8|2.6|2.2|134|XI(b) Thyroid carcinomas|60628650|2003
0-14|~|~|~|~|XI(c) Nasopharyngeal carcinomas|60628650|2003
0-14|1.6|2.3|1.9|119|XI(d) Malignant melanomas|60628650|2003
0-14|~|~|~|~|XI(e) Skin carcinomas|60628650|2003
0-14|1.5|2.1|1.8|110|XI(f) Other and unspecified carcinomas|60628650|2003
0-14|0.6|1.0|0.8|47|XII Other and unspecified malignant neoplasms|60628650|2003
0-14|0.2|0.5|0.3|20|XII(a) Other specified malignant tumors|60628650|2003
0-14|0.3|0.6|0.4|27|XII(b) Other unspecified malignant tumors|60628650|2003
0-19|165.0|170.6|167.8|13701|All ICCC Groups Combined|81425816|2003
0-19|42.0|44.9|43.5|3525|I Leukemias, myeloproliferative & myelodysplastic diseases|81425816|2003
0-19|29.5|31.9|30.7|2478|I(a) Lymphoid leukemias|81425816|2003
0-19|7.2|8.4|7.8|639|I(b) Acute myeloid leukemias|81425816|2003
0-19|2.0|2.6|2.3|188|I(c) Chronic myeloproliferative diseases|81425816|2003
0-19|1.4|2.0|1.7|137|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|81425816|2003
0-19|0.8|1.3|1.0|83|I(e) Unspecified and other specified leukemias|81425816|2003
0-19|23.2|25.3|24.2|1988|II Lymphomas and reticuloendothelial neoplasms|81425816|2003
0-19|11.7|13.2|12.4|1026|II(a) Hodgkin lymphomas|81425816|2003
0-19|7.5|8.7|8.1|661|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|81425816|2003
0-19|2.3|3.0|2.6|212|II(c) Burkitt lymphoma|81425816|2003
0-19|0.7|1.1|0.9|73|II(d) Miscellaneous lymphoreticular neoplasms|81425816|2003
0-19|0.1|0.3|0.2|16|II(e) Unspecified lymphomas|81425816|2003
0-19|29.0|31.4|30.2|2448|III CNS and misc intracranial and intraspinal neoplasms|81425816|2003
0-19|2.0|2.7|2.3|188|III(a) Ependymomas and choroid plexus tumor|81425816|2003
0-19|14.5|16.2|15.3|1246|III(b) Astrocytomas|81425816|2003
0-19|5.6|6.7|6.1|493|III(c) Intracranial and intraspinal embryonal tumors|81425816|2003
0-19|4.7|5.7|5.2|423|III(d) Other gliomas|81425816|2003
0-19|0.7|1.1|0.8|68|III(e) Other specified intracranial & intraspinal neoplasms|81425816|2003
0-19|0.2|0.5|0.4|30|III(f) Unspecified intracranial and intraspinal neoplasms|81425816|2003
0-19|7.6|8.9|8.2|668|IV Neuroblastoma and other peripheral nervous cell tumors|81425816|2003
0-19|7.4|8.7|8.0|653|IV(a) Neuroblastoma and ganglioneuroblastoma|81425816|2003
0-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|81425816|2003
0-19|11.5|13.0|12.2|1000|IX Soft tissue and other extraosseous sarcomas|81425816|2003
0-19|4.3|5.3|4.8|389|IX(a) Rhabdomyosarcomas|81425816|2003
0-19|1.2|1.8|1.5|120|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|81425816|2003
0-19|~|~|~|~|IX(c) Kaposi sarcoma|81425816|2003
0-19|4.2|5.2|4.7|386|IX(d) Other specified soft tissue sarcomas|81425816|2003
0-19|1.0|1.5|1.2|102|IX(e) Unspecified soft tissue sarcomas|81425816|2003
0-19|0.1|0.4|0.2|19|Not classified by ICCC|81425816|2003
0-19|2.7|3.5|3.1|251|V Retinoblastoma|81425816|2003
0-19|6.2|7.3|6.7|544|VI Renal tumors|81425816|2003
0-19|5.6|6.7|6.1|495|VI(a) Nephroblastoma and other nonepithelial renal tumors|81425816|2003
0-19|0.4|0.7|0.5|45|VI(b) Renal carcinomas|81425816|2003
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|81425816|2003
0-19|1.8|2.5|2.1|174|VII Hepatic tumors|81425816|2003
0-19|1.3|1.8|1.5|124|VII(a) Hepatoblastoma|81425816|2003
0-19|0.5|0.8|0.6|50|VII(b) Hepatic carcinomas|81425816|2003
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|81425816|2003
0-19|8.0|9.3|8.7|714|VIII Malignant bone tumors|81425816|2003
0-19|4.8|5.8|5.3|436|VIII(a) Osteosarcomas|81425816|2003
0-19|0.2|0.4|0.3|21|VIII(b) Chondrosarcomas|81425816|2003
0-19|2.2|2.9|2.6|212|VIII(c) Ewing tumor and related sarcomas of bone|81425816|2003
0-19|0.2|0.5|0.3|28|VIII(d) Other specified malignant bone tumors|81425816|2003
0-19|0.1|0.3|0.2|17|VIII(e) Unspecified malignant bone tumors|81425816|2003
0-19|9.6|11.0|10.3|848|X Germ cell, trophoblastic tumors & neoplasms of gonads|81425816|2003
0-19|1.1|1.6|1.4|112|X(a) Intracranial & intraspinal germ cell tumors|81425816|2003
0-19|1.2|1.8|1.5|121|X(b) Malignant extracranial & extragonadal germ cell tumors|81425816|2003
0-19|6.2|7.3|6.7|554|X(c) Malignant gonadal germ cell tumors|81425816|2003
0-19|0.2|0.5|0.3|29|X(d) Gonadal carcinomas|81425816|2003
0-19|0.3|0.5|0.4|32|X(e) Other and unspecified malignant gonadal tumors|81425816|2003
0-19|16.4|18.2|17.3|1433|XI Other malignant epithelial neoplasms and malignant melanomas|81425816|2003
0-19|0.1|0.4|0.2|20|XI(a) Adrenocortical carcinomas|81425816|2003
0-19|5.6|6.7|6.2|511|XI(b) Thyroid carcinomas|81425816|2003
0-19|0.5|0.9|0.7|54|XI(c) Nasopharyngeal carcinomas|81425816|2003
0-19|5.4|6.5|5.9|491|XI(d) Malignant melanomas|81425816|2003
0-19|~|~|~|~|XI(e) Skin carcinomas|81425816|2003
0-19|3.8|4.7|4.2|348|XI(f) Other and unspecified carcinomas|81425816|2003
0-19|0.9|1.3|1.1|89|XII Other and unspecified malignant neoplasms|81425816|2003
0-19|0.3|0.7|0.5|40|XII(a) Other specified malignant tumors|81425816|2003
0-19|0.4|0.8|0.6|49|XII(b) Other unspecified malignant tumors|81425816|2003
0-14|156.7|163.1|159.9|9737|All ICCC Groups Combined|60651802|2004
0-14|49.4|53.0|51.2|3105|I Leukemias, myeloproliferative & myelodysplastic diseases|60651802|2004
0-14|37.3|40.4|38.8|2348|I(a) Lymphoid leukemias|60651802|2004
0-14|7.2|8.7|7.9|485|I(b) Acute myeloid leukemias|60651802|2004
0-14|1.3|1.9|1.6|96|I(c) Chronic myeloproliferative diseases|60651802|2004
0-14|1.2|1.9|1.5|93|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60651802|2004
0-14|1.1|1.7|1.4|83|I(e) Unspecified and other specified leukemias|60651802|2004
0-14|15.1|17.1|16.0|981|II Lymphomas and reticuloendothelial neoplasms|60651802|2004
0-14|4.7|5.9|5.3|324|II(a) Hodgkin lymphomas|60651802|2004
0-14|6.2|7.6|6.9|419|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60651802|2004
0-14|2.1|2.9|2.4|147|II(c) Burkitt lymphoma|60651802|2004
0-14|1.0|1.6|1.3|79|II(d) Miscellaneous lymphoreticular neoplasms|60651802|2004
0-14|~|~|~|~|II(e) Unspecified lymphomas|60651802|2004
0-14|33.6|36.6|35.1|2123|III CNS and misc intracranial and intraspinal neoplasms|60651802|2004
0-14|2.6|3.4|3.0|181|III(a) Ependymomas and choroid plexus tumor|60651802|2004
0-14|16.5|18.7|17.6|1063|III(b) Astrocytomas|60651802|2004
0-14|7.1|8.5|7.8|471|III(c) Intracranial and intraspinal embryonal tumors|60651802|2004
0-14|4.8|6.0|5.4|324|III(d) Other gliomas|60651802|2004
0-14|0.6|1.1|0.8|49|III(e) Other specified intracranial & intraspinal neoplasms|60651802|2004
0-14|0.4|0.8|0.6|35|III(f) Unspecified intracranial and intraspinal neoplasms|60651802|2004
0-14|10.2|11.9|11.1|678|IV Neuroblastoma and other peripheral nervous cell tumors|60651802|2004
0-14|10.0|11.7|10.8|663|IV(a) Neuroblastoma and ganglioneuroblastoma|60651802|2004
0-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|60651802|2004
0-14|9.8|11.4|10.6|646|IX Soft tissue and other extraosseous sarcomas|60651802|2004
0-14|4.1|5.2|4.6|282|IX(a) Rhabdomyosarcomas|60651802|2004
0-14|1.0|1.5|1.2|76|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60651802|2004
0-14|~|~|~|~|IX(c) Kaposi sarcoma|60651802|2004
0-14|3.2|4.2|3.6|224|IX(d) Other specified soft tissue sarcomas|60651802|2004
0-14|0.8|1.3|1.0|62|IX(e) Unspecified soft tissue sarcomas|60651802|2004
0-14|~|~|~|~|Not classified by ICCC|60651802|2004
0-14|3.8|4.9|4.3|266|V Retinoblastoma|60651802|2004
0-14|7.4|8.9|8.1|495|VI Renal tumors|60651802|2004
0-14|7.1|8.5|7.8|472|VI(a) Nephroblastoma and other nonepithelial renal tumors|60651802|2004
0-14|0.2|0.6|0.4|23|VI(b) Renal carcinomas|60651802|2004
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|60651802|2004
0-14|2.3|3.1|2.7|164|VII Hepatic tumors|60651802|2004
0-14|2.0|2.8|2.4|145|VII(a) Hepatoblastoma|60651802|2004
0-14|~|~|~|~|VII(b) Hepatic carcinomas|60651802|2004
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60651802|2004
0-14|6.5|7.8|7.1|437|VIII Malignant bone tumors|60651802|2004
0-14|3.6|4.7|4.1|254|VIII(a) Osteosarcomas|60651802|2004
0-14|0.2|0.4|0.3|17|VIII(b) Chondrosarcomas|60651802|2004
0-14|2.0|2.7|2.3|143|VIII(c) Ewing tumor and related sarcomas of bone|60651802|2004
0-14|0.2|0.5|0.3|18|VIII(d) Other specified malignant bone tumors|60651802|2004
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|60651802|2004
0-14|5.0|6.2|5.6|346|X Germ cell, trophoblastic tumors & neoplasms of gonads|60651802|2004
0-14|1.3|1.9|1.6|96|X(a) Intracranial & intraspinal germ cell tumors|60651802|2004
0-14|1.1|1.6|1.3|82|X(b) Malignant extracranial & extragonadal germ cell tumors|60651802|2004
0-14|2.0|2.8|2.4|148|X(c) Malignant gonadal germ cell tumors|60651802|2004
0-14|~|~|~|~|X(d) Gonadal carcinomas|60651802|2004
0-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60651802|2004
0-14|6.5|7.8|7.1|439|XI Other malignant epithelial neoplasms and malignant melanomas|60651802|2004
0-14|0.2|0.4|0.3|16|XI(a) Adrenocortical carcinomas|60651802|2004
0-14|2.2|3.1|2.6|161|XI(b) Thyroid carcinomas|60651802|2004
0-14|0.2|0.6|0.4|24|XI(c) Nasopharyngeal carcinomas|60651802|2004
0-14|2.1|2.9|2.4|150|XI(d) Malignant melanomas|60651802|2004
0-14|~|~|~|~|XI(e) Skin carcinomas|60651802|2004
0-14|1.1|1.7|1.4|83|XI(f) Other and unspecified carcinomas|60651802|2004
0-14|0.5|1.0|0.7|44|XII Other and unspecified malignant neoplasms|60651802|2004
0-14|0.2|0.5|0.3|19|XII(a) Other specified malignant tumors|60651802|2004
0-14|0.3|0.6|0.4|25|XII(b) Other unspecified malignant tumors|60651802|2004
0-19|171.4|177.2|174.3|14321|All ICCC Groups Combined|81754354|2004
0-19|44.8|47.7|46.2|3769|I Leukemias, myeloproliferative & myelodysplastic diseases|81754354|2004
0-19|32.0|34.5|33.3|2701|I(a) Lymphoid leukemias|81754354|2004
0-19|7.6|8.8|8.2|675|I(b) Acute myeloid leukemias|81754354|2004
0-19|1.9|2.5|2.2|180|I(c) Chronic myeloproliferative diseases|81754354|2004
0-19|1.1|1.7|1.4|113|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|81754354|2004
0-19|1.0|1.5|1.2|100|I(e) Unspecified and other specified leukemias|81754354|2004
0-19|23.1|25.2|24.2|2000|II Lymphomas and reticuloendothelial neoplasms|81754354|2004
0-19|11.1|12.6|11.9|990|II(a) Hodgkin lymphomas|81754354|2004
0-19|7.9|9.2|8.6|706|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|81754354|2004
0-19|2.0|2.7|2.3|191|II(c) Burkitt lymphoma|81754354|2004
0-19|0.8|1.3|1.0|86|II(d) Miscellaneous lymphoreticular neoplasms|81754354|2004
0-19|0.2|0.5|0.3|27|II(e) Unspecified lymphomas|81754354|2004
0-19|30.9|33.4|32.1|2616|III CNS and misc intracranial and intraspinal neoplasms|81754354|2004
0-19|2.4|3.1|2.7|224|III(a) Ependymomas and choroid plexus tumor|81754354|2004
0-19|15.6|17.4|16.5|1345|III(b) Astrocytomas|81754354|2004
0-19|6.0|7.2|6.6|533|III(c) Intracranial and intraspinal embryonal tumors|81754354|2004
0-19|4.6|5.6|5.1|412|III(d) Other gliomas|81754354|2004
0-19|0.5|0.9|0.7|59|III(e) Other specified intracranial & intraspinal neoplasms|81754354|2004
0-19|0.4|0.7|0.5|43|III(f) Unspecified intracranial and intraspinal neoplasms|81754354|2004
0-19|7.9|9.1|8.5|695|IV Neuroblastoma and other peripheral nervous cell tumors|81754354|2004
0-19|7.6|8.8|8.2|672|IV(a) Neuroblastoma and ganglioneuroblastoma|81754354|2004
0-19|0.2|0.4|0.3|23|IV(b) Other peripheral nervous cell tumors|81754354|2004
0-19|11.3|12.8|12.0|991|IX Soft tissue and other extraosseous sarcomas|81754354|2004
0-19|3.9|4.8|4.3|351|IX(a) Rhabdomyosarcomas|81754354|2004
0-19|1.1|1.6|1.4|113|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|81754354|2004
0-19|~|~|~|~|IX(c) Kaposi sarcoma|81754354|2004
0-19|4.6|5.6|5.1|423|IX(d) Other specified soft tissue sarcomas|81754354|2004
0-19|1.0|1.5|1.2|100|IX(e) Unspecified soft tissue sarcomas|81754354|2004
0-19|0.2|0.4|0.3|24|Not classified by ICCC|81754354|2004
0-19|2.9|3.6|3.2|266|V Retinoblastoma|81754354|2004
0-19|6.0|7.1|6.5|530|VI Renal tumors|81754354|2004
0-19|5.4|6.5|5.9|480|VI(a) Nephroblastoma and other nonepithelial renal tumors|81754354|2004
0-19|0.4|0.8|0.6|47|VI(b) Renal carcinomas|81754354|2004
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|81754354|2004
0-19|2.1|2.8|2.4|197|VII Hepatic tumors|81754354|2004
0-19|1.5|2.1|1.8|145|VII(a) Hepatoblastoma|81754354|2004
0-19|0.4|0.8|0.6|48|VII(b) Hepatic carcinomas|81754354|2004
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|81754354|2004
0-19|8.4|9.7|9.1|750|VIII Malignant bone tumors|81754354|2004
0-19|4.7|5.7|5.1|426|VIII(a) Osteosarcomas|81754354|2004
0-19|0.4|0.7|0.5|42|VIII(b) Chondrosarcomas|81754354|2004
0-19|2.4|3.1|2.7|227|VIII(c) Ewing tumor and related sarcomas of bone|81754354|2004
0-19|0.4|0.7|0.5|42|VIII(d) Other specified malignant bone tumors|81754354|2004
0-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|81754354|2004
0-19|10.4|11.9|11.1|927|X Germ cell, trophoblastic tumors & neoplasms of gonads|81754354|2004
0-19|1.5|2.1|1.8|148|X(a) Intracranial & intraspinal germ cell tumors|81754354|2004
0-19|1.1|1.6|1.3|110|X(b) Malignant extracranial & extragonadal germ cell tumors|81754354|2004
0-19|6.7|7.9|7.3|609|X(c) Malignant gonadal germ cell tumors|81754354|2004
0-19|0.3|0.6|0.4|33|X(d) Gonadal carcinomas|81754354|2004
0-19|0.2|0.5|0.3|27|X(e) Other and unspecified malignant gonadal tumors|81754354|2004
0-19|16.9|18.7|17.8|1483|XI Other malignant epithelial neoplasms and malignant melanomas|81754354|2004
0-19|0.1|0.4|0.2|19|XI(a) Adrenocortical carcinomas|81754354|2004
0-19|6.3|7.4|6.8|567|XI(b) Thyroid carcinomas|81754354|2004
0-19|0.4|0.7|0.5|46|XI(c) Nasopharyngeal carcinomas|81754354|2004
0-19|5.9|7.0|6.4|537|XI(d) Malignant melanomas|81754354|2004
0-19|~|~|~|~|XI(e) Skin carcinomas|81754354|2004
0-19|3.3|4.1|3.7|307|XI(f) Other and unspecified carcinomas|81754354|2004
0-19|0.7|1.1|0.9|73|XII Other and unspecified malignant neoplasms|81754354|2004
0-19|0.2|0.5|0.4|29|XII(a) Other specified malignant tumors|81754354|2004
0-19|0.4|0.7|0.5|44|XII(b) Other unspecified malignant tumors|81754354|2004
0-14|152.9|159.2|156.0|9493|All ICCC Groups Combined|60519046|2005
0-14|47.5|51.0|49.2|2991|I Leukemias, myeloproliferative & myelodysplastic diseases|60519046|2005
0-14|35.9|39.0|37.5|2272|I(a) Lymphoid leukemias|60519046|2005
0-14|6.6|8.0|7.3|445|I(b) Acute myeloid leukemias|60519046|2005
0-14|1.1|1.8|1.4|87|I(c) Chronic myeloproliferative diseases|60519046|2005
0-14|1.4|2.0|1.7|101|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60519046|2005
0-14|1.1|1.7|1.4|86|I(e) Unspecified and other specified leukemias|60519046|2005
0-14|15.6|17.7|16.6|1013|II Lymphomas and reticuloendothelial neoplasms|60519046|2005
0-14|5.3|6.5|5.9|360|II(a) Hodgkin lymphomas|60519046|2005
0-14|5.8|7.1|6.4|391|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60519046|2005
0-14|2.2|3.0|2.6|155|II(c) Burkitt lymphoma|60519046|2005
0-14|1.2|1.9|1.5|93|II(d) Miscellaneous lymphoreticular neoplasms|60519046|2005
0-14|~|~|~|~|II(e) Unspecified lymphomas|60519046|2005
0-14|31.7|34.6|33.2|2003|III CNS and misc intracranial and intraspinal neoplasms|60519046|2005
0-14|2.9|3.8|3.3|200|III(a) Ependymomas and choroid plexus tumor|60519046|2005
0-14|15.7|17.8|16.7|1011|III(b) Astrocytomas|60519046|2005
0-14|6.3|7.7|7.0|422|III(c) Intracranial and intraspinal embryonal tumors|60519046|2005
0-14|4.5|5.7|5.1|306|III(d) Other gliomas|60519046|2005
0-14|0.4|0.8|0.6|35|III(e) Other specified intracranial & intraspinal neoplasms|60519046|2005
0-14|0.3|0.7|0.5|29|III(f) Unspecified intracranial and intraspinal neoplasms|60519046|2005
0-14|11.0|12.7|11.8|727|IV Neuroblastoma and other peripheral nervous cell tumors|60519046|2005
0-14|10.8|12.6|11.7|718|IV(a) Neuroblastoma and ganglioneuroblastoma|60519046|2005
0-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|60519046|2005
0-14|9.8|11.5|10.6|644|IX Soft tissue and other extraosseous sarcomas|60519046|2005
0-14|4.7|5.9|5.3|320|IX(a) Rhabdomyosarcomas|60519046|2005
0-14|0.9|1.4|1.1|69|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60519046|2005
0-14|~|~|~|~|IX(c) Kaposi sarcoma|60519046|2005
0-14|2.9|3.8|3.3|203|IX(d) Other specified soft tissue sarcomas|60519046|2005
0-14|0.6|1.1|0.8|50|IX(e) Unspecified soft tissue sarcomas|60519046|2005
0-14|0.2|0.5|0.3|18|Not classified by ICCC|60519046|2005
0-14|3.4|4.4|3.9|241|V Retinoblastoma|60519046|2005
0-14|7.5|9.0|8.2|501|VI Renal tumors|60519046|2005
0-14|7.2|8.6|7.8|478|VI(a) Nephroblastoma and other nonepithelial renal tumors|60519046|2005
0-14|0.2|0.5|0.3|19|VI(b) Renal carcinomas|60519046|2005
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|60519046|2005
0-14|2.0|2.8|2.4|145|VII Hepatic tumors|60519046|2005
0-14|1.6|2.3|1.9|116|VII(a) Hepatoblastoma|60519046|2005
0-14|0.3|0.6|0.4|27|VII(b) Hepatic carcinomas|60519046|2005
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60519046|2005
0-14|6.2|7.5|6.8|416|VIII Malignant bone tumors|60519046|2005
0-14|3.3|4.2|3.7|227|VIII(a) Osteosarcomas|60519046|2005
0-14|~|~|~|~|VIII(b) Chondrosarcomas|60519046|2005
0-14|2.1|2.9|2.4|148|VIII(c) Ewing tumor and related sarcomas of bone|60519046|2005
0-14|0.2|0.5|0.3|20|VIII(d) Other specified malignant bone tumors|60519046|2005
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|60519046|2005
0-14|4.9|6.1|5.5|338|X Germ cell, trophoblastic tumors & neoplasms of gonads|60519046|2005
0-14|1.1|1.7|1.4|83|X(a) Intracranial & intraspinal germ cell tumors|60519046|2005
0-14|1.3|2.0|1.6|100|X(b) Malignant extracranial & extragonadal germ cell tumors|60519046|2005
0-14|1.9|2.6|2.2|138|X(c) Malignant gonadal germ cell tumors|60519046|2005
0-14|~|~|~|~|X(d) Gonadal carcinomas|60519046|2005
0-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60519046|2005
0-14|6.2|7.5|6.9|420|XI Other malignant epithelial neoplasms and malignant melanomas|60519046|2005
0-14|~|~|~|~|XI(a) Adrenocortical carcinomas|60519046|2005
0-14|1.9|2.6|2.2|138|XI(b) Thyroid carcinomas|60519046|2005
0-14|~|~|~|~|XI(c) Nasopharyngeal carcinomas|60519046|2005
0-14|2.0|2.8|2.4|147|XI(d) Malignant melanomas|60519046|2005
0-14|~|~|~|~|XI(e) Skin carcinomas|60519046|2005
0-14|1.5|2.2|1.8|112|XI(f) Other and unspecified carcinomas|60519046|2005
0-14|0.4|0.8|0.6|36|XII Other and unspecified malignant neoplasms|60519046|2005
0-14|0.2|0.5|0.3|19|XII(a) Other specified malignant tumors|60519046|2005
0-14|0.2|0.5|0.3|17|XII(b) Other unspecified malignant tumors|60519046|2005
0-19|169.9|175.5|172.7|14270|All ICCC Groups Combined|82005260|2005
0-19|43.1|46.0|44.6|3650|I Leukemias, myeloproliferative & myelodysplastic diseases|82005260|2005
0-19|30.8|33.3|32.0|2614|I(a) Lymphoid leukemias|82005260|2005
0-19|7.0|8.2|7.5|624|I(b) Acute myeloid leukemias|82005260|2005
0-19|1.8|2.4|2.1|173|I(c) Chronic myeloproliferative diseases|82005260|2005
0-19|1.3|1.9|1.6|132|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82005260|2005
0-19|1.1|1.6|1.3|107|I(e) Unspecified and other specified leukemias|82005260|2005
0-19|24.8|27.0|25.8|2156|II Lymphomas and reticuloendothelial neoplasms|82005260|2005
0-19|12.0|13.5|12.7|1069|II(a) Hodgkin lymphomas|82005260|2005
0-19|8.4|9.7|9.0|749|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82005260|2005
0-19|2.2|2.9|2.5|205|II(c) Burkitt lymphoma|82005260|2005
0-19|1.0|1.5|1.3|104|II(d) Miscellaneous lymphoreticular neoplasms|82005260|2005
0-19|0.2|0.5|0.3|29|II(e) Unspecified lymphomas|82005260|2005
0-19|29.1|31.5|30.3|2473|III CNS and misc intracranial and intraspinal neoplasms|82005260|2005
0-19|2.6|3.3|2.9|241|III(a) Ependymomas and choroid plexus tumor|82005260|2005
0-19|14.6|16.4|15.5|1265|III(b) Astrocytomas|82005260|2005
0-19|5.4|6.5|5.9|480|III(c) Intracranial and intraspinal embryonal tumors|82005260|2005
0-19|4.4|5.4|4.9|397|III(d) Other gliomas|82005260|2005
0-19|0.5|0.8|0.6|52|III(e) Other specified intracranial & intraspinal neoplasms|82005260|2005
0-19|0.3|0.6|0.5|38|III(f) Unspecified intracranial and intraspinal neoplasms|82005260|2005
0-19|8.4|9.7|9.1|745|IV Neuroblastoma and other peripheral nervous cell tumors|82005260|2005
0-19|8.2|9.5|8.8|727|IV(a) Neuroblastoma and ganglioneuroblastoma|82005260|2005
0-19|0.1|0.3|0.2|18|IV(b) Other peripheral nervous cell tumors|82005260|2005
0-19|11.6|13.1|12.3|1018|IX Soft tissue and other extraosseous sarcomas|82005260|2005
0-19|4.4|5.4|4.9|398|IX(a) Rhabdomyosarcomas|82005260|2005
0-19|1.2|1.7|1.4|117|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82005260|2005
0-19|~|~|~|~|IX(c) Kaposi sarcoma|82005260|2005
0-19|4.4|5.4|4.9|408|IX(d) Other specified soft tissue sarcomas|82005260|2005
0-19|0.9|1.4|1.1|91|IX(e) Unspecified soft tissue sarcomas|82005260|2005
0-19|0.2|0.4|0.3|23|Not classified by ICCC|82005260|2005
0-19|2.6|3.3|2.9|243|V Retinoblastoma|82005260|2005
0-19|6.2|7.3|6.7|548|VI Renal tumors|82005260|2005
0-19|5.5|6.6|6.1|494|VI(a) Nephroblastoma and other nonepithelial renal tumors|82005260|2005
0-19|0.4|0.8|0.6|50|VI(b) Renal carcinomas|82005260|2005
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|82005260|2005
0-19|1.7|2.3|2.0|166|VII Hepatic tumors|82005260|2005
0-19|1.2|1.7|1.4|117|VII(a) Hepatoblastoma|82005260|2005
0-19|0.4|0.7|0.6|47|VII(b) Hepatic carcinomas|82005260|2005
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82005260|2005
0-19|8.3|9.5|8.9|738|VIII Malignant bone tumors|82005260|2005
0-19|4.6|5.5|5.0|418|VIII(a) Osteosarcomas|82005260|2005
0-19|0.2|0.4|0.3|23|VIII(b) Chondrosarcomas|82005260|2005
0-19|2.6|3.3|3.0|244|VIII(c) Ewing tumor and related sarcomas of bone|82005260|2005
0-19|0.3|0.6|0.4|36|VIII(d) Other specified malignant bone tumors|82005260|2005
0-19|0.1|0.3|0.2|17|VIII(e) Unspecified malignant bone tumors|82005260|2005
0-19|10.7|12.2|11.4|962|X Germ cell, trophoblastic tumors & neoplasms of gonads|82005260|2005
0-19|1.3|1.9|1.6|133|X(a) Intracranial & intraspinal germ cell tumors|82005260|2005
0-19|1.3|1.9|1.6|134|X(b) Malignant extracranial & extragonadal germ cell tumors|82005260|2005
0-19|6.9|8.1|7.5|635|X(c) Malignant gonadal germ cell tumors|82005260|2005
0-19|0.3|0.5|0.4|32|X(d) Gonadal carcinomas|82005260|2005
0-19|0.2|0.5|0.3|28|X(e) Other and unspecified malignant gonadal tumors|82005260|2005
0-19|16.6|18.4|17.5|1473|XI Other malignant epithelial neoplasms and malignant melanomas|82005260|2005
0-19|~|~|~|~|XI(a) Adrenocortical carcinomas|82005260|2005
0-19|5.6|6.7|6.1|519|XI(b) Thyroid carcinomas|82005260|2005
0-19|0.3|0.5|0.4|33|XI(c) Nasopharyngeal carcinomas|82005260|2005
0-19|6.0|7.1|6.5|550|XI(d) Malignant melanomas|82005260|2005
0-19|~|~|~|~|XI(e) Skin carcinomas|82005260|2005
0-19|3.8|4.6|4.2|352|XI(f) Other and unspecified carcinomas|82005260|2005
0-19|0.7|1.1|0.9|75|XII Other and unspecified malignant neoplasms|82005260|2005
0-19|0.3|0.5|0.4|32|XII(a) Other specified malignant tumors|82005260|2005
0-19|0.4|0.7|0.5|43|XII(b) Other unspecified malignant tumors|82005260|2005
0-14|155.9|162.2|159.0|9679|All ICCC Groups Combined|60516709|2006
0-14|49.9|53.5|51.6|3140|I Leukemias, myeloproliferative & myelodysplastic diseases|60516709|2006
0-14|37.3|40.5|38.9|2360|I(a) Lymphoid leukemias|60516709|2006
0-14|7.2|8.6|7.9|481|I(b) Acute myeloid leukemias|60516709|2006
0-14|1.4|2.1|1.8|107|I(c) Chronic myeloproliferative diseases|60516709|2006
0-14|1.5|2.2|1.8|110|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60516709|2006
0-14|1.1|1.7|1.3|82|I(e) Unspecified and other specified leukemias|60516709|2006
0-14|15.7|17.8|16.8|1017|II Lymphomas and reticuloendothelial neoplasms|60516709|2006
0-14|5.6|6.8|6.2|375|II(a) Hodgkin lymphomas|60516709|2006
0-14|5.8|7.1|6.4|389|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60516709|2006
0-14|2.1|2.9|2.5|151|II(c) Burkitt lymphoma|60516709|2006
0-14|1.2|1.8|1.5|90|II(d) Miscellaneous lymphoreticular neoplasms|60516709|2006
0-14|~|~|~|~|II(e) Unspecified lymphomas|60516709|2006
0-14|32.6|35.6|34.1|2063|III CNS and misc intracranial and intraspinal neoplasms|60516709|2006
0-14|2.6|3.5|3.0|185|III(a) Ependymomas and choroid plexus tumor|60516709|2006
0-14|15.4|17.5|16.4|995|III(b) Astrocytomas|60516709|2006
0-14|7.0|8.4|7.7|466|III(c) Intracranial and intraspinal embryonal tumors|60516709|2006
0-14|5.2|6.4|5.7|345|III(d) Other gliomas|60516709|2006
0-14|0.3|0.7|0.5|31|III(e) Other specified intracranial & intraspinal neoplasms|60516709|2006
0-14|0.5|0.9|0.7|41|III(f) Unspecified intracranial and intraspinal neoplasms|60516709|2006
0-14|9.5|11.2|10.3|636|IV Neuroblastoma and other peripheral nervous cell tumors|60516709|2006
0-14|9.4|11.1|10.2|630|IV(a) Neuroblastoma and ganglioneuroblastoma|60516709|2006
0-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|60516709|2006
0-14|9.8|11.5|10.7|648|IX Soft tissue and other extraosseous sarcomas|60516709|2006
0-14|4.4|5.5|4.9|298|IX(a) Rhabdomyosarcomas|60516709|2006
0-14|0.9|1.4|1.1|68|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60516709|2006
0-14|~|~|~|~|IX(c) Kaposi sarcoma|60516709|2006
0-14|3.1|4.0|3.5|214|IX(d) Other specified soft tissue sarcomas|60516709|2006
0-14|0.8|1.4|1.1|66|IX(e) Unspecified soft tissue sarcomas|60516709|2006
0-14|~|~|~|~|Not classified by ICCC|60516709|2006
0-14|3.6|4.6|4.1|253|V Retinoblastoma|60516709|2006
0-14|7.6|9.1|8.3|506|VI Renal tumors|60516709|2006
0-14|7.2|8.6|7.9|480|VI(a) Nephroblastoma and other nonepithelial renal tumors|60516709|2006
0-14|0.2|0.5|0.3|21|VI(b) Renal carcinomas|60516709|2006
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|60516709|2006
0-14|2.2|3.0|2.6|159|VII Hepatic tumors|60516709|2006
0-14|1.8|2.5|2.1|132|VII(a) Hepatoblastoma|60516709|2006
0-14|0.2|0.6|0.4|23|VII(b) Hepatic carcinomas|60516709|2006
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60516709|2006
0-14|6.4|7.7|7.0|424|VIII Malignant bone tumors|60516709|2006
0-14|3.5|4.5|4.0|242|VIII(a) Osteosarcomas|60516709|2006
0-14|~|~|~|~|VIII(b) Chondrosarcomas|60516709|2006
0-14|2.0|2.9|2.4|146|VIII(c) Ewing tumor and related sarcomas of bone|60516709|2006
0-14|0.2|0.5|0.3|18|VIII(d) Other specified malignant bone tumors|60516709|2006
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|60516709|2006
0-14|4.6|5.7|5.1|316|X Germ cell, trophoblastic tumors & neoplasms of gonads|60516709|2006
0-14|1.0|1.6|1.3|79|X(a) Intracranial & intraspinal germ cell tumors|60516709|2006
0-14|1.2|1.9|1.5|95|X(b) Malignant extracranial & extragonadal germ cell tumors|60516709|2006
0-14|1.7|2.5|2.1|126|X(c) Malignant gonadal germ cell tumors|60516709|2006
0-14|~|~|~|~|X(d) Gonadal carcinomas|60516709|2006
0-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60516709|2006
0-14|6.9|8.3|7.6|461|XI Other malignant epithelial neoplasms and malignant melanomas|60516709|2006
0-14|~|~|~|~|XI(a) Adrenocortical carcinomas|60516709|2006
0-14|2.3|3.1|2.7|163|XI(b) Thyroid carcinomas|60516709|2006
0-14|0.2|0.5|0.3|18|XI(c) Nasopharyngeal carcinomas|60516709|2006
0-14|2.0|2.8|2.4|147|XI(d) Malignant melanomas|60516709|2006
0-14|~|~|~|~|XI(e) Skin carcinomas|60516709|2006
0-14|1.5|2.2|1.9|114|XI(f) Other and unspecified carcinomas|60516709|2006
0-14|0.5|1.0|0.7|45|XII Other and unspecified malignant neoplasms|60516709|2006
0-14|0.3|0.6|0.4|27|XII(a) Other specified malignant tumors|60516709|2006
0-14|0.2|0.5|0.3|18|XII(b) Other unspecified malignant tumors|60516709|2006
0-19|170.4|176.1|173.2|14379|All ICCC Groups Combined|82324418|2006
0-19|45.5|48.5|47.0|3863|I Leukemias, myeloproliferative & myelodysplastic diseases|82324418|2006
0-19|32.1|34.6|33.3|2725|I(a) Lymphoid leukemias|82324418|2006
0-19|7.6|8.8|8.2|681|I(b) Acute myeloid leukemias|82324418|2006
0-19|2.1|2.8|2.4|202|I(c) Chronic myeloproliferative diseases|82324418|2006
0-19|1.4|2.0|1.7|139|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82324418|2006
0-19|1.2|1.7|1.4|116|I(e) Unspecified and other specified leukemias|82324418|2006
0-19|24.0|26.2|25.1|2105|II Lymphomas and reticuloendothelial neoplasms|82324418|2006
0-19|11.8|13.3|12.5|1058|II(a) Hodgkin lymphomas|82324418|2006
0-19|8.1|9.4|8.7|726|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82324418|2006
0-19|2.1|2.8|2.4|200|II(c) Burkitt lymphoma|82324418|2006
0-19|1.0|1.5|1.2|98|II(d) Miscellaneous lymphoreticular neoplasms|82324418|2006
0-19|0.2|0.4|0.3|23|II(e) Unspecified lymphomas|82324418|2006
0-19|30.1|32.5|31.3|2566|III CNS and misc intracranial and intraspinal neoplasms|82324418|2006
0-19|2.5|3.2|2.8|233|III(a) Ependymomas and choroid plexus tumor|82324418|2006
0-19|14.6|16.3|15.5|1271|III(b) Astrocytomas|82324418|2006
0-19|5.8|6.9|6.3|517|III(c) Intracranial and intraspinal embryonal tumors|82324418|2006
0-19|5.0|6.0|5.5|447|III(d) Other gliomas|82324418|2006
0-19|0.4|0.8|0.6|48|III(e) Other specified intracranial & intraspinal neoplasms|82324418|2006
0-19|0.5|0.8|0.6|50|III(f) Unspecified intracranial and intraspinal neoplasms|82324418|2006
0-19|7.3|8.5|7.9|652|IV Neuroblastoma and other peripheral nervous cell tumors|82324418|2006
0-19|7.2|8.4|7.7|638|IV(a) Neuroblastoma and ganglioneuroblastoma|82324418|2006
0-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|82324418|2006
0-19|11.0|12.5|11.7|975|IX Soft tissue and other extraosseous sarcomas|82324418|2006
0-19|4.1|5.1|4.6|377|IX(a) Rhabdomyosarcomas|82324418|2006
0-19|1.1|1.6|1.3|110|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82324418|2006
0-19|~|~|~|~|IX(c) Kaposi sarcoma|82324418|2006
0-19|4.1|5.0|4.5|380|IX(d) Other specified soft tissue sarcomas|82324418|2006
0-19|1.0|1.5|1.2|103|IX(e) Unspecified soft tissue sarcomas|82324418|2006
0-19|0.2|0.4|0.3|24|Not classified by ICCC|82324418|2006
0-19|2.7|3.5|3.1|254|V Retinoblastoma|82324418|2006
0-19|6.2|7.3|6.7|552|VI Renal tumors|82324418|2006
0-19|5.5|6.5|6.0|487|VI(a) Nephroblastoma and other nonepithelial renal tumors|82324418|2006
0-19|0.5|0.9|0.7|59|VI(b) Renal carcinomas|82324418|2006
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|82324418|2006
0-19|2.0|2.6|2.3|191|VII Hepatic tumors|82324418|2006
0-19|1.4|1.9|1.6|134|VII(a) Hepatoblastoma|82324418|2006
0-19|0.5|0.8|0.6|53|VII(b) Hepatic carcinomas|82324418|2006
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82324418|2006
0-19|8.6|10.0|9.3|775|VIII Malignant bone tumors|82324418|2006
0-19|4.9|5.9|5.4|449|VIII(a) Osteosarcomas|82324418|2006
0-19|0.1|0.3|0.2|17|VIII(b) Chondrosarcomas|82324418|2006
0-19|2.7|3.4|3.0|251|VIII(c) Ewing tumor and related sarcomas of bone|82324418|2006
0-19|0.4|0.7|0.5|44|VIII(d) Other specified malignant bone tumors|82324418|2006
0-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|82324418|2006
0-19|9.6|11.0|10.3|874|X Germ cell, trophoblastic tumors & neoplasms of gonads|82324418|2006
0-19|1.3|1.8|1.5|128|X(a) Intracranial & intraspinal germ cell tumors|82324418|2006
0-19|1.3|1.8|1.5|129|X(b) Malignant extracranial & extragonadal germ cell tumors|82324418|2006
0-19|5.9|6.9|6.4|546|X(c) Malignant gonadal germ cell tumors|82324418|2006
0-19|0.4|0.7|0.5|42|X(d) Gonadal carcinomas|82324418|2006
0-19|0.2|0.5|0.3|29|X(e) Other and unspecified malignant gonadal tumors|82324418|2006
0-19|16.5|18.3|17.4|1475|XI Other malignant epithelial neoplasms and malignant melanomas|82324418|2006
0-19|0.1|0.3|0.2|16|XI(a) Adrenocortical carcinomas|82324418|2006
0-19|6.2|7.3|6.8|575|XI(b) Thyroid carcinomas|82324418|2006
0-19|0.5|0.8|0.6|54|XI(c) Nasopharyngeal carcinomas|82324418|2006
0-19|4.9|5.9|5.4|461|XI(d) Malignant melanomas|82324418|2006
0-19|~|~|~|~|XI(e) Skin carcinomas|82324418|2006
0-19|3.8|4.7|4.3|362|XI(f) Other and unspecified carcinomas|82324418|2006
0-19|0.7|1.1|0.9|73|XII Other and unspecified malignant neoplasms|82324418|2006
0-19|0.4|0.7|0.5|41|XII(a) Other specified malignant tumors|82324418|2006
0-19|0.3|0.5|0.4|32|XII(b) Other unspecified malignant tumors|82324418|2006
0-14|159.2|165.6|162.4|9923|All ICCC Groups Combined|60681615|2007
0-14|50.4|54.0|52.2|3184|I Leukemias, myeloproliferative & myelodysplastic diseases|60681615|2007
0-14|38.5|41.7|40.1|2440|I(a) Lymphoid leukemias|60681615|2007
0-14|7.0|8.4|7.7|473|I(b) Acute myeloid leukemias|60681615|2007
0-14|1.4|2.0|1.7|102|I(c) Chronic myeloproliferative diseases|60681615|2007
0-14|1.3|1.9|1.6|97|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60681615|2007
0-14|0.9|1.5|1.2|72|I(e) Unspecified and other specified leukemias|60681615|2007
0-14|15.7|17.8|16.7|1012|II Lymphomas and reticuloendothelial neoplasms|60681615|2007
0-14|4.9|6.1|5.5|332|II(a) Hodgkin lymphomas|60681615|2007
0-14|6.4|7.7|7.0|425|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60681615|2007
0-14|2.3|3.1|2.7|160|II(c) Burkitt lymphoma|60681615|2007
0-14|1.0|1.6|1.3|82|II(d) Miscellaneous lymphoreticular neoplasms|60681615|2007
0-14|~|~|~|~|II(e) Unspecified lymphomas|60681615|2007
0-14|33.9|37.0|35.4|2153|III CNS and misc intracranial and intraspinal neoplasms|60681615|2007
0-14|2.5|3.4|2.9|178|III(a) Ependymomas and choroid plexus tumor|60681615|2007
0-14|15.9|18.0|17.0|1030|III(b) Astrocytomas|60681615|2007
0-14|7.1|8.5|7.7|471|III(c) Intracranial and intraspinal embryonal tumors|60681615|2007
0-14|5.9|7.2|6.5|396|III(d) Other gliomas|60681615|2007
0-14|0.6|1.0|0.8|46|III(e) Other specified intracranial & intraspinal neoplasms|60681615|2007
0-14|0.4|0.7|0.5|32|III(f) Unspecified intracranial and intraspinal neoplasms|60681615|2007
0-14|11.0|12.7|11.8|736|IV Neuroblastoma and other peripheral nervous cell tumors|60681615|2007
0-14|10.8|12.5|11.6|724|IV(a) Neuroblastoma and ganglioneuroblastoma|60681615|2007
0-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|60681615|2007
0-14|10.2|11.9|11.0|671|IX Soft tissue and other extraosseous sarcomas|60681615|2007
0-14|5.1|6.3|5.7|345|IX(a) Rhabdomyosarcomas|60681615|2007
0-14|0.9|1.5|1.2|73|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60681615|2007
0-14|~|~|~|~|IX(c) Kaposi sarcoma|60681615|2007
0-14|2.9|3.8|3.3|202|IX(d) Other specified soft tissue sarcomas|60681615|2007
0-14|0.6|1.1|0.8|51|IX(e) Unspecified soft tissue sarcomas|60681615|2007
0-14|~|~|~|~|Not classified by ICCC|60681615|2007
0-14|3.8|4.9|4.3|273|V Retinoblastoma|60681615|2007
0-14|7.9|9.4|8.6|530|VI Renal tumors|60681615|2007
0-14|7.5|8.9|8.2|503|VI(a) Nephroblastoma and other nonepithelial renal tumors|60681615|2007
0-14|0.3|0.6|0.4|26|VI(b) Renal carcinomas|60681615|2007
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|60681615|2007
0-14|2.2|3.0|2.6|159|VII Hepatic tumors|60681615|2007
0-14|1.9|2.7|2.3|141|VII(a) Hepatoblastoma|60681615|2007
0-14|0.2|0.5|0.3|18|VII(b) Hepatic carcinomas|60681615|2007
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60681615|2007
0-14|6.2|7.5|6.9|415|VIII Malignant bone tumors|60681615|2007
0-14|3.2|4.2|3.7|223|VIII(a) Osteosarcomas|60681615|2007
0-14|~|~|~|~|VIII(b) Chondrosarcomas|60681615|2007
0-14|2.1|2.9|2.5|151|VIII(c) Ewing tumor and related sarcomas of bone|60681615|2007
0-14|0.2|0.5|0.3|18|VIII(d) Other specified malignant bone tumors|60681615|2007
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|60681615|2007
0-14|4.9|6.1|5.5|338|X Germ cell, trophoblastic tumors & neoplasms of gonads|60681615|2007
0-14|1.1|1.7|1.4|86|X(a) Intracranial & intraspinal germ cell tumors|60681615|2007
0-14|1.0|1.6|1.3|82|X(b) Malignant extracranial & extragonadal germ cell tumors|60681615|2007
0-14|2.2|3.0|2.6|157|X(c) Malignant gonadal germ cell tumors|60681615|2007
0-14|~|~|~|~|X(d) Gonadal carcinomas|60681615|2007
0-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60681615|2007
0-14|5.9|7.2|6.6|400|XI Other malignant epithelial neoplasms and malignant melanomas|60681615|2007
0-14|~|~|~|~|XI(a) Adrenocortical carcinomas|60681615|2007
0-14|1.9|2.7|2.2|137|XI(b) Thyroid carcinomas|60681615|2007
0-14|0.2|0.4|0.3|17|XI(c) Nasopharyngeal carcinomas|60681615|2007
0-14|1.8|2.5|2.1|130|XI(d) Malignant melanomas|60681615|2007
0-14|~|~|~|~|XI(e) Skin carcinomas|60681615|2007
0-14|1.4|2.0|1.7|101|XI(f) Other and unspecified carcinomas|60681615|2007
0-14|0.5|0.9|0.7|42|XII Other and unspecified malignant neoplasms|60681615|2007
0-14|0.2|0.6|0.4|23|XII(a) Other specified malignant tumors|60681615|2007
0-14|0.2|0.5|0.3|19|XII(b) Other unspecified malignant tumors|60681615|2007
0-19|174.3|180.1|177.2|14805|All ICCC Groups Combined|82749431|2007
0-19|45.9|48.9|47.4|3917|I Leukemias, myeloproliferative & myelodysplastic diseases|82749431|2007
0-19|33.0|35.6|34.3|2819|I(a) Lymphoid leukemias|82749431|2007
0-19|7.4|8.6|8.0|667|I(b) Acute myeloid leukemias|82749431|2007
0-19|2.2|2.9|2.5|214|I(c) Chronic myeloproliferative diseases|82749431|2007
0-19|1.2|1.8|1.5|123|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82749431|2007
0-19|0.9|1.4|1.1|94|I(e) Unspecified and other specified leukemias|82749431|2007
0-19|24.0|26.1|25.0|2112|II Lymphomas and reticuloendothelial neoplasms|82749431|2007
0-19|11.4|12.9|12.1|1038|II(a) Hodgkin lymphomas|82749431|2007
0-19|8.1|9.4|8.8|733|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82749431|2007
0-19|2.3|3.0|2.6|214|II(c) Burkitt lymphoma|82749431|2007
0-19|0.9|1.4|1.1|92|II(d) Miscellaneous lymphoreticular neoplasms|82749431|2007
0-19|0.3|0.6|0.4|35|II(e) Unspecified lymphomas|82749431|2007
0-19|30.8|33.3|32.0|2636|III CNS and misc intracranial and intraspinal neoplasms|82749431|2007
0-19|2.2|2.9|2.5|209|III(a) Ependymomas and choroid plexus tumor|82749431|2007
0-19|15.3|17.0|16.1|1330|III(b) Astrocytomas|82749431|2007
0-19|5.9|7.1|6.5|532|III(c) Intracranial and intraspinal embryonal tumors|82749431|2007
0-19|5.2|6.3|5.7|469|III(d) Other gliomas|82749431|2007
0-19|0.5|0.9|0.7|58|III(e) Other specified intracranial & intraspinal neoplasms|82749431|2007
0-19|0.3|0.6|0.5|38|III(f) Unspecified intracranial and intraspinal neoplasms|82749431|2007
0-19|8.4|9.7|9.0|754|IV Neuroblastoma and other peripheral nervous cell tumors|82749431|2007
0-19|8.2|9.5|8.8|735|IV(a) Neuroblastoma and ganglioneuroblastoma|82749431|2007
0-19|0.1|0.4|0.2|19|IV(b) Other peripheral nervous cell tumors|82749431|2007
0-19|11.8|13.3|12.5|1049|IX Soft tissue and other extraosseous sarcomas|82749431|2007
0-19|4.7|5.7|5.2|426|IX(a) Rhabdomyosarcomas|82749431|2007
0-19|1.1|1.7|1.4|117|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82749431|2007
0-19|~|~|~|~|IX(c) Kaposi sarcoma|82749431|2007
0-19|4.3|5.3|4.8|403|IX(d) Other specified soft tissue sarcomas|82749431|2007
0-19|1.0|1.4|1.2|100|IX(e) Unspecified soft tissue sarcomas|82749431|2007
0-19|0.1|0.3|0.2|18|Not classified by ICCC|82749431|2007
0-19|2.9|3.7|3.2|273|V Retinoblastoma|82749431|2007
0-19|6.4|7.5|6.9|570|VI Renal tumors|82749431|2007
0-19|5.7|6.8|6.2|514|VI(a) Nephroblastoma and other nonepithelial renal tumors|82749431|2007
0-19|0.5|0.8|0.6|54|VI(b) Renal carcinomas|82749431|2007
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|82749431|2007
0-19|2.0|2.6|2.3|193|VII Hepatic tumors|82749431|2007
0-19|1.4|2.0|1.7|142|VII(a) Hepatoblastoma|82749431|2007
0-19|0.4|0.8|0.6|51|VII(b) Hepatic carcinomas|82749431|2007
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82749431|2007
0-19|8.2|9.5|8.8|736|VIII Malignant bone tumors|82749431|2007
0-19|4.3|5.2|4.7|394|VIII(a) Osteosarcomas|82749431|2007
0-19|0.2|0.5|0.4|31|VIII(b) Chondrosarcomas|82749431|2007
0-19|2.7|3.5|3.1|256|VIII(c) Ewing tumor and related sarcomas of bone|82749431|2007
0-19|0.3|0.6|0.4|34|VIII(d) Other specified malignant bone tumors|82749431|2007
0-19|0.2|0.4|0.3|21|VIII(e) Unspecified malignant bone tumors|82749431|2007
0-19|10.5|11.9|11.2|957|X Germ cell, trophoblastic tumors & neoplasms of gonads|82749431|2007
0-19|1.4|1.9|1.6|135|X(a) Intracranial & intraspinal germ cell tumors|82749431|2007
0-19|1.1|1.7|1.4|118|X(b) Malignant extracranial & extragonadal germ cell tumors|82749431|2007
0-19|6.9|8.1|7.5|646|X(c) Malignant gonadal germ cell tumors|82749431|2007
0-19|0.3|0.5|0.4|32|X(d) Gonadal carcinomas|82749431|2007
0-19|0.2|0.4|0.3|26|X(e) Other and unspecified malignant gonadal tumors|82749431|2007
0-19|16.8|18.6|17.7|1521|XI Other malignant epithelial neoplasms and malignant melanomas|82749431|2007
0-19|~|~|~|~|XI(a) Adrenocortical carcinomas|82749431|2007
0-19|6.8|7.9|7.3|634|XI(b) Thyroid carcinomas|82749431|2007
0-19|0.5|0.8|0.6|52|XI(c) Nasopharyngeal carcinomas|82749431|2007
0-19|4.9|5.9|5.4|461|XI(d) Malignant melanomas|82749431|2007
0-19|~|~|~|~|XI(e) Skin carcinomas|82749431|2007
0-19|3.7|4.6|4.1|352|XI(f) Other and unspecified carcinomas|82749431|2007
0-19|0.6|1.0|0.8|69|XII Other and unspecified malignant neoplasms|82749431|2007
0-19|0.2|0.5|0.3|29|XII(a) Other specified malignant tumors|82749431|2007
0-19|0.3|0.6|0.5|40|XII(b) Other unspecified malignant tumors|82749431|2007
0-14|161.9|168.4|165.1|10132|All ICCC Groups Combined|60907384|2008
0-14|52.2|55.9|54.1|3319|I Leukemias, myeloproliferative & myelodysplastic diseases|60907384|2008
0-14|39.5|42.8|41.1|2522|I(a) Lymphoid leukemias|60907384|2008
0-14|7.3|8.7|8.0|492|I(b) Acute myeloid leukemias|60907384|2008
0-14|1.8|2.6|2.2|134|I(c) Chronic myeloproliferative diseases|60907384|2008
0-14|1.4|2.0|1.7|104|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60907384|2008
0-14|0.8|1.4|1.1|67|I(e) Unspecified and other specified leukemias|60907384|2008
0-14|16.2|18.3|17.2|1045|II Lymphomas and reticuloendothelial neoplasms|60907384|2008
0-14|5.7|7.0|6.3|384|II(a) Hodgkin lymphomas|60907384|2008
0-14|6.1|7.5|6.8|410|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60907384|2008
0-14|2.3|3.1|2.7|163|II(c) Burkitt lymphoma|60907384|2008
0-14|0.9|1.5|1.2|74|II(d) Miscellaneous lymphoreticular neoplasms|60907384|2008
0-14|~|~|~|~|II(e) Unspecified lymphomas|60907384|2008
0-14|34.1|37.2|35.6|2175|III CNS and misc intracranial and intraspinal neoplasms|60907384|2008
0-14|2.2|3.1|2.6|162|III(a) Ependymomas and choroid plexus tumor|60907384|2008
0-14|16.7|18.8|17.7|1079|III(b) Astrocytomas|60907384|2008
0-14|7.5|8.9|8.2|501|III(c) Intracranial and intraspinal embryonal tumors|60907384|2008
0-14|5.4|6.7|6.0|367|III(d) Other gliomas|60907384|2008
0-14|0.5|1.0|0.7|44|III(e) Other specified intracranial & intraspinal neoplasms|60907384|2008
0-14|0.2|0.5|0.4|22|III(f) Unspecified intracranial and intraspinal neoplasms|60907384|2008
0-14|10.1|11.8|10.9|685|IV Neuroblastoma and other peripheral nervous cell tumors|60907384|2008
0-14|9.9|11.5|10.7|668|IV(a) Neuroblastoma and ganglioneuroblastoma|60907384|2008
0-14|0.2|0.4|0.3|17|IV(b) Other peripheral nervous cell tumors|60907384|2008
0-14|10.3|11.9|11.1|678|IX Soft tissue and other extraosseous sarcomas|60907384|2008
0-14|4.8|5.9|5.3|326|IX(a) Rhabdomyosarcomas|60907384|2008
0-14|0.8|1.3|1.0|62|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60907384|2008
0-14|~|~|~|~|IX(c) Kaposi sarcoma|60907384|2008
0-14|3.0|3.9|3.4|210|IX(d) Other specified soft tissue sarcomas|60907384|2008
0-14|1.0|1.6|1.3|79|IX(e) Unspecified soft tissue sarcomas|60907384|2008
0-14|0.2|0.5|0.3|18|Not classified by ICCC|60907384|2008
0-14|3.7|4.8|4.2|268|V Retinoblastoma|60907384|2008
0-14|8.3|9.8|9.0|557|VI Renal tumors|60907384|2008
0-14|7.9|9.3|8.6|532|VI(a) Nephroblastoma and other nonepithelial renal tumors|60907384|2008
0-14|0.2|0.6|0.4|23|VI(b) Renal carcinomas|60907384|2008
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|60907384|2008
0-14|2.2|3.1|2.6|164|VII Hepatic tumors|60907384|2008
0-14|1.9|2.6|2.2|140|VII(a) Hepatoblastoma|60907384|2008
0-14|0.3|0.6|0.4|24|VII(b) Hepatic carcinomas|60907384|2008
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60907384|2008
0-14|6.2|7.6|6.9|416|VIII Malignant bone tumors|60907384|2008
0-14|3.4|4.4|3.9|233|VIII(a) Osteosarcomas|60907384|2008
0-14|~|~|~|~|VIII(b) Chondrosarcomas|60907384|2008
0-14|2.1|2.9|2.4|148|VIII(c) Ewing tumor and related sarcomas of bone|60907384|2008
0-14|~|~|~|~|VIII(d) Other specified malignant bone tumors|60907384|2008
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|60907384|2008
0-14|4.7|5.9|5.3|325|X Germ cell, trophoblastic tumors & neoplasms of gonads|60907384|2008
0-14|1.1|1.7|1.4|83|X(a) Intracranial & intraspinal germ cell tumors|60907384|2008
0-14|1.1|1.7|1.4|89|X(b) Malignant extracranial & extragonadal germ cell tumors|60907384|2008
0-14|1.9|2.7|2.3|141|X(c) Malignant gonadal germ cell tumors|60907384|2008
0-14|~|~|~|~|X(d) Gonadal carcinomas|60907384|2008
0-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60907384|2008
0-14|6.6|8.0|7.3|443|XI Other malignant epithelial neoplasms and malignant melanomas|60907384|2008
0-14|0.1|0.4|0.3|16|XI(a) Adrenocortical carcinomas|60907384|2008
0-14|2.2|3.0|2.6|158|XI(b) Thyroid carcinomas|60907384|2008
0-14|0.2|0.4|0.3|17|XI(c) Nasopharyngeal carcinomas|60907384|2008
0-14|1.9|2.7|2.3|140|XI(d) Malignant melanomas|60907384|2008
0-14|~|~|~|~|XI(e) Skin carcinomas|60907384|2008
0-14|1.5|2.2|1.8|109|XI(f) Other and unspecified carcinomas|60907384|2008
0-14|0.4|0.9|0.6|39|XII Other and unspecified malignant neoplasms|60907384|2008
0-14|0.2|0.6|0.4|24|XII(a) Other specified malignant tumors|60907384|2008
0-14|~|~|~|~|XII(b) Other unspecified malignant tumors|60907384|2008
0-19|176.5|182.2|179.3|15054|All ICCC Groups Combined|83118264|2008
0-19|47.5|50.5|49.0|4070|I Leukemias, myeloproliferative & myelodysplastic diseases|83118264|2008
0-19|33.9|36.5|35.2|2910|I(a) Lymphoid leukemias|83118264|2008
0-19|7.7|9.0|8.3|701|I(b) Acute myeloid leukemias|83118264|2008
0-19|2.4|3.1|2.8|234|I(c) Chronic myeloproliferative diseases|83118264|2008
0-19|1.3|1.9|1.6|132|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|83118264|2008
0-19|0.9|1.4|1.1|93|I(e) Unspecified and other specified leukemias|83118264|2008
0-19|24.5|26.6|25.5|2162|II Lymphomas and reticuloendothelial neoplasms|83118264|2008
0-19|12.2|13.7|12.9|1107|II(a) Hodgkin lymphomas|83118264|2008
0-19|8.2|9.5|8.8|740|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|83118264|2008
0-19|2.2|2.9|2.6|211|II(c) Burkitt lymphoma|83118264|2008
0-19|0.7|1.2|0.9|78|II(d) Miscellaneous lymphoreticular neoplasms|83118264|2008
0-19|0.2|0.5|0.3|26|II(e) Unspecified lymphomas|83118264|2008
0-19|31.2|33.7|32.4|2685|III CNS and misc intracranial and intraspinal neoplasms|83118264|2008
0-19|2.0|2.7|2.3|195|III(a) Ependymomas and choroid plexus tumor|83118264|2008
0-19|15.6|17.3|16.4|1361|III(b) Astrocytomas|83118264|2008
0-19|6.2|7.3|6.7|557|III(c) Intracranial and intraspinal embryonal tumors|83118264|2008
0-19|5.3|6.4|5.8|481|III(d) Other gliomas|83118264|2008
0-19|0.5|0.9|0.7|59|III(e) Other specified intracranial & intraspinal neoplasms|83118264|2008
0-19|0.3|0.5|0.4|32|III(f) Unspecified intracranial and intraspinal neoplasms|83118264|2008
0-19|7.8|9.0|8.4|704|IV Neuroblastoma and other peripheral nervous cell tumors|83118264|2008
0-19|7.5|8.7|8.1|676|IV(a) Neuroblastoma and ganglioneuroblastoma|83118264|2008
0-19|0.2|0.5|0.3|28|IV(b) Other peripheral nervous cell tumors|83118264|2008
0-19|11.6|13.1|12.3|1032|IX Soft tissue and other extraosseous sarcomas|83118264|2008
0-19|4.6|5.6|5.1|425|IX(a) Rhabdomyosarcomas|83118264|2008
0-19|0.9|1.4|1.1|95|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|83118264|2008
0-19|~|~|~|~|IX(c) Kaposi sarcoma|83118264|2008
0-19|4.1|5.0|4.5|384|IX(d) Other specified soft tissue sarcomas|83118264|2008
0-19|1.2|1.8|1.5|126|IX(e) Unspecified soft tissue sarcomas|83118264|2008
0-19|0.2|0.4|0.3|24|Not classified by ICCC|83118264|2008
0-19|2.8|3.6|3.2|268|V Retinoblastoma|83118264|2008
0-19|6.7|7.8|7.2|601|VI Renal tumors|83118264|2008
0-19|5.9|7.0|6.5|537|VI(a) Nephroblastoma and other nonepithelial renal tumors|83118264|2008
0-19|0.5|0.9|0.7|61|VI(b) Renal carcinomas|83118264|2008
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|83118264|2008
0-19|1.9|2.6|2.3|190|VII Hepatic tumors|83118264|2008
0-19|1.4|2.0|1.7|142|VII(a) Hepatoblastoma|83118264|2008
0-19|0.4|0.7|0.6|47|VII(b) Hepatic carcinomas|83118264|2008
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|83118264|2008
0-19|8.2|9.5|8.8|739|VIII Malignant bone tumors|83118264|2008
0-19|4.5|5.5|5.0|415|VIII(a) Osteosarcomas|83118264|2008
0-19|0.3|0.6|0.4|34|VIII(b) Chondrosarcomas|83118264|2008
0-19|2.4|3.2|2.8|232|VIII(c) Ewing tumor and related sarcomas of bone|83118264|2008
0-19|0.3|0.6|0.4|35|VIII(d) Other specified malignant bone tumors|83118264|2008
0-19|0.2|0.4|0.3|23|VIII(e) Unspecified malignant bone tumors|83118264|2008
0-19|10.3|11.7|10.9|943|X Germ cell, trophoblastic tumors & neoplasms of gonads|83118264|2008
0-19|1.5|2.1|1.8|147|X(a) Intracranial & intraspinal germ cell tumors|83118264|2008
0-19|1.2|1.7|1.4|123|X(b) Malignant extracranial & extragonadal germ cell tumors|83118264|2008
0-19|6.7|7.8|7.2|629|X(c) Malignant gonadal germ cell tumors|83118264|2008
0-19|0.2|0.5|0.3|29|X(d) Gonadal carcinomas|83118264|2008
0-19|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|83118264|2008
0-19|17.3|19.2|18.2|1572|XI Other malignant epithelial neoplasms and malignant melanomas|83118264|2008
0-19|0.1|0.4|0.2|20|XI(a) Adrenocortical carcinomas|83118264|2008
0-19|7.6|8.8|8.1|705|XI(b) Thyroid carcinomas|83118264|2008
0-19|0.4|0.7|0.5|46|XI(c) Nasopharyngeal carcinomas|83118264|2008
0-19|4.5|5.4|4.9|422|XI(d) Malignant melanomas|83118264|2008
0-19|~|~|~|~|XI(e) Skin carcinomas|83118264|2008
0-19|3.9|4.8|4.3|374|XI(f) Other and unspecified carcinomas|83118264|2008
0-19|0.6|1.0|0.8|64|XII Other and unspecified malignant neoplasms|83118264|2008
0-19|0.3|0.5|0.4|32|XII(a) Other specified malignant tumors|83118264|2008
0-19|0.3|0.5|0.4|32|XII(b) Other unspecified malignant tumors|83118264|2008
0-14|160.5|166.9|163.7|10057|All ICCC Groups Combined|61087581|2009
0-14|50.9|54.5|52.7|3247|I Leukemias, myeloproliferative & myelodysplastic diseases|61087581|2009
0-14|39.6|42.8|41.2|2537|I(a) Lymphoid leukemias|61087581|2009
0-14|6.6|8.0|7.3|448|I(b) Acute myeloid leukemias|61087581|2009
0-14|1.3|1.9|1.6|97|I(c) Chronic myeloproliferative diseases|61087581|2009
0-14|1.2|1.9|1.5|95|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61087581|2009
0-14|0.9|1.4|1.1|70|I(e) Unspecified and other specified leukemias|61087581|2009
0-14|15.9|18.0|16.9|1031|II Lymphomas and reticuloendothelial neoplasms|61087581|2009
0-14|5.2|6.4|5.8|349|II(a) Hodgkin lymphomas|61087581|2009
0-14|6.3|7.7|7.0|425|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61087581|2009
0-14|2.0|2.8|2.4|143|II(c) Burkitt lymphoma|61087581|2009
0-14|1.3|2.0|1.6|102|II(d) Miscellaneous lymphoreticular neoplasms|61087581|2009
0-14|~|~|~|~|II(e) Unspecified lymphomas|61087581|2009
0-14|34.2|37.2|35.7|2185|III CNS and misc intracranial and intraspinal neoplasms|61087581|2009
0-14|2.1|2.9|2.5|155|III(a) Ependymomas and choroid plexus tumor|61087581|2009
0-14|16.7|18.9|17.8|1088|III(b) Astrocytomas|61087581|2009
0-14|7.0|8.4|7.6|469|III(c) Intracranial and intraspinal embryonal tumors|61087581|2009
0-14|6.1|7.4|6.7|409|III(d) Other gliomas|61087581|2009
0-14|0.4|0.8|0.6|34|III(e) Other specified intracranial & intraspinal neoplasms|61087581|2009
0-14|0.3|0.7|0.5|30|III(f) Unspecified intracranial and intraspinal neoplasms|61087581|2009
0-14|10.0|11.7|10.8|673|IV Neuroblastoma and other peripheral nervous cell tumors|61087581|2009
0-14|9.9|11.5|10.6|663|IV(a) Neuroblastoma and ganglioneuroblastoma|61087581|2009
0-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|61087581|2009
0-14|10.0|11.6|10.8|659|IX Soft tissue and other extraosseous sarcomas|61087581|2009
0-14|4.0|5.1|4.5|277|IX(a) Rhabdomyosarcomas|61087581|2009
0-14|1.0|1.6|1.3|78|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61087581|2009
0-14|~|~|~|~|IX(c) Kaposi sarcoma|61087581|2009
0-14|3.3|4.3|3.8|232|IX(d) Other specified soft tissue sarcomas|61087581|2009
0-14|0.9|1.5|1.2|72|IX(e) Unspecified soft tissue sarcomas|61087581|2009
0-14|0.2|0.5|0.3|20|Not classified by ICCC|61087581|2009
0-14|4.0|5.1|4.5|284|V Retinoblastoma|61087581|2009
0-14|8.5|10.0|9.2|573|VI Renal tumors|61087581|2009
0-14|7.9|9.4|8.6|535|VI(a) Nephroblastoma and other nonepithelial renal tumors|61087581|2009
0-14|0.4|0.8|0.6|36|VI(b) Renal carcinomas|61087581|2009
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|61087581|2009
0-14|1.8|2.6|2.2|137|VII Hepatic tumors|61087581|2009
0-14|1.5|2.2|1.9|116|VII(a) Hepatoblastoma|61087581|2009
0-14|0.2|0.5|0.3|19|VII(b) Hepatic carcinomas|61087581|2009
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61087581|2009
0-14|6.4|7.7|7.0|427|VIII Malignant bone tumors|61087581|2009
0-14|3.5|4.5|4.0|241|VIII(a) Osteosarcomas|61087581|2009
0-14|~|~|~|~|VIII(b) Chondrosarcomas|61087581|2009
0-14|2.0|2.8|2.4|144|VIII(c) Ewing tumor and related sarcomas of bone|61087581|2009
0-14|0.3|0.6|0.4|24|VIII(d) Other specified malignant bone tumors|61087581|2009
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|61087581|2009
0-14|4.9|6.1|5.5|334|X Germ cell, trophoblastic tumors & neoplasms of gonads|61087581|2009
0-14|1.1|1.7|1.4|85|X(a) Intracranial & intraspinal germ cell tumors|61087581|2009
0-14|0.9|1.5|1.2|74|X(b) Malignant extracranial & extragonadal germ cell tumors|61087581|2009
0-14|2.2|3.0|2.6|160|X(c) Malignant gonadal germ cell tumors|61087581|2009
0-14|~|~|~|~|X(d) Gonadal carcinomas|61087581|2009
0-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|61087581|2009
0-14|6.6|7.9|7.2|438|XI Other malignant epithelial neoplasms and malignant melanomas|61087581|2009
0-14|~|~|~|~|XI(a) Adrenocortical carcinomas|61087581|2009
0-14|2.5|3.4|2.9|177|XI(b) Thyroid carcinomas|61087581|2009
0-14|0.3|0.6|0.4|25|XI(c) Nasopharyngeal carcinomas|61087581|2009
0-14|1.3|2.0|1.7|101|XI(d) Malignant melanomas|61087581|2009
0-14|~|~|~|~|XI(e) Skin carcinomas|61087581|2009
0-14|1.6|2.3|1.9|115|XI(f) Other and unspecified carcinomas|61087581|2009
0-14|0.6|1.0|0.8|49|XII Other and unspecified malignant neoplasms|61087581|2009
0-14|0.2|0.5|0.3|21|XII(a) Other specified malignant tumors|61087581|2009
0-14|0.3|0.7|0.5|28|XII(b) Other unspecified malignant tumors|61087581|2009
0-19|175.7|181.4|178.5|14997|All ICCC Groups Combined|83280391|2009
0-19|46.1|49.1|47.5|3962|I Leukemias, myeloproliferative & myelodysplastic diseases|83280391|2009
0-19|33.6|36.1|34.8|2892|I(a) Lymphoid leukemias|83280391|2009
0-19|7.1|8.3|7.6|642|I(b) Acute myeloid leukemias|83280391|2009
0-19|2.0|2.7|2.4|201|I(c) Chronic myeloproliferative diseases|83280391|2009
0-19|1.3|1.8|1.5|130|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|83280391|2009
0-19|0.9|1.4|1.2|97|I(e) Unspecified and other specified leukemias|83280391|2009
0-19|24.3|26.4|25.3|2149|II Lymphomas and reticuloendothelial neoplasms|83280391|2009
0-19|11.9|13.4|12.6|1083|II(a) Hodgkin lymphomas|83280391|2009
0-19|8.2|9.5|8.9|745|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|83280391|2009
0-19|1.9|2.6|2.2|184|II(c) Burkitt lymphoma|83280391|2009
0-19|1.1|1.6|1.3|111|II(d) Miscellaneous lymphoreticular neoplasms|83280391|2009
0-19|0.2|0.5|0.3|26|II(e) Unspecified lymphomas|83280391|2009
0-19|31.0|33.4|32.2|2668|III CNS and misc intracranial and intraspinal neoplasms|83280391|2009
0-19|2.1|2.8|2.4|203|III(a) Ependymomas and choroid plexus tumor|83280391|2009
0-19|15.5|17.2|16.3|1355|III(b) Astrocytomas|83280391|2009
0-19|5.8|6.9|6.4|526|III(c) Intracranial and intraspinal embryonal tumors|83280391|2009
0-19|5.5|6.6|6.0|499|III(d) Other gliomas|83280391|2009
0-19|0.4|0.8|0.6|49|III(e) Other specified intracranial & intraspinal neoplasms|83280391|2009
0-19|0.3|0.6|0.4|36|III(f) Unspecified intracranial and intraspinal neoplasms|83280391|2009
0-19|7.7|8.9|8.3|691|IV Neuroblastoma and other peripheral nervous cell tumors|83280391|2009
0-19|7.4|8.7|8.0|668|IV(a) Neuroblastoma and ganglioneuroblastoma|83280391|2009
0-19|0.2|0.4|0.3|23|IV(b) Other peripheral nervous cell tumors|83280391|2009
0-19|11.5|13.0|12.2|1025|IX Soft tissue and other extraosseous sarcomas|83280391|2009
0-19|3.8|4.7|4.3|355|IX(a) Rhabdomyosarcomas|83280391|2009
0-19|1.3|1.8|1.6|131|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|83280391|2009
0-19|~|~|~|~|IX(c) Kaposi sarcoma|83280391|2009
0-19|4.5|5.5|5.0|418|IX(d) Other specified soft tissue sarcomas|83280391|2009
0-19|1.1|1.6|1.4|114|IX(e) Unspecified soft tissue sarcomas|83280391|2009
0-19|0.2|0.5|0.3|28|Not classified by ICCC|83280391|2009
0-19|3.0|3.8|3.4|284|V Retinoblastoma|83280391|2009
0-19|6.8|8.0|7.4|616|VI Renal tumors|83280391|2009
0-19|6.0|7.1|6.6|545|VI(a) Nephroblastoma and other nonepithelial renal tumors|83280391|2009
0-19|0.6|1.0|0.8|69|VI(b) Renal carcinomas|83280391|2009
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|83280391|2009
0-19|1.7|2.3|2.0|167|VII Hepatic tumors|83280391|2009
0-19|1.1|1.7|1.4|116|VII(a) Hepatoblastoma|83280391|2009
0-19|0.4|0.8|0.6|49|VII(b) Hepatic carcinomas|83280391|2009
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|83280391|2009
0-19|8.4|9.7|9.0|758|VIII Malignant bone tumors|83280391|2009
0-19|4.6|5.6|5.1|425|VIII(a) Osteosarcomas|83280391|2009
0-19|0.2|0.5|0.3|27|VIII(b) Chondrosarcomas|83280391|2009
0-19|2.6|3.3|2.9|247|VIII(c) Ewing tumor and related sarcomas of bone|83280391|2009
0-19|0.4|0.7|0.5|42|VIII(d) Other specified malignant bone tumors|83280391|2009
0-19|0.1|0.3|0.2|17|VIII(e) Unspecified malignant bone tumors|83280391|2009
0-19|10.9|12.3|11.6|994|X Germ cell, trophoblastic tumors & neoplasms of gonads|83280391|2009
0-19|1.4|2.0|1.7|142|X(a) Intracranial & intraspinal germ cell tumors|83280391|2009
0-19|1.1|1.6|1.4|116|X(b) Malignant extracranial & extragonadal germ cell tumors|83280391|2009
0-19|7.0|8.2|7.6|654|X(c) Malignant gonadal germ cell tumors|83280391|2009
0-19|0.5|0.8|0.6|53|X(d) Gonadal carcinomas|83280391|2009
0-19|0.2|0.5|0.3|29|X(e) Other and unspecified malignant gonadal tumors|83280391|2009
0-19|17.4|19.3|18.3|1579|XI Other malignant epithelial neoplasms and malignant melanomas|83280391|2009
0-19|0.2|0.4|0.2|21|XI(a) Adrenocortical carcinomas|83280391|2009
0-19|7.7|9.0|8.3|720|XI(b) Thyroid carcinomas|83280391|2009
0-19|0.5|0.9|0.7|59|XI(c) Nasopharyngeal carcinomas|83280391|2009
0-19|4.0|4.9|4.4|383|XI(d) Malignant melanomas|83280391|2009
0-19|~|~|~|~|XI(e) Skin carcinomas|83280391|2009
0-19|4.1|5.0|4.5|387|XI(f) Other and unspecified carcinomas|83280391|2009
0-19|0.7|1.1|0.9|76|XII Other and unspecified malignant neoplasms|83280391|2009
0-19|0.2|0.5|0.4|31|XII(a) Other specified malignant tumors|83280391|2009
0-19|0.4|0.7|0.5|45|XII(b) Other unspecified malignant tumors|83280391|2009
0-14|167.6|174.2|170.9|10507|All ICCC Groups Combined|61200649|2010
0-14|52.5|56.2|54.3|3349|I Leukemias, myeloproliferative & myelodysplastic diseases|61200649|2010
0-14|39.4|42.6|41.0|2528|I(a) Lymphoid leukemias|61200649|2010
0-14|7.1|8.5|7.8|478|I(b) Acute myeloid leukemias|61200649|2010
0-14|1.6|2.3|1.9|118|I(c) Chronic myeloproliferative diseases|61200649|2010
0-14|1.6|2.3|1.9|118|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61200649|2010
0-14|1.4|2.1|1.7|107|I(e) Unspecified and other specified leukemias|61200649|2010
0-14|19.0|21.2|20.1|1226|II Lymphomas and reticuloendothelial neoplasms|61200649|2010
0-14|4.8|5.9|5.3|324|II(a) Hodgkin lymphomas|61200649|2010
0-14|6.5|7.8|7.1|435|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61200649|2010
0-14|2.1|2.9|2.5|151|II(c) Burkitt lymphoma|61200649|2010
0-14|4.4|5.6|5.0|306|II(d) Miscellaneous lymphoreticular neoplasms|61200649|2010
0-14|~|~|~|~|II(e) Unspecified lymphomas|61200649|2010
0-14|35.2|38.3|36.7|2254|III CNS and misc intracranial and intraspinal neoplasms|61200649|2010
0-14|2.9|3.8|3.3|205|III(a) Ependymomas and choroid plexus tumor|61200649|2010
0-14|17.7|19.9|18.8|1154|III(b) Astrocytomas|61200649|2010
0-14|6.7|8.1|7.4|455|III(c) Intracranial and intraspinal embryonal tumors|61200649|2010
0-14|5.6|6.8|6.2|378|III(d) Other gliomas|61200649|2010
0-14|0.5|0.9|0.6|39|III(e) Other specified intracranial & intraspinal neoplasms|61200649|2010
0-14|0.2|0.6|0.4|23|III(f) Unspecified intracranial and intraspinal neoplasms|61200649|2010
0-14|10.4|12.1|11.2|696|IV Neuroblastoma and other peripheral nervous cell tumors|61200649|2010
0-14|10.2|11.9|11.0|685|IV(a) Neuroblastoma and ganglioneuroblastoma|61200649|2010
0-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|61200649|2010
0-14|10.8|12.5|11.7|714|IX Soft tissue and other extraosseous sarcomas|61200649|2010
0-14|5.0|6.2|5.6|344|IX(a) Rhabdomyosarcomas|61200649|2010
0-14|0.6|1.1|0.8|50|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61200649|2010
0-14|~|~|~|~|IX(c) Kaposi sarcoma|61200649|2010
0-14|3.4|4.5|3.9|240|IX(d) Other specified soft tissue sarcomas|61200649|2010
0-14|1.0|1.6|1.3|80|IX(e) Unspecified soft tissue sarcomas|61200649|2010
0-14|~|~|~|~|Not classified by ICCC|61200649|2010
0-14|4.0|5.1|4.6|283|V Retinoblastoma|61200649|2010
0-14|7.8|9.2|8.5|527|VI Renal tumors|61200649|2010
0-14|7.4|8.9|8.1|506|VI(a) Nephroblastoma and other nonepithelial renal tumors|61200649|2010
0-14|0.2|0.5|0.3|19|VI(b) Renal carcinomas|61200649|2010
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|61200649|2010
0-14|2.6|3.5|3.0|187|VII Hepatic tumors|61200649|2010
0-14|2.1|3.0|2.5|157|VII(a) Hepatoblastoma|61200649|2010
0-14|0.3|0.7|0.5|29|VII(b) Hepatic carcinomas|61200649|2010
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61200649|2010
0-14|6.1|7.4|6.7|408|VIII Malignant bone tumors|61200649|2010
0-14|3.2|4.2|3.7|225|VIII(a) Osteosarcomas|61200649|2010
0-14|~|~|~|~|VIII(b) Chondrosarcomas|61200649|2010
0-14|2.0|2.8|2.4|143|VIII(c) Ewing tumor and related sarcomas of bone|61200649|2010
0-14|0.2|0.5|0.3|20|VIII(d) Other specified malignant bone tumors|61200649|2010
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|61200649|2010
0-14|5.6|6.8|6.2|378|X Germ cell, trophoblastic tumors & neoplasms of gonads|61200649|2010
0-14|1.5|2.2|1.8|111|X(a) Intracranial & intraspinal germ cell tumors|61200649|2010
0-14|1.1|1.7|1.4|84|X(b) Malignant extracranial & extragonadal germ cell tumors|61200649|2010
0-14|2.2|3.0|2.6|159|X(c) Malignant gonadal germ cell tumors|61200649|2010
0-14|~|~|~|~|X(d) Gonadal carcinomas|61200649|2010
0-14|0.2|0.4|0.3|16|X(e) Other and unspecified malignant gonadal tumors|61200649|2010
0-14|6.4|7.8|7.1|430|XI Other malignant epithelial neoplasms and malignant melanomas|61200649|2010
0-14|~|~|~|~|XI(a) Adrenocortical carcinomas|61200649|2010
0-14|2.5|3.3|2.9|175|XI(b) Thyroid carcinomas|61200649|2010
0-14|0.2|0.4|0.3|17|XI(c) Nasopharyngeal carcinomas|61200649|2010
0-14|1.5|2.2|1.8|110|XI(d) Malignant melanomas|61200649|2010
0-14|~|~|~|~|XI(e) Skin carcinomas|61200649|2010
0-14|1.5|2.2|1.8|109|XI(f) Other and unspecified carcinomas|61200649|2010
0-14|0.5|0.9|0.6|40|XII Other and unspecified malignant neoplasms|61200649|2010
0-14|0.3|0.6|0.4|25|XII(a) Other specified malignant tumors|61200649|2010
0-14|~|~|~|~|XII(b) Other unspecified malignant tumors|61200649|2010
0-19|179.6|185.4|182.5|15280|All ICCC Groups Combined|83181748|2010
0-19|47.6|50.7|49.1|4089|I Leukemias, myeloproliferative & myelodysplastic diseases|83181748|2010
0-19|33.4|35.9|34.6|2875|I(a) Lymphoid leukemias|83181748|2010
0-19|7.8|9.0|8.4|702|I(b) Acute myeloid leukemias|83181748|2010
0-19|2.3|3.0|2.7|225|I(c) Chronic myeloproliferative diseases|83181748|2010
0-19|1.5|2.1|1.8|150|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|83181748|2010
0-19|1.4|1.9|1.6|137|I(e) Unspecified and other specified leukemias|83181748|2010
0-19|26.5|28.7|27.6|2325|II Lymphomas and reticuloendothelial neoplasms|83181748|2010
0-19|11.4|12.9|12.1|1035|II(a) Hodgkin lymphomas|83181748|2010
0-19|8.0|9.3|8.7|725|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|83181748|2010
0-19|2.1|2.8|2.4|202|II(c) Burkitt lymphoma|83181748|2010
0-19|3.6|4.5|4.0|334|II(d) Miscellaneous lymphoreticular neoplasms|83181748|2010
0-19|0.2|0.5|0.3|29|II(e) Unspecified lymphomas|83181748|2010
0-19|31.5|33.9|32.7|2709|III CNS and misc intracranial and intraspinal neoplasms|83181748|2010
0-19|2.5|3.3|2.9|239|III(a) Ependymomas and choroid plexus tumor|83181748|2010
0-19|16.2|18.0|17.1|1419|III(b) Astrocytomas|83181748|2010
0-19|5.6|6.6|6.1|503|III(c) Intracranial and intraspinal embryonal tumors|83181748|2010
0-19|5.2|6.2|5.7|470|III(d) Other gliomas|83181748|2010
0-19|0.5|0.8|0.6|51|III(e) Other specified intracranial & intraspinal neoplasms|83181748|2010
0-19|0.2|0.5|0.3|27|III(f) Unspecified intracranial and intraspinal neoplasms|83181748|2010
0-19|8.0|9.3|8.6|714|IV Neuroblastoma and other peripheral nervous cell tumors|83181748|2010
0-19|7.8|9.0|8.4|696|IV(a) Neuroblastoma and ganglioneuroblastoma|83181748|2010
0-19|0.1|0.3|0.2|18|IV(b) Other peripheral nervous cell tumors|83181748|2010
0-19|12.1|13.7|12.9|1076|IX Soft tissue and other extraosseous sarcomas|83181748|2010
0-19|4.8|5.8|5.3|439|IX(a) Rhabdomyosarcomas|83181748|2010
0-19|0.8|1.3|1.1|89|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|83181748|2010
0-19|~|~|~|~|IX(c) Kaposi sarcoma|83181748|2010
0-19|4.3|5.2|4.8|399|IX(d) Other specified soft tissue sarcomas|83181748|2010
0-19|1.5|2.0|1.7|145|IX(e) Unspecified soft tissue sarcomas|83181748|2010
0-19|0.1|0.4|0.2|20|Not classified by ICCC|83181748|2010
0-19|3.0|3.8|3.4|283|V Retinoblastoma|83181748|2010
0-19|6.1|7.3|6.7|557|VI Renal tumors|83181748|2010
0-19|5.6|6.7|6.2|513|VI(a) Nephroblastoma and other nonepithelial renal tumors|83181748|2010
0-19|0.4|0.7|0.5|42|VI(b) Renal carcinomas|83181748|2010
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|83181748|2010
0-19|2.3|3.0|2.6|221|VII Hepatic tumors|83181748|2010
0-19|1.6|2.2|1.9|160|VII(a) Hepatoblastoma|83181748|2010
0-19|0.5|0.9|0.7|59|VII(b) Hepatic carcinomas|83181748|2010
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|83181748|2010
0-19|7.7|9.0|8.3|698|VIII Malignant bone tumors|83181748|2010
0-19|4.3|5.2|4.7|397|VIII(a) Osteosarcomas|83181748|2010
0-19|0.3|0.5|0.4|32|VIII(b) Chondrosarcomas|83181748|2010
0-19|2.3|3.0|2.6|218|VIII(c) Ewing tumor and related sarcomas of bone|83181748|2010
0-19|0.3|0.6|0.4|36|VIII(d) Other specified malignant bone tumors|83181748|2010
0-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|83181748|2010
0-19|10.8|12.3|11.6|983|X Germ cell, trophoblastic tumors & neoplasms of gonads|83181748|2010
0-19|1.7|2.3|2.0|167|X(a) Intracranial & intraspinal germ cell tumors|83181748|2010
0-19|1.1|1.6|1.3|112|X(b) Malignant extracranial & extragonadal germ cell tumors|83181748|2010
0-19|6.7|7.9|7.3|626|X(c) Malignant gonadal germ cell tumors|83181748|2010
0-19|0.4|0.7|0.5|43|X(d) Gonadal carcinomas|83181748|2010
0-19|0.3|0.6|0.4|35|X(e) Other and unspecified malignant gonadal tumors|83181748|2010
0-19|17.2|19.0|18.1|1546|XI Other malignant epithelial neoplasms and malignant melanomas|83181748|2010
0-19|0.2|0.4|0.3|21|XI(a) Adrenocortical carcinomas|83181748|2010
0-19|8.0|9.3|8.6|742|XI(b) Thyroid carcinomas|83181748|2010
0-19|0.4|0.8|0.6|49|XI(c) Nasopharyngeal carcinomas|83181748|2010
0-19|3.6|4.5|4.0|344|XI(d) Malignant melanomas|83181748|2010
0-19|~|~|~|~|XI(e) Skin carcinomas|83181748|2010
0-19|4.0|4.9|4.5|381|XI(f) Other and unspecified carcinomas|83181748|2010
0-19|0.5|0.9|0.7|59|XII Other and unspecified malignant neoplasms|83181748|2010
0-19|0.3|0.6|0.4|34|XII(a) Other specified malignant tumors|83181748|2010
0-19|0.2|0.4|0.3|25|XII(b) Other unspecified malignant tumors|83181748|2010
0-14|167.3|173.9|170.6|10476|All ICCC Groups Combined|61168399|2011
0-14|52.5|56.2|54.3|3343|I Leukemias, myeloproliferative & myelodysplastic diseases|61168399|2011
0-14|40.3|43.6|41.9|2583|I(a) Lymphoid leukemias|61168399|2011
0-14|7.0|8.4|7.7|472|I(b) Acute myeloid leukemias|61168399|2011
0-14|1.5|2.2|1.8|112|I(c) Chronic myeloproliferative diseases|61168399|2011
0-14|1.1|1.7|1.3|83|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61168399|2011
0-14|1.2|1.9|1.5|93|I(e) Unspecified and other specified leukemias|61168399|2011
0-14|19.2|21.5|20.4|1243|II Lymphomas and reticuloendothelial neoplasms|61168399|2011
0-14|4.6|5.8|5.2|316|II(a) Hodgkin lymphomas|61168399|2011
0-14|5.8|7.0|6.4|389|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61168399|2011
0-14|2.3|3.1|2.7|162|II(c) Burkitt lymphoma|61168399|2011
0-14|5.3|6.5|5.9|362|II(d) Miscellaneous lymphoreticular neoplasms|61168399|2011
0-14|~|~|~|~|II(e) Unspecified lymphomas|61168399|2011
0-14|34.5|37.5|36.0|2207|III CNS and misc intracranial and intraspinal neoplasms|61168399|2011
0-14|3.0|3.9|3.4|210|III(a) Ependymomas and choroid plexus tumor|61168399|2011
0-14|17.1|19.3|18.2|1115|III(b) Astrocytomas|61168399|2011
0-14|6.4|7.7|7.0|433|III(c) Intracranial and intraspinal embryonal tumors|61168399|2011
0-14|5.7|7.0|6.3|385|III(d) Other gliomas|61168399|2011
0-14|0.4|0.8|0.6|35|III(e) Other specified intracranial & intraspinal neoplasms|61168399|2011
0-14|0.3|0.7|0.5|29|III(f) Unspecified intracranial and intraspinal neoplasms|61168399|2011
0-14|10.5|12.2|11.3|699|IV Neuroblastoma and other peripheral nervous cell tumors|61168399|2011
0-14|10.3|11.9|11.1|686|IV(a) Neuroblastoma and ganglioneuroblastoma|61168399|2011
0-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|61168399|2011
0-14|10.3|12.0|11.1|681|IX Soft tissue and other extraosseous sarcomas|61168399|2011
0-14|4.6|5.8|5.2|320|IX(a) Rhabdomyosarcomas|61168399|2011
0-14|0.8|1.3|1.0|64|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61168399|2011
0-14|~|~|~|~|IX(c) Kaposi sarcoma|61168399|2011
0-14|3.3|4.3|3.8|229|IX(d) Other specified soft tissue sarcomas|61168399|2011
0-14|0.8|1.4|1.1|66|IX(e) Unspecified soft tissue sarcomas|61168399|2011
0-14|~|~|~|~|Not classified by ICCC|61168399|2011
0-14|3.7|4.8|4.2|263|V Retinoblastoma|61168399|2011
0-14|8.2|9.8|9.0|556|VI Renal tumors|61168399|2011
0-14|7.9|9.4|8.6|533|VI(a) Nephroblastoma and other nonepithelial renal tumors|61168399|2011
0-14|0.2|0.5|0.4|22|VI(b) Renal carcinomas|61168399|2011
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|61168399|2011
0-14|2.7|3.6|3.2|196|VII Hepatic tumors|61168399|2011
0-14|2.3|3.1|2.7|167|VII(a) Hepatoblastoma|61168399|2011
0-14|0.3|0.6|0.4|25|VII(b) Hepatic carcinomas|61168399|2011
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61168399|2011
0-14|6.8|8.1|7.4|452|VIII Malignant bone tumors|61168399|2011
0-14|3.6|4.7|4.1|250|VIII(a) Osteosarcomas|61168399|2011
0-14|~|~|~|~|VIII(b) Chondrosarcomas|61168399|2011
0-14|2.4|3.3|2.8|172|VIII(c) Ewing tumor and related sarcomas of bone|61168399|2011
0-14|~|~|~|~|VIII(d) Other specified malignant bone tumors|61168399|2011
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|61168399|2011
0-14|4.6|5.7|5.1|314|X Germ cell, trophoblastic tumors & neoplasms of gonads|61168399|2011
0-14|1.2|1.9|1.5|93|X(a) Intracranial & intraspinal germ cell tumors|61168399|2011
0-14|1.0|1.5|1.2|75|X(b) Malignant extracranial & extragonadal germ cell tumors|61168399|2011
0-14|1.8|2.6|2.2|132|X(c) Malignant gonadal germ cell tumors|61168399|2011
0-14|~|~|~|~|X(d) Gonadal carcinomas|61168399|2011
0-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|61168399|2011
0-14|7.1|8.5|7.7|471|XI Other malignant epithelial neoplasms and malignant melanomas|61168399|2011
0-14|~|~|~|~|XI(a) Adrenocortical carcinomas|61168399|2011
0-14|2.9|3.8|3.3|202|XI(b) Thyroid carcinomas|61168399|2011
0-14|0.2|0.5|0.3|19|XI(c) Nasopharyngeal carcinomas|61168399|2011
0-14|1.7|2.5|2.1|127|XI(d) Malignant melanomas|61168399|2011
0-14|~|~|~|~|XI(e) Skin carcinomas|61168399|2011
0-14|1.4|2.1|1.7|106|XI(f) Other and unspecified carcinomas|61168399|2011
0-14|0.5|0.9|0.6|39|XII Other and unspecified malignant neoplasms|61168399|2011
0-14|0.2|0.4|0.3|17|XII(a) Other specified malignant tumors|61168399|2011
0-14|0.2|0.5|0.4|22|XII(b) Other unspecified malignant tumors|61168399|2011
0-19|181.5|187.4|184.4|15364|All ICCC Groups Combined|82826880|2011
0-19|47.8|50.9|49.4|4092|I Leukemias, myeloproliferative & myelodysplastic diseases|82826880|2011
0-19|34.6|37.2|35.8|2966|I(a) Lymphoid leukemias|82826880|2011
0-19|7.7|9.0|8.3|694|I(b) Acute myeloid leukemias|82826880|2011
0-19|2.1|2.8|2.4|203|I(c) Chronic myeloproliferative diseases|82826880|2011
0-19|1.1|1.6|1.3|107|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82826880|2011
0-19|1.2|1.8|1.5|122|I(e) Unspecified and other specified leukemias|82826880|2011
0-19|26.9|29.2|28.0|2346|II Lymphomas and reticuloendothelial neoplasms|82826880|2011
0-19|11.1|12.6|11.9|1003|II(a) Hodgkin lymphomas|82826880|2011
0-19|7.9|9.1|8.5|707|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82826880|2011
0-19|2.2|2.9|2.5|208|II(c) Burkitt lymphoma|82826880|2011
0-19|4.4|5.3|4.8|399|II(d) Miscellaneous lymphoreticular neoplasms|82826880|2011
0-19|0.2|0.5|0.3|29|II(e) Unspecified lymphomas|82826880|2011
0-19|32.2|34.7|33.4|2763|III CNS and misc intracranial and intraspinal neoplasms|82826880|2011
0-19|2.5|3.3|2.9|237|III(a) Ependymomas and choroid plexus tumor|82826880|2011
0-19|16.5|18.3|17.4|1438|III(b) Astrocytomas|82826880|2011
0-19|5.6|6.7|6.1|507|III(c) Intracranial and intraspinal embryonal tumors|82826880|2011
0-19|5.5|6.6|6.0|496|III(d) Other gliomas|82826880|2011
0-19|0.4|0.8|0.6|50|III(e) Other specified intracranial & intraspinal neoplasms|82826880|2011
0-19|0.3|0.6|0.4|35|III(f) Unspecified intracranial and intraspinal neoplasms|82826880|2011
0-19|8.0|9.3|8.6|715|IV Neuroblastoma and other peripheral nervous cell tumors|82826880|2011
0-19|7.8|9.0|8.4|694|IV(a) Neuroblastoma and ganglioneuroblastoma|82826880|2011
0-19|0.2|0.4|0.3|21|IV(b) Other peripheral nervous cell tumors|82826880|2011
0-19|11.5|13.0|12.2|1017|IX Soft tissue and other extraosseous sarcomas|82826880|2011
0-19|4.3|5.2|4.7|392|IX(a) Rhabdomyosarcomas|82826880|2011
0-19|1.1|1.6|1.3|109|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82826880|2011
0-19|~|~|~|~|IX(c) Kaposi sarcoma|82826880|2011
0-19|4.4|5.3|4.8|403|IX(d) Other specified soft tissue sarcomas|82826880|2011
0-19|1.0|1.5|1.3|106|IX(e) Unspecified soft tissue sarcomas|82826880|2011
0-19|0.2|0.4|0.3|23|Not classified by ICCC|82826880|2011
0-19|2.8|3.6|3.2|263|V Retinoblastoma|82826880|2011
0-19|6.6|7.8|7.2|596|VI Renal tumors|82826880|2011
0-19|6.0|7.1|6.5|539|VI(a) Nephroblastoma and other nonepithelial renal tumors|82826880|2011
0-19|0.5|0.9|0.7|56|VI(b) Renal carcinomas|82826880|2011
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|82826880|2011
0-19|2.3|3.0|2.6|216|VII Hepatic tumors|82826880|2011
0-19|1.7|2.4|2.0|168|VII(a) Hepatoblastoma|82826880|2011
0-19|0.4|0.7|0.5|44|VII(b) Hepatic carcinomas|82826880|2011
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82826880|2011
0-19|8.3|9.6|9.0|744|VIII Malignant bone tumors|82826880|2011
0-19|4.6|5.6|5.1|422|VIII(a) Osteosarcomas|82826880|2011
0-19|0.2|0.4|0.2|21|VIII(b) Chondrosarcomas|82826880|2011
0-19|2.8|3.6|3.2|262|VIII(c) Ewing tumor and related sarcomas of bone|82826880|2011
0-19|0.2|0.5|0.3|26|VIII(d) Other specified malignant bone tumors|82826880|2011
0-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|82826880|2011
0-19|10.1|11.5|10.8|913|X Germ cell, trophoblastic tumors & neoplasms of gonads|82826880|2011
0-19|1.4|2.0|1.7|138|X(a) Intracranial & intraspinal germ cell tumors|82826880|2011
0-19|1.2|1.7|1.4|117|X(b) Malignant extracranial & extragonadal germ cell tumors|82826880|2011
0-19|6.6|7.8|7.2|610|X(c) Malignant gonadal germ cell tumors|82826880|2011
0-19|0.2|0.5|0.3|26|X(d) Gonadal carcinomas|82826880|2011
0-19|0.2|0.4|0.3|22|X(e) Other and unspecified malignant gonadal tumors|82826880|2011
0-19|18.2|20.1|19.1|1618|XI Other malignant epithelial neoplasms and malignant melanomas|82826880|2011
0-19|0.1|0.4|0.2|19|XI(a) Adrenocortical carcinomas|82826880|2011
0-19|8.7|10.0|9.4|795|XI(b) Thyroid carcinomas|82826880|2011
0-19|0.5|0.8|0.6|52|XI(c) Nasopharyngeal carcinomas|82826880|2011
0-19|3.9|4.8|4.3|365|XI(d) Malignant melanomas|82826880|2011
0-19|~|~|~|~|XI(e) Skin carcinomas|82826880|2011
0-19|4.0|5.0|4.5|380|XI(f) Other and unspecified carcinomas|82826880|2011
0-19|0.5|0.9|0.7|58|XII Other and unspecified malignant neoplasms|82826880|2011
0-19|0.2|0.5|0.3|28|XII(a) Other specified malignant tumors|82826880|2011
0-19|0.2|0.5|0.4|30|XII(b) Other unspecified malignant tumors|82826880|2011
0-14|166.8|173.3|170.0|10421|All ICCC Groups Combined|61112950|2012
0-14|50.8|54.4|52.6|3231|I Leukemias, myeloproliferative & myelodysplastic diseases|61112950|2012
0-14|38.8|42.0|40.4|2481|I(a) Lymphoid leukemias|61112950|2012
0-14|6.5|7.9|7.2|439|I(b) Acute myeloid leukemias|61112950|2012
0-14|1.4|2.0|1.7|103|I(c) Chronic myeloproliferative diseases|61112950|2012
0-14|1.4|2.0|1.7|102|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61112950|2012
0-14|1.4|2.1|1.7|106|I(e) Unspecified and other specified leukemias|61112950|2012
0-14|20.6|23.0|21.8|1330|II Lymphomas and reticuloendothelial neoplasms|61112950|2012
0-14|5.2|6.4|5.8|351|II(a) Hodgkin lymphomas|61112950|2012
0-14|6.8|8.2|7.5|458|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61112950|2012
0-14|2.0|2.8|2.3|143|II(c) Burkitt lymphoma|61112950|2012
0-14|5.2|6.4|5.8|354|II(d) Miscellaneous lymphoreticular neoplasms|61112950|2012
0-14|0.3|0.6|0.4|24|II(e) Unspecified lymphomas|61112950|2012
0-14|34.0|37.0|35.5|2173|III CNS and misc intracranial and intraspinal neoplasms|61112950|2012
0-14|2.5|3.4|2.9|181|III(a) Ependymomas and choroid plexus tumor|61112950|2012
0-14|17.8|20.0|18.9|1155|III(b) Astrocytomas|61112950|2012
0-14|6.5|7.8|7.1|437|III(c) Intracranial and intraspinal embryonal tumors|61112950|2012
0-14|4.7|5.8|5.2|319|III(d) Other gliomas|61112950|2012
0-14|0.4|0.8|0.6|36|III(e) Other specified intracranial & intraspinal neoplasms|61112950|2012
0-14|0.5|1.0|0.7|45|III(f) Unspecified intracranial and intraspinal neoplasms|61112950|2012
0-14|10.7|12.4|11.5|708|IV Neuroblastoma and other peripheral nervous cell tumors|61112950|2012
0-14|10.4|12.1|11.3|694|IV(a) Neuroblastoma and ganglioneuroblastoma|61112950|2012
0-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|61112950|2012
0-14|10.3|12.0|11.1|678|IX Soft tissue and other extraosseous sarcomas|61112950|2012
0-14|4.5|5.6|5.0|309|IX(a) Rhabdomyosarcomas|61112950|2012
0-14|0.9|1.5|1.2|72|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61112950|2012
0-14|~|~|~|~|IX(c) Kaposi sarcoma|61112950|2012
0-14|3.1|4.1|3.6|220|IX(d) Other specified soft tissue sarcomas|61112950|2012
0-14|1.0|1.5|1.2|75|IX(e) Unspecified soft tissue sarcomas|61112950|2012
0-14|~|~|~|~|Not classified by ICCC|61112950|2012
0-14|3.9|5.0|4.4|272|V Retinoblastoma|61112950|2012
0-14|7.9|9.4|8.6|532|VI Renal tumors|61112950|2012
0-14|7.5|9.0|8.2|507|VI(a) Nephroblastoma and other nonepithelial renal tumors|61112950|2012
0-14|0.2|0.5|0.3|20|VI(b) Renal carcinomas|61112950|2012
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|61112950|2012
0-14|2.9|3.8|3.3|205|VII Hepatic tumors|61112950|2012
0-14|2.4|3.3|2.8|175|VII(a) Hepatoblastoma|61112950|2012
0-14|0.3|0.7|0.5|28|VII(b) Hepatic carcinomas|61112950|2012
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61112950|2012
0-14|6.6|8.0|7.3|444|VIII Malignant bone tumors|61112950|2012
0-14|3.9|5.0|4.4|269|VIII(a) Osteosarcomas|61112950|2012
0-14|~|~|~|~|VIII(b) Chondrosarcomas|61112950|2012
0-14|1.9|2.6|2.2|136|VIII(c) Ewing tumor and related sarcomas of bone|61112950|2012
0-14|0.2|0.5|0.3|20|VIII(d) Other specified malignant bone tumors|61112950|2012
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|61112950|2012
0-14|4.6|5.8|5.2|317|X Germ cell, trophoblastic tumors & neoplasms of gonads|61112950|2012
0-14|1.1|1.7|1.4|84|X(a) Intracranial & intraspinal germ cell tumors|61112950|2012
0-14|1.2|1.9|1.5|93|X(b) Malignant extracranial & extragonadal germ cell tumors|61112950|2012
0-14|1.7|2.5|2.1|126|X(c) Malignant gonadal germ cell tumors|61112950|2012
0-14|~|~|~|~|X(d) Gonadal carcinomas|61112950|2012
0-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|61112950|2012
0-14|7.0|8.4|7.7|467|XI Other malignant epithelial neoplasms and malignant melanomas|61112950|2012
0-14|~|~|~|~|XI(a) Adrenocortical carcinomas|61112950|2012
0-14|2.8|3.8|3.3|199|XI(b) Thyroid carcinomas|61112950|2012
0-14|~|~|~|~|XI(c) Nasopharyngeal carcinomas|61112950|2012
0-14|1.6|2.3|1.9|118|XI(d) Malignant melanomas|61112950|2012
0-14|~|~|~|~|XI(e) Skin carcinomas|61112950|2012
0-14|1.6|2.3|2.0|119|XI(f) Other and unspecified carcinomas|61112950|2012
0-14|0.6|1.1|0.8|52|XII Other and unspecified malignant neoplasms|61112950|2012
0-14|0.3|0.6|0.4|25|XII(a) Other specified malignant tumors|61112950|2012
0-14|0.3|0.6|0.4|27|XII(b) Other unspecified malignant tumors|61112950|2012
0-19|182.8|188.7|185.8|15392|All ICCC Groups Combined|82482164|2012
0-19|46.4|49.4|47.8|3951|I Leukemias, myeloproliferative & myelodysplastic diseases|82482164|2012
0-19|33.0|35.5|34.2|2822|I(a) Lymphoid leukemias|82482164|2012
0-19|7.2|8.5|7.8|650|I(b) Acute myeloid leukemias|82482164|2012
0-19|2.2|2.9|2.5|209|I(c) Chronic myeloproliferative diseases|82482164|2012
0-19|1.3|1.8|1.5|124|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82482164|2012
0-19|1.5|2.1|1.8|146|I(e) Unspecified and other specified leukemias|82482164|2012
0-19|28.9|31.3|30.1|2499|II Lymphomas and reticuloendothelial neoplasms|82482164|2012
0-19|11.8|13.3|12.6|1051|II(a) Hodgkin lymphomas|82482164|2012
0-19|9.2|10.6|9.9|821|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82482164|2012
0-19|2.0|2.7|2.3|191|II(c) Burkitt lymphoma|82482164|2012
0-19|4.4|5.3|4.8|397|II(d) Miscellaneous lymphoreticular neoplasms|82482164|2012
0-19|0.3|0.6|0.5|39|II(e) Unspecified lymphomas|82482164|2012
0-19|31.2|33.6|32.4|2667|III CNS and misc intracranial and intraspinal neoplasms|82482164|2012
0-19|2.3|3.1|2.7|221|III(a) Ependymomas and choroid plexus tumor|82482164|2012
0-19|16.6|18.4|17.5|1440|III(b) Astrocytomas|82482164|2012
0-19|5.3|6.4|5.8|479|III(c) Intracranial and intraspinal embryonal tumors|82482164|2012
0-19|4.7|5.7|5.2|428|III(d) Other gliomas|82482164|2012
0-19|0.4|0.7|0.6|46|III(e) Other specified intracranial & intraspinal neoplasms|82482164|2012
0-19|0.5|0.8|0.6|53|III(f) Unspecified intracranial and intraspinal neoplasms|82482164|2012
0-19|8.2|9.5|8.8|726|IV Neuroblastoma and other peripheral nervous cell tumors|82482164|2012
0-19|7.9|9.2|8.6|706|IV(a) Neuroblastoma and ganglioneuroblastoma|82482164|2012
0-19|0.1|0.4|0.2|20|IV(b) Other peripheral nervous cell tumors|82482164|2012
0-19|11.1|12.6|11.8|976|IX Soft tissue and other extraosseous sarcomas|82482164|2012
0-19|4.1|5.0|4.5|375|IX(a) Rhabdomyosarcomas|82482164|2012
0-19|1.0|1.5|1.3|104|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82482164|2012
0-19|~|~|~|~|IX(c) Kaposi sarcoma|82482164|2012
0-19|4.1|5.0|4.5|376|IX(d) Other specified soft tissue sarcomas|82482164|2012
0-19|1.2|1.7|1.4|116|IX(e) Unspecified soft tissue sarcomas|82482164|2012
0-19|0.1|0.4|0.2|19|Not classified by ICCC|82482164|2012
0-19|2.9|3.7|3.3|273|V Retinoblastoma|82482164|2012
0-19|6.5|7.7|7.1|583|VI Renal tumors|82482164|2012
0-19|5.7|6.8|6.3|517|VI(a) Nephroblastoma and other nonepithelial renal tumors|82482164|2012
0-19|0.6|0.9|0.7|61|VI(b) Renal carcinomas|82482164|2012
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|82482164|2012
0-19|2.4|3.2|2.8|230|VII Hepatic tumors|82482164|2012
0-19|1.8|2.5|2.1|176|VII(a) Hepatoblastoma|82482164|2012
0-19|0.5|0.8|0.6|52|VII(b) Hepatic carcinomas|82482164|2012
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82482164|2012
0-19|8.4|9.8|9.1|751|VIII Malignant bone tumors|82482164|2012
0-19|4.8|5.8|5.2|433|VIII(a) Osteosarcomas|82482164|2012
0-19|0.2|0.5|0.3|28|VIII(b) Chondrosarcomas|82482164|2012
0-19|2.5|3.2|2.8|235|VIII(c) Ewing tumor and related sarcomas of bone|82482164|2012
0-19|0.3|0.6|0.4|36|VIII(d) Other specified malignant bone tumors|82482164|2012
0-19|0.1|0.4|0.2|19|VIII(e) Unspecified malignant bone tumors|82482164|2012
0-19|10.9|12.4|11.7|977|X Germ cell, trophoblastic tumors & neoplasms of gonads|82482164|2012
0-19|1.3|1.9|1.6|131|X(a) Intracranial & intraspinal germ cell tumors|82482164|2012
0-19|1.4|2.0|1.7|141|X(b) Malignant extracranial & extragonadal germ cell tumors|82482164|2012
0-19|7.1|8.2|7.6|643|X(c) Malignant gonadal germ cell tumors|82482164|2012
0-19|0.3|0.6|0.4|35|X(d) Gonadal carcinomas|82482164|2012
0-19|0.2|0.5|0.3|27|X(e) Other and unspecified malignant gonadal tumors|82482164|2012
0-19|18.8|20.7|19.8|1658|XI Other malignant epithelial neoplasms and malignant melanomas|82482164|2012
0-19|0.2|0.4|0.3|22|XI(a) Adrenocortical carcinomas|82482164|2012
0-19|9.1|10.4|9.7|818|XI(b) Thyroid carcinomas|82482164|2012
0-19|0.3|0.6|0.5|38|XI(c) Nasopharyngeal carcinomas|82482164|2012
0-19|3.8|4.7|4.3|357|XI(d) Malignant melanomas|82482164|2012
0-19|~|~|~|~|XI(e) Skin carcinomas|82482164|2012
0-19|4.5|5.5|5.0|415|XI(f) Other and unspecified carcinomas|82482164|2012
0-19|0.8|1.2|1.0|82|XII Other and unspecified malignant neoplasms|82482164|2012
0-19|0.3|0.6|0.4|36|XII(a) Other specified malignant tumors|82482164|2012
0-19|0.4|0.7|0.6|46|XII(b) Other unspecified malignant tumors|82482164|2012
0-14|169.4|176.0|172.6|10559|All ICCC Groups Combined|61067428|2013
0-14|49.5|53.1|51.3|3141|I Leukemias, myeloproliferative & myelodysplastic diseases|61067428|2013
0-14|36.6|39.7|38.1|2335|I(a) Lymphoid leukemias|61067428|2013
0-14|7.2|8.6|7.8|480|I(b) Acute myeloid leukemias|61067428|2013
0-14|1.4|2.0|1.7|102|I(c) Chronic myeloproliferative diseases|61067428|2013
0-14|1.2|1.8|1.5|92|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61067428|2013
0-14|1.8|2.6|2.2|132|I(e) Unspecified and other specified leukemias|61067428|2013
0-14|20.6|23.0|21.8|1330|II Lymphomas and reticuloendothelial neoplasms|61067428|2013
0-14|5.0|6.2|5.5|337|II(a) Hodgkin lymphomas|61067428|2013
0-14|6.7|8.1|7.4|449|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61067428|2013
0-14|1.9|2.7|2.3|141|II(c) Burkitt lymphoma|61067428|2013
0-14|5.7|7.0|6.4|389|II(d) Miscellaneous lymphoreticular neoplasms|61067428|2013
0-14|~|~|~|~|II(e) Unspecified lymphomas|61067428|2013
0-14|35.5|38.6|37.0|2263|III CNS and misc intracranial and intraspinal neoplasms|61067428|2013
0-14|2.7|3.6|3.2|193|III(a) Ependymomas and choroid plexus tumor|61067428|2013
0-14|18.4|20.7|19.5|1193|III(b) Astrocytomas|61067428|2013
0-14|6.3|7.6|6.9|422|III(c) Intracranial and intraspinal embryonal tumors|61067428|2013
0-14|5.6|6.9|6.2|381|III(d) Other gliomas|61067428|2013
0-14|0.5|1.0|0.7|45|III(e) Other specified intracranial & intraspinal neoplasms|61067428|2013
0-14|0.3|0.7|0.5|29|III(f) Unspecified intracranial and intraspinal neoplasms|61067428|2013
0-14|11.3|13.1|12.2|749|IV Neuroblastoma and other peripheral nervous cell tumors|61067428|2013
0-14|11.1|12.8|11.9|731|IV(a) Neuroblastoma and ganglioneuroblastoma|61067428|2013
0-14|0.2|0.5|0.3|18|IV(b) Other peripheral nervous cell tumors|61067428|2013
0-14|10.4|12.1|11.2|684|IX Soft tissue and other extraosseous sarcomas|61067428|2013
0-14|4.7|5.9|5.3|322|IX(a) Rhabdomyosarcomas|61067428|2013
0-14|1.0|1.5|1.2|74|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61067428|2013
0-14|~|~|~|~|IX(c) Kaposi sarcoma|61067428|2013
0-14|3.2|4.2|3.7|226|IX(d) Other specified soft tissue sarcomas|61067428|2013
0-14|0.8|1.3|1.0|61|IX(e) Unspecified soft tissue sarcomas|61067428|2013
0-14|0.1|0.4|0.3|16|Not classified by ICCC|61067428|2013
0-14|3.8|4.9|4.3|267|V Retinoblastoma|61067428|2013
0-14|8.3|9.8|9.0|552|VI Renal tumors|61067428|2013
0-14|7.8|9.3|8.5|525|VI(a) Nephroblastoma and other nonepithelial renal tumors|61067428|2013
0-14|0.3|0.6|0.4|24|VI(b) Renal carcinomas|61067428|2013
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|61067428|2013
0-14|2.5|3.4|2.9|179|VII Hepatic tumors|61067428|2013
0-14|2.1|2.9|2.5|151|VII(a) Hepatoblastoma|61067428|2013
0-14|0.3|0.6|0.4|26|VII(b) Hepatic carcinomas|61067428|2013
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61067428|2013
0-14|6.7|8.1|7.4|449|VIII Malignant bone tumors|61067428|2013
0-14|3.3|4.3|3.8|229|VIII(a) Osteosarcomas|61067428|2013
0-14|~|~|~|~|VIII(b) Chondrosarcomas|61067428|2013
0-14|2.5|3.3|2.9|175|VIII(c) Ewing tumor and related sarcomas of bone|61067428|2013
0-14|0.3|0.6|0.4|27|VIII(d) Other specified malignant bone tumors|61067428|2013
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|61067428|2013
0-14|5.2|6.4|5.8|353|X Germ cell, trophoblastic tumors & neoplasms of gonads|61067428|2013
0-14|1.4|2.1|1.7|103|X(a) Intracranial & intraspinal germ cell tumors|61067428|2013
0-14|1.1|1.6|1.3|81|X(b) Malignant extracranial & extragonadal germ cell tumors|61067428|2013
0-14|2.1|2.9|2.4|148|X(c) Malignant gonadal germ cell tumors|61067428|2013
0-14|~|~|~|~|X(d) Gonadal carcinomas|61067428|2013
0-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|61067428|2013
0-14|8.1|9.6|8.8|536|XI Other malignant epithelial neoplasms and malignant melanomas|61067428|2013
0-14|~|~|~|~|XI(a) Adrenocortical carcinomas|61067428|2013
0-14|3.1|4.1|3.6|219|XI(b) Thyroid carcinomas|61067428|2013
0-14|0.2|0.5|0.4|22|XI(c) Nasopharyngeal carcinomas|61067428|2013
0-14|1.8|2.5|2.1|129|XI(d) Malignant melanomas|61067428|2013
0-14|~|~|~|~|XI(e) Skin carcinomas|61067428|2013
0-14|2.1|2.9|2.5|153|XI(f) Other and unspecified carcinomas|61067428|2013
0-14|0.5|0.9|0.7|40|XII Other and unspecified malignant neoplasms|61067428|2013
0-14|0.3|0.6|0.4|24|XII(a) Other specified malignant tumors|61067428|2013
0-14|0.1|0.4|0.3|16|XII(b) Other unspecified malignant tumors|61067428|2013
0-19|182.2|188.1|185.2|15270|All ICCC Groups Combined|82244884|2013
0-19|45.5|48.5|47.0|3865|I Leukemias, myeloproliferative & myelodysplastic diseases|82244884|2013
0-19|31.4|33.9|32.6|2683|I(a) Lymphoid leukemias|82244884|2013
0-19|7.7|8.9|8.3|682|I(b) Acute myeloid leukemias|82244884|2013
0-19|2.1|2.8|2.4|202|I(c) Chronic myeloproliferative diseases|82244884|2013
0-19|1.4|1.9|1.6|135|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82244884|2013
0-19|1.7|2.3|2.0|163|I(e) Unspecified and other specified leukemias|82244884|2013
0-19|27.3|29.6|28.4|2351|II Lymphomas and reticuloendothelial neoplasms|82244884|2013
0-19|10.9|12.4|11.6|964|II(a) Hodgkin lymphomas|82244884|2013
0-19|8.5|9.8|9.1|753|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82244884|2013
0-19|2.0|2.7|2.3|189|II(c) Burkitt lymphoma|82244884|2013
0-19|4.6|5.6|5.1|415|II(d) Miscellaneous lymphoreticular neoplasms|82244884|2013
0-19|0.2|0.5|0.4|30|II(e) Unspecified lymphomas|82244884|2013
0-19|32.2|34.7|33.5|2747|III CNS and misc intracranial and intraspinal neoplasms|82244884|2013
0-19|2.4|3.1|2.7|222|III(a) Ependymomas and choroid plexus tumor|82244884|2013
0-19|17.1|19.0|18.1|1483|III(b) Astrocytomas|82244884|2013
0-19|5.2|6.2|5.7|468|III(c) Intracranial and intraspinal embryonal tumors|82244884|2013
0-19|5.3|6.3|5.8|474|III(d) Other gliomas|82244884|2013
0-19|0.6|0.9|0.7|60|III(e) Other specified intracranial & intraspinal neoplasms|82244884|2013
0-19|0.3|0.7|0.5|40|III(f) Unspecified intracranial and intraspinal neoplasms|82244884|2013
0-19|8.7|10.0|9.3|766|IV Neuroblastoma and other peripheral nervous cell tumors|82244884|2013
0-19|8.4|9.7|9.0|741|IV(a) Neuroblastoma and ganglioneuroblastoma|82244884|2013
0-19|0.2|0.4|0.3|25|IV(b) Other peripheral nervous cell tumors|82244884|2013
0-19|11.2|12.7|11.9|981|IX Soft tissue and other extraosseous sarcomas|82244884|2013
0-19|4.4|5.3|4.8|396|IX(a) Rhabdomyosarcomas|82244884|2013
0-19|1.0|1.5|1.3|105|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82244884|2013
0-19|~|~|~|~|IX(c) Kaposi sarcoma|82244884|2013
0-19|4.1|5.0|4.6|376|IX(d) Other specified soft tissue sarcomas|82244884|2013
0-19|1.0|1.5|1.2|103|IX(e) Unspecified soft tissue sarcomas|82244884|2013
0-19|0.2|0.4|0.3|23|Not classified by ICCC|82244884|2013
0-19|2.9|3.7|3.3|267|V Retinoblastoma|82244884|2013
0-19|6.8|8.0|7.4|605|VI Renal tumors|82244884|2013
0-19|5.9|7.0|6.5|531|VI(a) Nephroblastoma and other nonepithelial renal tumors|82244884|2013
0-19|0.7|1.1|0.9|71|VI(b) Renal carcinomas|82244884|2013
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|82244884|2013
0-19|2.2|2.9|2.5|206|VII Hepatic tumors|82244884|2013
0-19|1.6|2.2|1.8|151|VII(a) Hepatoblastoma|82244884|2013
0-19|0.5|0.8|0.6|53|VII(b) Hepatic carcinomas|82244884|2013
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82244884|2013
0-19|8.5|9.9|9.2|758|VIII Malignant bone tumors|82244884|2013
0-19|4.5|5.5|5.0|409|VIII(a) Osteosarcomas|82244884|2013
0-19|0.2|0.5|0.3|29|VIII(b) Chondrosarcomas|82244884|2013
0-19|2.8|3.6|3.2|261|VIII(c) Ewing tumor and related sarcomas of bone|82244884|2013
0-19|0.4|0.7|0.5|45|VIII(d) Other specified malignant bone tumors|82244884|2013
0-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|82244884|2013
0-19|11.2|12.7|11.9|990|X Germ cell, trophoblastic tumors & neoplasms of gonads|82244884|2013
0-19|1.6|2.3|1.9|159|X(a) Intracranial & intraspinal germ cell tumors|82244884|2013
0-19|1.1|1.7|1.4|114|X(b) Malignant extracranial & extragonadal germ cell tumors|82244884|2013
0-19|7.0|8.2|7.6|636|X(c) Malignant gonadal germ cell tumors|82244884|2013
0-19|0.4|0.7|0.6|47|X(d) Gonadal carcinomas|82244884|2013
0-19|0.3|0.6|0.4|34|X(e) Other and unspecified malignant gonadal tumors|82244884|2013
0-19|18.8|20.7|19.7|1640|XI Other malignant epithelial neoplasms and malignant melanomas|82244884|2013
0-19|~|~|~|~|XI(a) Adrenocortical carcinomas|82244884|2013
0-19|8.8|10.1|9.4|787|XI(b) Thyroid carcinomas|82244884|2013
0-19|0.5|0.8|0.6|52|XI(c) Nasopharyngeal carcinomas|82244884|2013
0-19|3.8|4.7|4.2|351|XI(d) Malignant melanomas|82244884|2013
0-19|~|~|~|~|XI(e) Skin carcinomas|82244884|2013
0-19|4.7|5.7|5.2|434|XI(f) Other and unspecified carcinomas|82244884|2013
0-19|0.7|1.1|0.9|71|XII Other and unspecified malignant neoplasms|82244884|2013
0-19|0.3|0.6|0.4|37|XII(a) Other specified malignant tumors|82244884|2013
0-19|0.3|0.6|0.4|34|XII(b) Other unspecified malignant tumors|82244884|2013
0-14|173.1|179.7|176.4|10788|All ICCC Groups Combined|61053030|2014
0-14|50.5|54.1|52.3|3201|I Leukemias, myeloproliferative & myelodysplastic diseases|61053030|2014
0-14|37.6|40.7|39.1|2396|I(a) Lymphoid leukemias|61053030|2014
0-14|7.2|8.7|7.9|485|I(b) Acute myeloid leukemias|61053030|2014
0-14|1.3|1.9|1.6|95|I(c) Chronic myeloproliferative diseases|61053030|2014
0-14|1.3|2.0|1.6|99|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61053030|2014
0-14|1.7|2.5|2.1|126|I(e) Unspecified and other specified leukemias|61053030|2014
0-14|22.4|24.8|23.6|1437|II Lymphomas and reticuloendothelial neoplasms|61053030|2014
0-14|5.0|6.2|5.5|337|II(a) Hodgkin lymphomas|61053030|2014
0-14|7.7|9.2|8.4|514|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61053030|2014
0-14|2.4|3.2|2.8|170|II(c) Burkitt lymphoma|61053030|2014
0-14|5.9|7.2|6.5|398|II(d) Miscellaneous lymphoreticular neoplasms|61053030|2014
0-14|0.2|0.5|0.3|18|II(e) Unspecified lymphomas|61053030|2014
0-14|35.3|38.4|36.8|2250|III CNS and misc intracranial and intraspinal neoplasms|61053030|2014
0-14|2.8|3.7|3.2|199|III(a) Ependymomas and choroid plexus tumor|61053030|2014
0-14|17.9|20.1|19.0|1160|III(b) Astrocytomas|61053030|2014
0-14|6.7|8.1|7.4|452|III(c) Intracranial and intraspinal embryonal tumors|61053030|2014
0-14|5.2|6.4|5.8|352|III(d) Other gliomas|61053030|2014
0-14|0.6|1.1|0.8|51|III(e) Other specified intracranial & intraspinal neoplasms|61053030|2014
0-14|0.4|0.8|0.6|36|III(f) Unspecified intracranial and intraspinal neoplasms|61053030|2014
0-14|11.1|12.9|12.0|736|IV Neuroblastoma and other peripheral nervous cell tumors|61053030|2014
0-14|10.9|12.6|11.8|723|IV(a) Neuroblastoma and ganglioneuroblastoma|61053030|2014
0-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|61053030|2014
0-14|10.4|12.1|11.3|688|IX Soft tissue and other extraosseous sarcomas|61053030|2014
0-14|4.4|5.5|4.9|303|IX(a) Rhabdomyosarcomas|61053030|2014
0-14|1.0|1.5|1.2|75|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61053030|2014
0-14|~|~|~|~|IX(c) Kaposi sarcoma|61053030|2014
0-14|3.4|4.4|3.9|236|IX(d) Other specified soft tissue sarcomas|61053030|2014
0-14|0.9|1.5|1.2|73|IX(e) Unspecified soft tissue sarcomas|61053030|2014
0-14|0.2|0.5|0.3|20|Not classified by ICCC|61053030|2014
0-14|3.8|4.9|4.4|268|V Retinoblastoma|61053030|2014
0-14|8.4|10.0|9.2|563|VI Renal tumors|61053030|2014
0-14|8.0|9.5|8.7|535|VI(a) Nephroblastoma and other nonepithelial renal tumors|61053030|2014
0-14|0.3|0.6|0.4|26|VI(b) Renal carcinomas|61053030|2014
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|61053030|2014
0-14|2.6|3.5|3.0|187|VII Hepatic tumors|61053030|2014
0-14|2.2|3.1|2.6|161|VII(a) Hepatoblastoma|61053030|2014
0-14|0.3|0.6|0.4|26|VII(b) Hepatic carcinomas|61053030|2014
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61053030|2014
0-14|7.3|8.7|8.0|484|VIII Malignant bone tumors|61053030|2014
0-14|3.9|5.0|4.4|267|VIII(a) Osteosarcomas|61053030|2014
0-14|~|~|~|~|VIII(b) Chondrosarcomas|61053030|2014
0-14|2.3|3.2|2.7|167|VIII(c) Ewing tumor and related sarcomas of bone|61053030|2014
0-14|0.3|0.7|0.5|29|VIII(d) Other specified malignant bone tumors|61053030|2014
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|61053030|2014
0-14|5.1|6.4|5.7|350|X Germ cell, trophoblastic tumors & neoplasms of gonads|61053030|2014
0-14|1.2|1.8|1.5|89|X(a) Intracranial & intraspinal germ cell tumors|61053030|2014
0-14|1.3|2.0|1.6|101|X(b) Malignant extracranial & extragonadal germ cell tumors|61053030|2014
0-14|1.9|2.7|2.3|139|X(c) Malignant gonadal germ cell tumors|61053030|2014
0-14|~|~|~|~|X(d) Gonadal carcinomas|61053030|2014
0-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|61053030|2014
0-14|8.6|10.1|9.3|566|XI Other malignant epithelial neoplasms and malignant melanomas|61053030|2014
0-14|~|~|~|~|XI(a) Adrenocortical carcinomas|61053030|2014
0-14|3.4|4.4|3.9|235|XI(b) Thyroid carcinomas|61053030|2014
0-14|~|~|~|~|XI(c) Nasopharyngeal carcinomas|61053030|2014
0-14|1.9|2.6|2.2|136|XI(d) Malignant melanomas|61053030|2014
0-14|~|~|~|~|XI(e) Skin carcinomas|61053030|2014
0-14|2.4|3.2|2.8|170|XI(f) Other and unspecified carcinomas|61053030|2014
0-14|0.4|0.9|0.6|38|XII Other and unspecified malignant neoplasms|61053030|2014
0-14|0.2|0.6|0.4|23|XII(a) Other specified malignant tumors|61053030|2014
0-14|~|~|~|~|XII(b) Other unspecified malignant tumors|61053030|2014
0-19|188.2|194.1|191.1|15735|All ICCC Groups Combined|82105856|2014
0-19|46.8|49.8|48.3|3969|I Leukemias, myeloproliferative & myelodysplastic diseases|82105856|2014
0-19|32.4|35.0|33.7|2766|I(a) Lymphoid leukemias|82105856|2014
0-19|8.0|9.2|8.6|706|I(b) Acute myeloid leukemias|82105856|2014
0-19|2.2|2.8|2.5|205|I(c) Chronic myeloproliferative diseases|82105856|2014
0-19|1.3|1.8|1.5|127|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82105856|2014
0-19|1.7|2.3|2.0|165|I(e) Unspecified and other specified leukemias|82105856|2014
0-19|30.2|32.6|31.4|2585|II Lymphomas and reticuloendothelial neoplasms|82105856|2014
0-19|11.2|12.7|11.9|989|II(a) Hodgkin lymphomas|82105856|2014
0-19|10.2|11.6|10.9|896|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82105856|2014
0-19|2.3|3.0|2.7|218|II(c) Burkitt lymphoma|82105856|2014
0-19|5.0|6.0|5.5|450|II(d) Miscellaneous lymphoreticular neoplasms|82105856|2014
0-19|0.3|0.5|0.4|32|II(e) Unspecified lymphomas|82105856|2014
0-19|32.3|34.8|33.5|2750|III CNS and misc intracranial and intraspinal neoplasms|82105856|2014
0-19|2.4|3.2|2.8|229|III(a) Ependymomas and choroid plexus tumor|82105856|2014
0-19|17.0|18.8|17.9|1465|III(b) Astrocytomas|82105856|2014
0-19|5.5|6.6|6.1|496|III(c) Intracranial and intraspinal embryonal tumors|82105856|2014
0-19|4.9|6.0|5.4|445|III(d) Other gliomas|82105856|2014
0-19|0.6|1.0|0.8|68|III(e) Other specified intracranial & intraspinal neoplasms|82105856|2014
0-19|0.4|0.8|0.6|47|III(f) Unspecified intracranial and intraspinal neoplasms|82105856|2014
0-19|8.6|10.0|9.3|762|IV Neuroblastoma and other peripheral nervous cell tumors|82105856|2014
0-19|8.3|9.6|8.9|733|IV(a) Neuroblastoma and ganglioneuroblastoma|82105856|2014
0-19|0.2|0.5|0.4|29|IV(b) Other peripheral nervous cell tumors|82105856|2014
0-19|11.7|13.2|12.4|1022|IX Soft tissue and other extraosseous sarcomas|82105856|2014
0-19|3.9|4.8|4.4|359|IX(a) Rhabdomyosarcomas|82105856|2014
0-19|1.3|1.8|1.5|127|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82105856|2014
0-19|~|~|~|~|IX(c) Kaposi sarcoma|82105856|2014
0-19|4.6|5.5|5.0|415|IX(d) Other specified soft tissue sarcomas|82105856|2014
0-19|1.2|1.7|1.4|116|IX(e) Unspecified soft tissue sarcomas|82105856|2014
0-19|0.2|0.5|0.3|26|Not classified by ICCC|82105856|2014
0-19|2.9|3.7|3.3|268|V Retinoblastoma|82105856|2014
0-19|6.7|7.9|7.3|601|VI Renal tumors|82105856|2014
0-19|6.1|7.2|6.6|546|VI(a) Nephroblastoma and other nonepithelial renal tumors|82105856|2014
0-19|0.5|0.8|0.6|53|VI(b) Renal carcinomas|82105856|2014
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|82105856|2014
0-19|2.2|2.9|2.5|209|VII Hepatic tumors|82105856|2014
0-19|1.7|2.3|2.0|161|VII(a) Hepatoblastoma|82105856|2014
0-19|0.4|0.8|0.6|47|VII(b) Hepatic carcinomas|82105856|2014
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82105856|2014
0-19|8.8|10.1|9.4|775|VIII Malignant bone tumors|82105856|2014
0-19|4.7|5.7|5.2|429|VIII(a) Osteosarcomas|82105856|2014
0-19|0.2|0.5|0.4|29|VIII(b) Chondrosarcomas|82105856|2014
0-19|2.7|3.5|3.1|251|VIII(c) Ewing tumor and related sarcomas of bone|82105856|2014
0-19|0.4|0.7|0.5|45|VIII(d) Other specified malignant bone tumors|82105856|2014
0-19|0.2|0.4|0.3|21|VIII(e) Unspecified malignant bone tumors|82105856|2014
0-19|10.5|12.0|11.3|933|X Germ cell, trophoblastic tumors & neoplasms of gonads|82105856|2014
0-19|1.4|2.0|1.7|136|X(a) Intracranial & intraspinal germ cell tumors|82105856|2014
0-19|1.4|2.0|1.7|138|X(b) Malignant extracranial & extragonadal germ cell tumors|82105856|2014
0-19|6.5|7.6|7.0|586|X(c) Malignant gonadal germ cell tumors|82105856|2014
0-19|0.3|0.7|0.5|40|X(d) Gonadal carcinomas|82105856|2014
0-19|0.3|0.6|0.4|33|X(e) Other and unspecified malignant gonadal tumors|82105856|2014
0-19|20.5|22.5|21.5|1783|XI Other malignant epithelial neoplasms and malignant melanomas|82105856|2014
0-19|0.2|0.4|0.3|21|XI(a) Adrenocortical carcinomas|82105856|2014
0-19|9.9|11.4|10.6|883|XI(b) Thyroid carcinomas|82105856|2014
0-19|0.2|0.5|0.4|30|XI(c) Nasopharyngeal carcinomas|82105856|2014
0-19|3.7|4.6|4.2|344|XI(d) Malignant melanomas|82105856|2014
0-19|~|~|~|~|XI(e) Skin carcinomas|82105856|2014
0-19|5.5|6.6|6.0|499|XI(f) Other and unspecified carcinomas|82105856|2014
0-19|0.5|0.8|0.6|52|XII Other and unspecified malignant neoplasms|82105856|2014
0-19|0.2|0.5|0.3|28|XII(a) Other specified malignant tumors|82105856|2014
0-19|0.2|0.4|0.3|24|XII(b) Other unspecified malignant tumors|82105856|2014
0-14|173.3|176.2|174.7|52880|All ICCC Groups Combined|302007630|2014-2018
0-14|52.5|54.2|53.3|16172|I Leukemias, myeloproliferative & myelodysplastic diseases|302007630|2014-2018
0-14|39.7|41.1|40.4|12247|I(a) Lymphoid leukemias|302007630|2014-2018
0-14|7.5|8.1|7.8|2358|I(b) Acute myeloid leukemias|302007630|2014-2018
0-14|1.6|1.9|1.7|518|I(c) Chronic myeloproliferative diseases|302007630|2014-2018
0-14|1.3|1.5|1.4|420|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|302007630|2014-2018
0-14|1.9|2.2|2.1|629|I(e) Unspecified and other specified leukemias|302007630|2014-2018
0-14|22.2|23.3|22.7|6860|II Lymphomas and reticuloendothelial neoplasms|302007630|2014-2018
0-14|5.6|6.1|5.8|1759|II(a) Hodgkin lymphomas|302007630|2014-2018
0-14|7.6|8.3|7.9|2390|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|302007630|2014-2018
0-14|2.3|2.7|2.5|760|II(c) Burkitt lymphoma|302007630|2014-2018
0-14|6.0|6.5|6.2|1885|II(d) Miscellaneous lymphoreticular neoplasms|302007630|2014-2018
0-14|0.2|0.3|0.2|66|II(e) Unspecified lymphomas|302007630|2014-2018
0-14|34.1|35.4|34.7|10502|III CNS and misc intracranial and intraspinal neoplasms|302007630|2014-2018
0-14|2.8|3.2|3.0|921|III(a) Ependymomas and choroid plexus tumor|302007630|2014-2018
0-14|17.2|18.1|17.7|5337|III(b) Astrocytomas|302007630|2014-2018
0-14|6.5|7.1|6.8|2051|III(c) Intracranial and intraspinal embryonal tumors|302007630|2014-2018
0-14|5.7|6.3|6.0|1815|III(d) Other gliomas|302007630|2014-2018
0-14|0.6|0.8|0.7|216|III(e) Other specified intracranial & intraspinal neoplasms|302007630|2014-2018
0-14|0.5|0.6|0.5|162|III(f) Unspecified intracranial and intraspinal neoplasms|302007630|2014-2018
0-14|11.2|12.0|11.6|3518|IV Neuroblastoma and other peripheral nervous cell tumors|302007630|2014-2018
0-14|11.0|11.8|11.4|3466|IV(a) Neuroblastoma and ganglioneuroblastoma|302007630|2014-2018
0-14|0.1|0.2|0.2|52|IV(b) Other peripheral nervous cell tumors|302007630|2014-2018
0-14|10.7|11.5|11.1|3359|IX Soft tissue and other extraosseous sarcomas|302007630|2014-2018
0-14|4.9|5.5|5.2|1574|IX(a) Rhabdomyosarcomas|302007630|2014-2018
0-14|0.9|1.2|1.0|314|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|302007630|2014-2018
0-14|~|~|~|~|IX(c) Kaposi sarcoma|302007630|2014-2018
0-14|3.4|3.9|3.6|1097|IX(d) Other specified soft tissue sarcomas|302007630|2014-2018
0-14|1.1|1.4|1.2|370|IX(e) Unspecified soft tissue sarcomas|302007630|2014-2018
0-14|0.8|1.0|0.9|268|Not classified by ICCC|302007630|2014-2018
0-14|4.1|4.5|4.3|1306|V Retinoblastoma|302007630|2014-2018
0-14|8.6|9.2|8.9|2705|VI Renal tumors|302007630|2014-2018
0-14|8.1|8.7|8.4|2558|VI(a) Nephroblastoma and other nonepithelial renal tumors|302007630|2014-2018
0-14|0.4|0.5|0.5|136|VI(b) Renal carcinomas|302007630|2014-2018
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|302007630|2014-2018
0-14|2.8|3.2|3.0|920|VII Hepatic tumors|302007630|2014-2018
0-14|2.5|2.8|2.6|805|VII(a) Hepatoblastoma|302007630|2014-2018
0-14|0.3|0.4|0.4|107|VII(b) Hepatic carcinomas|302007630|2014-2018
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|302007630|2014-2018
0-14|7.5|8.1|7.8|2345|VIII Malignant bone tumors|302007630|2014-2018
0-14|4.0|4.5|4.3|1282|VIII(a) Osteosarcomas|302007630|2014-2018
0-14|0.2|0.3|0.2|64|VIII(b) Chondrosarcomas|302007630|2014-2018
0-14|2.5|2.9|2.7|822|VIII(c) Ewing tumor and related sarcomas of bone|302007630|2014-2018
0-14|0.4|0.5|0.4|132|VIII(d) Other specified malignant bone tumors|302007630|2014-2018
0-14|0.1|0.2|0.1|45|VIII(e) Unspecified malignant bone tumors|302007630|2014-2018
0-14|5.5|6.0|5.8|1739|X Germ cell, trophoblastic tumors & neoplasms of gonads|302007630|2014-2018
0-14|1.5|1.8|1.7|498|X(a) Intracranial & intraspinal germ cell tumors|302007630|2014-2018
0-14|1.3|1.6|1.4|432|X(b) Malignant extracranial & extragonadal germ cell tumors|302007630|2014-2018
0-14|2.2|2.5|2.4|714|X(c) Malignant gonadal germ cell tumors|302007630|2014-2018
0-14|0.1|0.1|0.1|31|X(d) Gonadal carcinomas|302007630|2014-2018
0-14|0.2|0.3|0.2|64|X(e) Other and unspecified malignant gonadal tumors|302007630|2014-2018
0-14|9.4|10.1|9.8|2943|XI Other malignant epithelial neoplasms and malignant melanomas|302007630|2014-2018
0-14|0.1|0.3|0.2|59|XI(a) Adrenocortical carcinomas|302007630|2014-2018
0-14|3.4|3.9|3.6|1097|XI(b) Thyroid carcinomas|302007630|2014-2018
0-14|0.1|0.2|0.2|54|XI(c) Nasopharyngeal carcinomas|302007630|2014-2018
0-14|1.7|2.0|1.9|569|XI(d) Malignant melanomas|302007630|2014-2018
0-14|~|~|~|~|XI(e) Skin carcinomas|302007630|2014-2018
0-14|3.6|4.0|3.8|1149|XI(f) Other and unspecified carcinomas|302007630|2014-2018
0-14|0.7|0.9|0.8|243|XII Other and unspecified malignant neoplasms|302007630|2014-2018
0-14|0.4|0.6|0.5|142|XII(a) Other specified malignant tumors|302007630|2014-2018
0-14|0.3|0.4|0.3|101|XII(b) Other unspecified malignant tumors|302007630|2014-2018
0-19|189.9|192.6|191.3|78023|All ICCC Groups Combined|406542905|2014-2018
0-19|48.3|49.6|48.9|19917|I Leukemias, myeloproliferative & myelodysplastic diseases|406542905|2014-2018
0-19|34.3|35.4|34.9|14175|I(a) Lymphoid leukemias|406542905|2014-2018
0-19|7.9|8.5|8.2|3343|I(b) Acute myeloid leukemias|406542905|2014-2018
0-19|2.4|2.7|2.6|1052|I(c) Chronic myeloproliferative diseases|406542905|2014-2018
0-19|1.2|1.5|1.3|546|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|406542905|2014-2018
0-19|1.8|2.1|2.0|801|I(e) Unspecified and other specified leukemias|406542905|2014-2018
0-19|29.9|30.9|30.4|12424|II Lymphomas and reticuloendothelial neoplasms|406542905|2014-2018
0-19|12.0|12.6|12.3|5054|II(a) Hodgkin lymphomas|406542905|2014-2018
0-19|9.8|10.4|10.1|4134|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|406542905|2014-2018
0-19|2.3|2.6|2.5|1002|II(c) Burkitt lymphoma|406542905|2014-2018
0-19|4.9|5.4|5.1|2085|II(d) Miscellaneous lymphoreticular neoplasms|406542905|2014-2018
0-19|0.3|0.4|0.4|149|II(e) Unspecified lymphomas|406542905|2014-2018
0-19|31.1|32.2|31.7|12851|III CNS and misc intracranial and intraspinal neoplasms|406542905|2014-2018
0-19|2.5|2.8|2.6|1073|III(a) Ependymomas and choroid plexus tumor|406542905|2014-2018
0-19|16.1|16.8|16.4|6681|III(b) Astrocytomas|406542905|2014-2018
0-19|5.3|5.8|5.6|2258|III(c) Intracranial and intraspinal embryonal tumors|406542905|2014-2018
0-19|5.5|6.0|5.7|2323|III(d) Other gliomas|406542905|2014-2018
0-19|0.7|0.8|0.7|303|III(e) Other specified intracranial & intraspinal neoplasms|406542905|2014-2018
0-19|0.5|0.6|0.5|213|III(f) Unspecified intracranial and intraspinal neoplasms|406542905|2014-2018
0-19|8.7|9.2|8.9|3634|IV Neuroblastoma and other peripheral nervous cell tumors|406542905|2014-2018
0-19|8.4|9.0|8.7|3531|IV(a) Neuroblastoma and ganglioneuroblastoma|406542905|2014-2018
0-19|0.2|0.3|0.3|103|IV(b) Other peripheral nervous cell tumors|406542905|2014-2018
0-19|12.0|12.7|12.3|5027|IX Soft tissue and other extraosseous sarcomas|406542905|2014-2018
0-19|4.6|5.0|4.8|1941|IX(a) Rhabdomyosarcomas|406542905|2014-2018
0-19|1.2|1.4|1.3|513|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|406542905|2014-2018
0-19|~|~|~|~|IX(c) Kaposi sarcoma|406542905|2014-2018
0-19|4.6|5.0|4.8|1946|IX(d) Other specified soft tissue sarcomas|406542905|2014-2018
0-19|1.4|1.6|1.5|612|IX(e) Unspecified soft tissue sarcomas|406542905|2014-2018
0-19|0.7|0.9|0.8|338|Not classified by ICCC|406542905|2014-2018
0-19|3.0|3.4|3.2|1308|V Retinoblastoma|406542905|2014-2018
0-19|6.9|7.4|7.2|2914|VI Renal tumors|406542905|2014-2018
0-19|6.1|6.6|6.4|2595|VI(a) Nephroblastoma and other nonepithelial renal tumors|406542905|2014-2018
0-19|0.7|0.8|0.7|306|VI(b) Renal carcinomas|406542905|2014-2018
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|406542905|2014-2018
0-19|2.4|2.8|2.6|1058|VII Hepatic tumors|406542905|2014-2018
0-19|1.9|2.1|2.0|808|VII(a) Hepatoblastoma|406542905|2014-2018
0-19|0.5|0.7|0.6|238|VII(b) Hepatic carcinomas|406542905|2014-2018
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|406542905|2014-2018
0-19|9.2|9.8|9.5|3869|VIII Malignant bone tumors|406542905|2014-2018
0-19|5.0|5.5|5.2|2128|VIII(a) Osteosarcomas|406542905|2014-2018
0-19|0.3|0.4|0.4|144|VIII(b) Chondrosarcomas|406542905|2014-2018
0-19|3.0|3.3|3.2|1290|VIII(c) Ewing tumor and related sarcomas of bone|406542905|2014-2018
0-19|0.5|0.6|0.5|218|VIII(d) Other specified malignant bone tumors|406542905|2014-2018
0-19|0.2|0.3|0.2|89|VIII(e) Unspecified malignant bone tumors|406542905|2014-2018
0-19|10.8|11.5|11.1|4572|X Germ cell, trophoblastic tumors & neoplasms of gonads|406542905|2014-2018
0-19|1.7|2.0|1.9|754|X(a) Intracranial & intraspinal germ cell tumors|406542905|2014-2018
0-19|1.3|1.5|1.4|574|X(b) Malignant extracranial & extragonadal germ cell tumors|406542905|2014-2018
0-19|6.8|7.3|7.0|2897|X(c) Malignant gonadal germ cell tumors|406542905|2014-2018
0-19|0.4|0.5|0.4|186|X(d) Gonadal carcinomas|406542905|2014-2018
0-19|0.3|0.5|0.4|161|X(e) Other and unspecified malignant gonadal tumors|406542905|2014-2018
0-19|23.2|24.1|23.7|9740|XI Other malignant epithelial neoplasms and malignant melanomas|406542905|2014-2018
0-19|0.2|0.3|0.2|88|XI(a) Adrenocortical carcinomas|406542905|2014-2018
0-19|10.7|11.4|11.0|4547|XI(b) Thyroid carcinomas|406542905|2014-2018
0-19|0.4|0.5|0.4|184|XI(c) Nasopharyngeal carcinomas|406542905|2014-2018
0-19|3.5|3.9|3.7|1512|XI(d) Malignant melanomas|406542905|2014-2018
0-19|0.1|0.1|0.1|41|XI(e) Skin carcinomas|406542905|2014-2018
0-19|7.9|8.5|8.2|3368|XI(f) Other and unspecified carcinomas|406542905|2014-2018
0-19|0.8|1.0|0.9|371|XII Other and unspecified malignant neoplasms|406542905|2014-2018
0-19|0.4|0.6|0.5|201|XII(a) Other specified malignant tumors|406542905|2014-2018
0-19|0.4|0.5|0.4|170|XII(b) Other unspecified malignant tumors|406542905|2014-2018
0-14|175.5|182.2|178.8|10938|All ICCC Groups Combined|60999224|2015
0-14|53.0|56.8|54.9|3361|I Leukemias, myeloproliferative & myelodysplastic diseases|60999224|2015
0-14|39.9|43.1|41.5|2540|I(a) Lymphoid leukemias|60999224|2015
0-14|7.2|8.7|7.9|485|I(b) Acute myeloid leukemias|60999224|2015
0-14|1.6|2.3|1.9|117|I(c) Chronic myeloproliferative diseases|60999224|2015
0-14|1.2|1.9|1.5|93|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60999224|2015
0-14|1.7|2.5|2.1|126|I(e) Unspecified and other specified leukemias|60999224|2015
0-14|22.1|24.5|23.3|1418|II Lymphomas and reticuloendothelial neoplasms|60999224|2015
0-14|5.4|6.6|6.0|362|II(a) Hodgkin lymphomas|60999224|2015
0-14|6.8|8.2|7.5|455|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60999224|2015
0-14|2.2|3.0|2.5|155|II(c) Burkitt lymphoma|60999224|2015
0-14|6.4|7.7|7.0|429|II(d) Miscellaneous lymphoreticular neoplasms|60999224|2015
0-14|0.2|0.4|0.3|17|II(e) Unspecified lymphomas|60999224|2015
0-14|34.1|37.1|35.5|2171|III CNS and misc intracranial and intraspinal neoplasms|60999224|2015
0-14|2.7|3.6|3.1|189|III(a) Ependymomas and choroid plexus tumor|60999224|2015
0-14|17.1|19.2|18.1|1108|III(b) Astrocytomas|60999224|2015
0-14|6.6|8.0|7.3|447|III(c) Intracranial and intraspinal embryonal tumors|60999224|2015
0-14|5.3|6.6|5.9|360|III(d) Other gliomas|60999224|2015
0-14|0.5|0.9|0.7|42|III(e) Other specified intracranial & intraspinal neoplasms|60999224|2015
0-14|0.3|0.6|0.4|25|III(f) Unspecified intracranial and intraspinal neoplasms|60999224|2015
0-14|11.4|13.2|12.3|757|IV Neuroblastoma and other peripheral nervous cell tumors|60999224|2015
0-14|11.2|13.0|12.1|745|IV(a) Neuroblastoma and ganglioneuroblastoma|60999224|2015
0-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|60999224|2015
0-14|10.5|12.2|11.3|690|IX Soft tissue and other extraosseous sarcomas|60999224|2015
0-14|4.7|5.9|5.3|323|IX(a) Rhabdomyosarcomas|60999224|2015
0-14|0.9|1.4|1.1|67|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60999224|2015
0-14|~|~|~|~|IX(c) Kaposi sarcoma|60999224|2015
0-14|3.3|4.3|3.8|229|IX(d) Other specified soft tissue sarcomas|60999224|2015
0-14|0.9|1.5|1.2|70|IX(e) Unspecified soft tissue sarcomas|60999224|2015
0-14|~|~|~|~|Not classified by ICCC|60999224|2015
0-14|4.4|5.5|4.9|305|V Retinoblastoma|60999224|2015
0-14|9.0|10.6|9.8|602|VI Renal tumors|60999224|2015
0-14|8.6|10.2|9.4|576|VI(a) Nephroblastoma and other nonepithelial renal tumors|60999224|2015
0-14|0.3|0.6|0.4|24|VI(b) Renal carcinomas|60999224|2015
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|60999224|2015
0-14|2.8|3.7|3.2|200|VII Hepatic tumors|60999224|2015
0-14|2.4|3.3|2.8|173|VII(a) Hepatoblastoma|60999224|2015
0-14|0.3|0.6|0.4|26|VII(b) Hepatic carcinomas|60999224|2015
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60999224|2015
0-14|6.9|8.3|7.5|457|VIII Malignant bone tumors|60999224|2015
0-14|3.4|4.5|3.9|238|VIII(a) Osteosarcomas|60999224|2015
0-14|~|~|~|~|VIII(b) Chondrosarcomas|60999224|2015
0-14|2.3|3.1|2.7|164|VIII(c) Ewing tumor and related sarcomas of bone|60999224|2015
0-14|0.4|0.7|0.5|32|VIII(d) Other specified malignant bone tumors|60999224|2015
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|60999224|2015
0-14|4.9|6.1|5.5|335|X Germ cell, trophoblastic tumors & neoplasms of gonads|60999224|2015
0-14|1.3|2.0|1.6|100|X(a) Intracranial & intraspinal germ cell tumors|60999224|2015
0-14|1.1|1.7|1.3|83|X(b) Malignant extracranial & extragonadal germ cell tumors|60999224|2015
0-14|1.9|2.6|2.2|136|X(c) Malignant gonadal germ cell tumors|60999224|2015
0-14|~|~|~|~|X(d) Gonadal carcinomas|60999224|2015
0-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60999224|2015
0-14|8.9|10.5|9.7|586|XI Other malignant epithelial neoplasms and malignant melanomas|60999224|2015
0-14|~|~|~|~|XI(a) Adrenocortical carcinomas|60999224|2015
0-14|3.0|4.0|3.5|211|XI(b) Thyroid carcinomas|60999224|2015
0-14|~|~|~|~|XI(c) Nasopharyngeal carcinomas|60999224|2015
0-14|1.8|2.5|2.1|129|XI(d) Malignant melanomas|60999224|2015
0-14|~|~|~|~|XI(e) Skin carcinomas|60999224|2015
0-14|3.3|4.2|3.7|226|XI(f) Other and unspecified carcinomas|60999224|2015
0-14|0.5|1.0|0.7|46|XII Other and unspecified malignant neoplasms|60999224|2015
0-14|0.3|0.7|0.5|31|XII(a) Other specified malignant tumors|60999224|2015
0-14|~|~|~|~|XII(b) Other unspecified malignant tumors|60999224|2015
0-19|193.4|199.4|196.4|16178|All ICCC Groups Combined|82080244|2015
0-19|49.0|52.1|50.5|4154|I Leukemias, myeloproliferative & myelodysplastic diseases|82080244|2015
0-19|34.6|37.2|35.9|2949|I(a) Lymphoid leukemias|82080244|2015
0-19|7.8|9.0|8.4|692|I(b) Acute myeloid leukemias|82080244|2015
0-19|2.4|3.1|2.7|226|I(c) Chronic myeloproliferative diseases|82080244|2015
0-19|1.2|1.8|1.5|123|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82080244|2015
0-19|1.7|2.3|2.0|164|I(e) Unspecified and other specified leukemias|82080244|2015
0-19|29.8|32.3|31.0|2558|II Lymphomas and reticuloendothelial neoplasms|82080244|2015
0-19|11.7|13.2|12.5|1032|II(a) Hodgkin lymphomas|82080244|2015
0-19|9.3|10.7|10.0|820|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82080244|2015
0-19|2.1|2.8|2.5|202|II(c) Burkitt lymphoma|82080244|2015
0-19|5.2|6.3|5.7|469|II(d) Miscellaneous lymphoreticular neoplasms|82080244|2015
0-19|0.3|0.6|0.4|35|II(e) Unspecified lymphomas|82080244|2015
0-19|31.4|33.9|32.6|2676|III CNS and misc intracranial and intraspinal neoplasms|82080244|2015
0-19|2.4|3.1|2.8|226|III(a) Ependymomas and choroid plexus tumor|82080244|2015
0-19|15.8|17.6|16.6|1365|III(b) Astrocytomas|82080244|2015
0-19|5.6|6.7|6.1|500|III(c) Intracranial and intraspinal embryonal tumors|82080244|2015
0-19|5.4|6.4|5.9|483|III(d) Other gliomas|82080244|2015
0-19|0.6|1.0|0.8|66|III(e) Other specified intracranial & intraspinal neoplasms|82080244|2015
0-19|0.3|0.6|0.4|36|III(f) Unspecified intracranial and intraspinal neoplasms|82080244|2015
0-19|8.9|10.2|9.5|785|IV Neuroblastoma and other peripheral nervous cell tumors|82080244|2015
0-19|8.6|9.9|9.2|760|IV(a) Neuroblastoma and ganglioneuroblastoma|82080244|2015
0-19|0.2|0.4|0.3|25|IV(b) Other peripheral nervous cell tumors|82080244|2015
0-19|11.8|13.4|12.6|1035|IX Soft tissue and other extraosseous sarcomas|82080244|2015
0-19|4.4|5.4|4.9|400|IX(a) Rhabdomyosarcomas|82080244|2015
0-19|1.2|1.7|1.4|117|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82080244|2015
0-19|~|~|~|~|IX(c) Kaposi sarcoma|82080244|2015
0-19|4.3|5.3|4.8|393|IX(d) Other specified soft tissue sarcomas|82080244|2015
0-19|1.2|1.8|1.5|121|IX(e) Unspecified soft tissue sarcomas|82080244|2015
0-19|0.1|0.3|0.2|16|Not classified by ICCC|82080244|2015
0-19|3.3|4.1|3.7|306|V Retinoblastoma|82080244|2015
0-19|7.3|8.5|7.9|650|VI Renal tumors|82080244|2015
0-19|6.5|7.7|7.1|581|VI(a) Nephroblastoma and other nonepithelial renal tumors|82080244|2015
0-19|0.6|1.0|0.8|67|VI(b) Renal carcinomas|82080244|2015
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|82080244|2015
0-19|2.5|3.2|2.8|232|VII Hepatic tumors|82080244|2015
0-19|1.8|2.4|2.1|174|VII(a) Hepatoblastoma|82080244|2015
0-19|0.5|0.9|0.7|56|VII(b) Hepatic carcinomas|82080244|2015
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82080244|2015
0-19|8.6|9.9|9.2|757|VIII Malignant bone tumors|82080244|2015
0-19|4.5|5.4|4.9|405|VIII(a) Osteosarcomas|82080244|2015
0-19|0.3|0.5|0.4|31|VIII(b) Chondrosarcomas|82080244|2015
0-19|2.8|3.5|3.1|257|VIII(c) Ewing tumor and related sarcomas of bone|82080244|2015
0-19|0.4|0.7|0.5|45|VIII(d) Other specified malignant bone tumors|82080244|2015
0-19|0.1|0.4|0.2|19|VIII(e) Unspecified malignant bone tumors|82080244|2015
0-19|11.0|12.5|11.7|972|X Germ cell, trophoblastic tumors & neoplasms of gonads|82080244|2015
0-19|1.6|2.2|1.9|153|X(a) Intracranial & intraspinal germ cell tumors|82080244|2015
0-19|1.1|1.7|1.4|114|X(b) Malignant extracranial & extragonadal germ cell tumors|82080244|2015
0-19|7.0|8.2|7.6|634|X(c) Malignant gonadal germ cell tumors|82080244|2015
0-19|0.3|0.7|0.5|40|X(d) Gonadal carcinomas|82080244|2015
0-19|0.3|0.5|0.4|31|X(e) Other and unspecified malignant gonadal tumors|82080244|2015
0-19|22.6|24.8|23.7|1965|XI Other malignant epithelial neoplasms and malignant melanomas|82080244|2015
0-19|~|~|~|~|XI(a) Adrenocortical carcinomas|82080244|2015
0-19|10.2|11.6|10.9|902|XI(b) Thyroid carcinomas|82080244|2015
0-19|0.4|0.8|0.6|50|XI(c) Nasopharyngeal carcinomas|82080244|2015
0-19|3.5|4.4|3.9|324|XI(d) Malignant melanomas|82080244|2015
0-19|~|~|~|~|XI(e) Skin carcinomas|82080244|2015
0-19|7.5|8.7|8.1|672|XI(f) Other and unspecified carcinomas|82080244|2015
0-19|0.7|1.1|0.9|72|XII Other and unspecified malignant neoplasms|82080244|2015
0-19|0.4|0.7|0.6|46|XII(a) Other specified malignant tumors|82080244|2015
0-19|0.2|0.5|0.3|26|XII(b) Other unspecified malignant tumors|82080244|2015
0-14|174.1|180.8|177.4|10843|All ICCC Groups Combined|60977312|2016
0-14|53.6|57.3|55.4|3393|I Leukemias, myeloproliferative & myelodysplastic diseases|60977312|2016
0-14|40.0|43.3|41.6|2548|I(a) Lymphoid leukemias|60977312|2016
0-14|7.5|8.9|8.2|499|I(b) Acute myeloid leukemias|60977312|2016
0-14|1.7|2.5|2.1|127|I(c) Chronic myeloproliferative diseases|60977312|2016
0-14|1.2|1.8|1.5|90|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60977312|2016
0-14|1.8|2.5|2.1|129|I(e) Unspecified and other specified leukemias|60977312|2016
0-14|21.3|23.6|22.4|1365|II Lymphomas and reticuloendothelial neoplasms|60977312|2016
0-14|5.2|6.5|5.8|354|II(a) Hodgkin lymphomas|60977312|2016
0-14|7.8|9.2|8.5|515|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60977312|2016
0-14|2.0|2.8|2.4|146|II(c) Burkitt lymphoma|60977312|2016
0-14|5.0|6.1|5.5|338|II(d) Miscellaneous lymphoreticular neoplasms|60977312|2016
0-14|~|~|~|~|II(e) Unspecified lymphomas|60977312|2016
0-14|33.9|36.9|35.3|2159|III CNS and misc intracranial and intraspinal neoplasms|60977312|2016
0-14|2.4|3.3|2.8|174|III(a) Ependymomas and choroid plexus tumor|60977312|2016
0-14|16.2|18.3|17.2|1053|III(b) Astrocytomas|60977312|2016
0-14|6.2|7.5|6.8|418|III(c) Intracranial and intraspinal embryonal tumors|60977312|2016
0-14|6.3|7.7|7.0|425|III(d) Other gliomas|60977312|2016
0-14|0.6|1.1|0.8|51|III(e) Other specified intracranial & intraspinal neoplasms|60977312|2016
0-14|0.4|0.9|0.6|38|III(f) Unspecified intracranial and intraspinal neoplasms|60977312|2016
0-14|10.7|12.4|11.5|709|IV Neuroblastoma and other peripheral nervous cell tumors|60977312|2016
0-14|10.6|12.3|11.4|701|IV(a) Neuroblastoma and ganglioneuroblastoma|60977312|2016
0-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|60977312|2016
0-14|10.5|12.2|11.3|691|IX Soft tissue and other extraosseous sarcomas|60977312|2016
0-14|5.1|6.3|5.7|347|IX(a) Rhabdomyosarcomas|60977312|2016
0-14|0.7|1.2|1.0|59|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60977312|2016
0-14|~|~|~|~|IX(c) Kaposi sarcoma|60977312|2016
0-14|3.1|4.1|3.6|220|IX(d) Other specified soft tissue sarcomas|60977312|2016
0-14|0.8|1.3|1.1|64|IX(e) Unspecified soft tissue sarcomas|60977312|2016
0-14|0.2|0.5|0.3|19|Not classified by ICCC|60977312|2016
0-14|3.8|4.8|4.3|264|V Retinoblastoma|60977312|2016
0-14|8.0|9.5|8.7|534|VI Renal tumors|60977312|2016
0-14|7.5|8.9|8.2|501|VI(a) Nephroblastoma and other nonepithelial renal tumors|60977312|2016
0-14|0.3|0.7|0.5|31|VI(b) Renal carcinomas|60977312|2016
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|60977312|2016
0-14|2.7|3.6|3.1|193|VII Hepatic tumors|60977312|2016
0-14|2.5|3.3|2.9|177|VII(a) Hepatoblastoma|60977312|2016
0-14|~|~|~|~|VII(b) Hepatic carcinomas|60977312|2016
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60977312|2016
0-14|7.4|8.9|8.1|493|VIII Malignant bone tumors|60977312|2016
0-14|3.9|4.9|4.4|266|VIII(a) Osteosarcomas|60977312|2016
0-14|~|~|~|~|VIII(b) Chondrosarcomas|60977312|2016
0-14|2.5|3.4|2.9|179|VIII(c) Ewing tumor and related sarcomas of bone|60977312|2016
0-14|0.3|0.7|0.5|30|VIII(d) Other specified malignant bone tumors|60977312|2016
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|60977312|2016
0-14|5.3|6.6|5.9|362|X Germ cell, trophoblastic tumors & neoplasms of gonads|60977312|2016
0-14|1.5|2.3|1.9|114|X(a) Intracranial & intraspinal germ cell tumors|60977312|2016
0-14|1.1|1.7|1.3|82|X(b) Malignant extracranial & extragonadal germ cell tumors|60977312|2016
0-14|2.1|2.9|2.5|150|X(c) Malignant gonadal germ cell tumors|60977312|2016
0-14|~|~|~|~|X(d) Gonadal carcinomas|60977312|2016
0-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60977312|2016
0-14|9.3|10.9|10.0|609|XI Other malignant epithelial neoplasms and malignant melanomas|60977312|2016
0-14|~|~|~|~|XI(a) Adrenocortical carcinomas|60977312|2016
0-14|3.0|4.0|3.5|210|XI(b) Thyroid carcinomas|60977312|2016
0-14|~|~|~|~|XI(c) Nasopharyngeal carcinomas|60977312|2016
0-14|1.6|2.3|1.9|118|XI(d) Malignant melanomas|60977312|2016
0-14|~|~|~|~|XI(e) Skin carcinomas|60977312|2016
0-14|3.7|4.8|4.2|256|XI(f) Other and unspecified carcinomas|60977312|2016
0-14|0.6|1.1|0.8|52|XII Other and unspecified malignant neoplasms|60977312|2016
0-14|0.4|0.8|0.5|33|XII(a) Other specified malignant tumors|60977312|2016
0-14|0.2|0.5|0.3|19|XII(b) Other unspecified malignant tumors|60977312|2016
0-19|191.5|197.6|194.5|16029|All ICCC Groups Combined|82106582|2016
0-19|49.0|52.1|50.5|4150|I Leukemias, myeloproliferative & myelodysplastic diseases|82106582|2016
0-19|34.5|37.1|35.8|2940|I(a) Lymphoid leukemias|82106582|2016
0-19|7.9|9.2|8.5|701|I(b) Acute myeloid leukemias|82106582|2016
0-19|2.4|3.2|2.8|231|I(c) Chronic myeloproliferative diseases|82106582|2016
0-19|1.2|1.7|1.5|120|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82106582|2016
0-19|1.6|2.3|1.9|158|I(e) Unspecified and other specified leukemias|82106582|2016
0-19|29.3|31.7|30.5|2516|II Lymphomas and reticuloendothelial neoplasms|82106582|2016
0-19|11.8|13.3|12.6|1042|II(a) Hodgkin lymphomas|82106582|2016
0-19|9.7|11.1|10.4|858|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82106582|2016
0-19|2.2|2.9|2.5|206|II(c) Burkitt lymphoma|82106582|2016
0-19|4.1|5.1|4.6|377|II(d) Miscellaneous lymphoreticular neoplasms|82106582|2016
0-19|0.3|0.6|0.4|33|II(e) Unspecified lymphomas|82106582|2016
0-19|30.5|32.9|31.7|2596|III CNS and misc intracranial and intraspinal neoplasms|82106582|2016
0-19|2.2|2.9|2.5|205|III(a) Ependymomas and choroid plexus tumor|82106582|2016
0-19|14.9|16.6|15.7|1292|III(b) Astrocytomas|82106582|2016
0-19|5.1|6.2|5.6|461|III(c) Intracranial and intraspinal embryonal tumors|82106582|2016
0-19|5.8|6.9|6.4|520|III(d) Other gliomas|82106582|2016
0-19|0.7|1.1|0.9|72|III(e) Other specified intracranial & intraspinal neoplasms|82106582|2016
0-19|0.4|0.7|0.6|46|III(f) Unspecified intracranial and intraspinal neoplasms|82106582|2016
0-19|8.2|9.5|8.8|724|IV Neuroblastoma and other peripheral nervous cell tumors|82106582|2016
0-19|8.0|9.3|8.6|711|IV(a) Neuroblastoma and ganglioneuroblastoma|82106582|2016
0-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|82106582|2016
0-19|11.8|13.4|12.6|1037|IX Soft tissue and other extraosseous sarcomas|82106582|2016
0-19|4.7|5.7|5.2|423|IX(a) Rhabdomyosarcomas|82106582|2016
0-19|0.9|1.3|1.1|90|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82106582|2016
0-19|~|~|~|~|IX(c) Kaposi sarcoma|82106582|2016
0-19|4.4|5.3|4.8|399|IX(d) Other specified soft tissue sarcomas|82106582|2016
0-19|1.2|1.8|1.5|123|IX(e) Unspecified soft tissue sarcomas|82106582|2016
0-19|0.2|0.5|0.3|26|Not classified by ICCC|82106582|2016
0-19|2.8|3.6|3.2|264|V Retinoblastoma|82106582|2016
0-19|6.5|7.6|7.0|578|VI Renal tumors|82106582|2016
0-19|5.6|6.7|6.1|504|VI(a) Nephroblastoma and other nonepithelial renal tumors|82106582|2016
0-19|0.7|1.1|0.9|71|VI(b) Renal carcinomas|82106582|2016
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|82106582|2016
0-19|2.3|3.0|2.6|216|VII Hepatic tumors|82106582|2016
0-19|1.8|2.5|2.2|177|VII(a) Hepatoblastoma|82106582|2016
0-19|0.3|0.6|0.4|37|VII(b) Hepatic carcinomas|82106582|2016
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82106582|2016
0-19|9.2|10.6|9.9|815|VIII Malignant bone tumors|82106582|2016
0-19|4.8|5.8|5.3|435|VIII(a) Osteosarcomas|82106582|2016
0-19|0.2|0.4|0.3|25|VIII(b) Chondrosarcomas|82106582|2016
0-19|3.1|4.0|3.5|290|VIII(c) Ewing tumor and related sarcomas of bone|82106582|2016
0-19|0.5|0.8|0.6|53|VIII(d) Other specified malignant bone tumors|82106582|2016
0-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|82106582|2016
0-19|10.6|12.1|11.3|941|X Germ cell, trophoblastic tumors & neoplasms of gonads|82106582|2016
0-19|1.7|2.4|2.0|168|X(a) Intracranial & intraspinal germ cell tumors|82106582|2016
0-19|1.1|1.6|1.3|111|X(b) Malignant extracranial & extragonadal germ cell tumors|82106582|2016
0-19|6.6|7.7|7.1|595|X(c) Malignant gonadal germ cell tumors|82106582|2016
0-19|0.3|0.6|0.4|37|X(d) Gonadal carcinomas|82106582|2016
0-19|0.2|0.5|0.4|30|X(e) Other and unspecified malignant gonadal tumors|82106582|2016
0-19|23.9|26.1|25.0|2078|XI Other malignant epithelial neoplasms and malignant melanomas|82106582|2016
0-19|~|~|~|~|XI(a) Adrenocortical carcinomas|82106582|2016
0-19|10.5|12.0|11.2|934|XI(b) Thyroid carcinomas|82106582|2016
0-19|0.2|0.5|0.3|28|XI(c) Nasopharyngeal carcinomas|82106582|2016
0-19|3.5|4.4|3.9|325|XI(d) Malignant melanomas|82106582|2016
0-19|~|~|~|~|XI(e) Skin carcinomas|82106582|2016
0-19|8.6|9.9|9.2|765|XI(f) Other and unspecified carcinomas|82106582|2016
0-19|0.9|1.3|1.1|88|XII Other and unspecified malignant neoplasms|82106582|2016
0-19|0.4|0.8|0.6|47|XII(a) Other specified malignant tumors|82106582|2016
0-19|0.4|0.7|0.5|41|XII(b) Other unspecified malignant tumors|82106582|2016
0-14|168.8|175.4|172.1|10518|All ICCC Groups Combined|60968112|2017
0-14|49.8|53.4|51.6|3160|I Leukemias, myeloproliferative & myelodysplastic diseases|60968112|2017
0-14|37.6|40.7|39.1|2397|I(a) Lymphoid leukemias|60968112|2017
0-14|6.9|8.3|7.6|463|I(b) Acute myeloid leukemias|60968112|2017
0-14|1.4|2.0|1.7|102|I(c) Chronic myeloproliferative diseases|60968112|2017
0-14|1.0|1.6|1.3|78|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60968112|2017
0-14|1.6|2.3|2.0|120|I(e) Unspecified and other specified leukemias|60968112|2017
0-14|21.2|23.6|22.4|1366|II Lymphomas and reticuloendothelial neoplasms|60968112|2017
0-14|5.2|6.5|5.8|354|II(a) Hodgkin lymphomas|60968112|2017
0-14|6.6|8.0|7.2|441|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60968112|2017
0-14|2.2|3.1|2.6|160|II(c) Burkitt lymphoma|60968112|2017
0-14|6.0|7.3|6.6|402|II(d) Miscellaneous lymphoreticular neoplasms|60968112|2017
0-14|~|~|~|~|II(e) Unspecified lymphomas|60968112|2017
0-14|35.3|38.4|36.8|2248|III CNS and misc intracranial and intraspinal neoplasms|60968112|2017
0-14|3.0|3.9|3.4|210|III(a) Ependymomas and choroid plexus tumor|60968112|2017
0-14|17.7|19.9|18.8|1145|III(b) Astrocytomas|60968112|2017
0-14|6.2|7.6|6.9|419|III(c) Intracranial and intraspinal embryonal tumors|60968112|2017
0-14|6.0|7.3|6.6|401|III(d) Other gliomas|60968112|2017
0-14|0.4|0.8|0.6|35|III(e) Other specified intracranial & intraspinal neoplasms|60968112|2017
0-14|0.4|0.9|0.6|38|III(f) Unspecified intracranial and intraspinal neoplasms|60968112|2017
0-14|10.0|11.7|10.8|664|IV Neuroblastoma and other peripheral nervous cell tumors|60968112|2017
0-14|9.9|11.6|10.7|656|IV(a) Neuroblastoma and ganglioneuroblastoma|60968112|2017
0-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|60968112|2017
0-14|10.2|11.8|11.0|670|IX Soft tissue and other extraosseous sarcomas|60968112|2017
0-14|4.7|5.9|5.3|322|IX(a) Rhabdomyosarcomas|60968112|2017
0-14|0.6|1.1|0.9|52|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60968112|2017
0-14|~|~|~|~|IX(c) Kaposi sarcoma|60968112|2017
0-14|2.8|3.7|3.2|197|IX(d) Other specified soft tissue sarcomas|60968112|2017
0-14|1.3|2.0|1.6|99|IX(e) Unspecified soft tissue sarcomas|60968112|2017
0-14|~|~|~|~|Not classified by ICCC|60968112|2017
0-14|3.6|4.7|4.1|254|V Retinoblastoma|60968112|2017
0-14|7.7|9.2|8.4|518|VI Renal tumors|60968112|2017
0-14|7.2|8.7|7.9|487|VI(a) Nephroblastoma and other nonepithelial renal tumors|60968112|2017
0-14|0.3|0.7|0.5|29|VI(b) Renal carcinomas|60968112|2017
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|60968112|2017
0-14|2.4|3.2|2.8|171|VII Hepatic tumors|60968112|2017
0-14|2.1|2.8|2.4|149|VII(a) Hepatoblastoma|60968112|2017
0-14|0.2|0.5|0.3|18|VII(b) Hepatic carcinomas|60968112|2017
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60968112|2017
0-14|6.8|8.2|7.5|456|VIII Malignant bone tumors|60968112|2017
0-14|3.9|5.0|4.4|270|VIII(a) Osteosarcomas|60968112|2017
0-14|~|~|~|~|VIII(b) Chondrosarcomas|60968112|2017
0-14|2.0|2.8|2.4|145|VIII(c) Ewing tumor and related sarcomas of bone|60968112|2017
0-14|0.2|0.5|0.3|20|VIII(d) Other specified malignant bone tumors|60968112|2017
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|60968112|2017
0-14|5.5|6.8|6.1|373|X Germ cell, trophoblastic tumors & neoplasms of gonads|60968112|2017
0-14|1.5|2.3|1.9|114|X(a) Intracranial & intraspinal germ cell tumors|60968112|2017
0-14|1.2|1.8|1.4|88|X(b) Malignant extracranial & extragonadal germ cell tumors|60968112|2017
0-14|2.0|2.8|2.4|145|X(c) Malignant gonadal germ cell tumors|60968112|2017
0-14|~|~|~|~|X(d) Gonadal carcinomas|60968112|2017
0-14|0.2|0.5|0.3|21|X(e) Other and unspecified malignant gonadal tumors|60968112|2017
0-14|8.5|10.0|9.2|563|XI Other malignant epithelial neoplasms and malignant melanomas|60968112|2017
0-14|~|~|~|~|XI(a) Adrenocortical carcinomas|60968112|2017
0-14|2.8|3.7|3.2|198|XI(b) Thyroid carcinomas|60968112|2017
0-14|~|~|~|~|XI(c) Nasopharyngeal carcinomas|60968112|2017
0-14|1.1|1.7|1.3|82|XI(d) Malignant melanomas|60968112|2017
0-14|~|~|~|~|XI(e) Skin carcinomas|60968112|2017
0-14|3.7|4.8|4.2|256|XI(f) Other and unspecified carcinomas|60968112|2017
0-14|0.8|1.4|1.1|65|XII Other and unspecified malignant neoplasms|60968112|2017
0-14|0.4|0.9|0.6|38|XII(a) Other specified malignant tumors|60968112|2017
0-14|0.3|0.6|0.4|27|XII(b) Other unspecified malignant tumors|60968112|2017
0-19|185.1|191.0|188.0|15481|All ICCC Groups Combined|82062709|2017
0-19|45.5|48.5|47.0|3859|I Leukemias, myeloproliferative & myelodysplastic diseases|82062709|2017
0-19|32.3|34.8|33.5|2751|I(a) Lymphoid leukemias|82062709|2017
0-19|7.3|8.5|7.9|648|I(b) Acute myeloid leukemias|82062709|2017
0-19|2.2|2.9|2.6|211|I(c) Chronic myeloproliferative diseases|82062709|2017
0-19|0.9|1.4|1.2|95|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82062709|2017
0-19|1.6|2.2|1.9|154|I(e) Unspecified and other specified leukemias|82062709|2017
0-19|28.8|31.2|30.0|2476|II Lymphomas and reticuloendothelial neoplasms|82062709|2017
0-19|11.5|13.0|12.2|1013|II(a) Hodgkin lymphomas|82062709|2017
0-19|8.9|10.3|9.6|789|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82062709|2017
0-19|2.2|2.8|2.5|203|II(c) Burkitt lymphoma|82062709|2017
0-19|4.9|6.0|5.4|444|II(d) Miscellaneous lymphoreticular neoplasms|82062709|2017
0-19|0.2|0.5|0.3|27|II(e) Unspecified lymphomas|82062709|2017
0-19|32.3|34.8|33.5|2745|III CNS and misc intracranial and intraspinal neoplasms|82062709|2017
0-19|2.5|3.3|2.9|238|III(a) Ependymomas and choroid plexus tumor|82062709|2017
0-19|16.5|18.4|17.4|1429|III(b) Astrocytomas|82062709|2017
0-19|5.2|6.3|5.7|469|III(c) Intracranial and intraspinal embryonal tumors|82062709|2017
0-19|5.7|6.8|6.3|513|III(d) Other gliomas|82062709|2017
0-19|0.4|0.8|0.6|46|III(e) Other specified intracranial & intraspinal neoplasms|82062709|2017
0-19|0.5|0.8|0.6|50|III(f) Unspecified intracranial and intraspinal neoplasms|82062709|2017
0-19|7.8|9.1|8.4|692|IV Neuroblastoma and other peripheral nervous cell tumors|82062709|2017
0-19|7.6|8.9|8.3|676|IV(a) Neuroblastoma and ganglioneuroblastoma|82062709|2017
0-19|0.1|0.3|0.2|16|IV(b) Other peripheral nervous cell tumors|82062709|2017
0-19|11.7|13.3|12.5|1028|IX Soft tissue and other extraosseous sarcomas|82062709|2017
0-19|4.6|5.5|5.0|414|IX(a) Rhabdomyosarcomas|82062709|2017
0-19|0.9|1.3|1.1|89|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82062709|2017
0-19|~|~|~|~|IX(c) Kaposi sarcoma|82062709|2017
0-19|4.1|5.0|4.5|375|IX(d) Other specified soft tissue sarcomas|82062709|2017
0-19|1.5|2.1|1.8|148|IX(e) Unspecified soft tissue sarcomas|82062709|2017
0-19|0.1|0.3|0.2|16|Not classified by ICCC|82062709|2017
0-19|2.7|3.5|3.1|255|V Retinoblastoma|82062709|2017
0-19|6.2|7.3|6.7|554|VI Renal tumors|82062709|2017
0-19|5.5|6.6|6.0|495|VI(a) Nephroblastoma and other nonepithelial renal tumors|82062709|2017
0-19|0.5|0.9|0.7|57|VI(b) Renal carcinomas|82062709|2017
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|82062709|2017
0-19|2.1|2.8|2.5|202|VII Hepatic tumors|82062709|2017
0-19|1.6|2.2|1.8|151|VII(a) Hepatoblastoma|82062709|2017
0-19|0.4|0.8|0.6|47|VII(b) Hepatic carcinomas|82062709|2017
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82062709|2017
0-19|8.7|10.1|9.4|774|VIII Malignant bone tumors|82062709|2017
0-19|4.9|5.9|5.4|446|VIII(a) Osteosarcomas|82062709|2017
0-19|0.2|0.5|0.3|26|VIII(b) Chondrosarcomas|82062709|2017
0-19|2.6|3.3|2.9|240|VIII(c) Ewing tumor and related sarcomas of bone|82062709|2017
0-19|0.3|0.7|0.5|40|VIII(d) Other specified malignant bone tumors|82062709|2017
0-19|0.2|0.4|0.3|22|VIII(e) Unspecified malignant bone tumors|82062709|2017
0-19|10.4|11.8|11.1|919|X Germ cell, trophoblastic tumors & neoplasms of gonads|82062709|2017
0-19|1.8|2.4|2.1|173|X(a) Intracranial & intraspinal germ cell tumors|82062709|2017
0-19|1.1|1.6|1.3|107|X(b) Malignant extracranial & extragonadal germ cell tumors|82062709|2017
0-19|6.2|7.4|6.8|564|X(c) Malignant gonadal germ cell tumors|82062709|2017
0-19|0.3|0.5|0.4|31|X(d) Gonadal carcinomas|82062709|2017
0-19|0.4|0.7|0.5|44|X(e) Other and unspecified malignant gonadal tumors|82062709|2017
0-19|21.5|23.6|22.5|1874|XI Other malignant epithelial neoplasms and malignant melanomas|82062709|2017
0-19|~|~|~|~|XI(a) Adrenocortical carcinomas|82062709|2017
0-19|9.5|10.9|10.2|850|XI(b) Thyroid carcinomas|82062709|2017
0-19|0.4|0.7|0.5|42|XI(c) Nasopharyngeal carcinomas|82062709|2017
0-19|2.6|3.4|3.0|247|XI(d) Malignant melanomas|82062709|2017
0-19|~|~|~|~|XI(e) Skin carcinomas|82062709|2017
0-19|7.9|9.2|8.6|710|XI(f) Other and unspecified carcinomas|82062709|2017
0-19|0.8|1.3|1.1|87|XII Other and unspecified malignant neoplasms|82062709|2017
0-19|0.4|0.8|0.6|47|XII(a) Other specified malignant tumors|82062709|2017
0-19|0.3|0.7|0.5|40|XII(b) Other unspecified malignant tumors|82062709|2017
0-14|165.7|172.3|168.9|10194|All ICCC Groups Combined|60245835|2018
0-14|51.1|54.8|52.9|3199|I Leukemias, myeloproliferative & myelodysplastic diseases|60245835|2018
0-14|39.3|42.5|40.9|2472|I(a) Lymphoid leukemias|60245835|2018
0-14|6.7|8.1|7.4|446|I(b) Acute myeloid leukemias|60245835|2018
0-14|1.0|1.6|1.3|79|I(c) Chronic myeloproliferative diseases|60245835|2018
0-14|0.8|1.3|1.0|62|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60245835|2018
0-14|2.0|2.7|2.3|140|I(e) Unspecified and other specified leukemias|60245835|2018
0-14|20.6|23.0|21.7|1311|II Lymphomas and reticuloendothelial neoplasms|60245835|2018
0-14|5.4|6.6|6.0|361|II(a) Hodgkin lymphomas|60245835|2018
0-14|7.2|8.7|7.9|478|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60245835|2018
0-14|1.8|2.6|2.2|133|II(c) Burkitt lymphoma|60245835|2018
0-14|4.9|6.1|5.5|328|II(d) Miscellaneous lymphoreticular neoplasms|60245835|2018
0-14|~|~|~|~|II(e) Unspecified lymphomas|60245835|2018
0-14|27.8|30.5|29.1|1757|III CNS and misc intracranial and intraspinal neoplasms|60245835|2018
0-14|2.3|3.1|2.7|163|III(a) Ependymomas and choroid plexus tumor|60245835|2018
0-14|14.0|16.0|15.0|903|III(b) Astrocytomas|60245835|2018
0-14|4.9|6.1|5.4|328|III(c) Intracranial and intraspinal embryonal tumors|60245835|2018
0-14|4.3|5.4|4.8|292|III(d) Other gliomas|60245835|2018
0-14|0.4|0.9|0.6|38|III(e) Other specified intracranial & intraspinal neoplasms|60245835|2018
0-14|0.4|0.8|0.5|33|III(f) Unspecified intracranial and intraspinal neoplasms|60245835|2018
0-14|10.4|12.1|11.2|676|IV Neuroblastoma and other peripheral nervous cell tumors|60245835|2018
0-14|10.2|11.9|11.1|665|IV(a) Neuroblastoma and ganglioneuroblastoma|60245835|2018
0-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|60245835|2018
0-14|9.8|11.5|10.6|641|IX Soft tissue and other extraosseous sarcomas|60245835|2018
0-14|4.3|5.4|4.8|289|IX(a) Rhabdomyosarcomas|60245835|2018
0-14|0.8|1.3|1.1|63|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60245835|2018
0-14|~|~|~|~|IX(c) Kaposi sarcoma|60245835|2018
0-14|3.2|4.2|3.7|224|IX(d) Other specified soft tissue sarcomas|60245835|2018
0-14|0.8|1.4|1.1|64|IX(e) Unspecified soft tissue sarcomas|60245835|2018
0-14|3.0|4.0|3.5|210|Not classified by ICCC|60245835|2018
0-14|3.3|4.3|3.8|229|V Retinoblastoma|60245835|2018
0-14|7.8|9.3|8.5|515|VI Renal tumors|60245835|2018
0-14|7.3|8.8|8.0|486|VI(a) Nephroblastoma and other nonepithelial renal tumors|60245835|2018
0-14|0.3|0.6|0.4|26|VI(b) Renal carcinomas|60245835|2018
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|60245835|2018
0-14|2.5|3.4|3.0|178|VII Hepatic tumors|60245835|2018
0-14|2.2|3.0|2.5|153|VII(a) Hepatoblastoma|60245835|2018
0-14|0.2|0.6|0.4|23|VII(b) Hepatic carcinomas|60245835|2018
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60245835|2018
0-14|7.1|8.6|7.8|473|VIII Malignant bone tumors|60245835|2018
0-14|3.6|4.7|4.1|250|VIII(a) Osteosarcomas|60245835|2018
0-14|0.2|0.4|0.3|17|VIII(b) Chondrosarcomas|60245835|2018
0-14|2.5|3.3|2.9|173|VIII(c) Ewing tumor and related sarcomas of bone|60245835|2018
0-14|0.2|0.5|0.3|21|VIII(d) Other specified malignant bone tumors|60245835|2018
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|60245835|2018
0-14|4.9|6.1|5.5|330|X Germ cell, trophoblastic tumors & neoplasms of gonads|60245835|2018
0-14|1.1|1.7|1.4|84|X(a) Intracranial & intraspinal germ cell tumors|60245835|2018
0-14|1.0|1.6|1.3|79|X(b) Malignant extracranial & extragonadal germ cell tumors|60245835|2018
0-14|2.1|2.9|2.5|150|X(c) Malignant gonadal germ cell tumors|60245835|2018
0-14|~|~|~|~|X(d) Gonadal carcinomas|60245835|2018
0-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60245835|2018
0-14|9.7|11.3|10.5|632|XI Other malignant epithelial neoplasms and malignant melanomas|60245835|2018
0-14|0.2|0.5|0.3|20|XI(a) Adrenocortical carcinomas|60245835|2018
0-14|3.6|4.7|4.1|249|XI(b) Thyroid carcinomas|60245835|2018
0-14|~|~|~|~|XI(c) Nasopharyngeal carcinomas|60245835|2018
0-14|1.4|2.1|1.7|104|XI(d) Malignant melanomas|60245835|2018
0-14|~|~|~|~|XI(e) Skin carcinomas|60245835|2018
0-14|3.6|4.6|4.1|246|XI(f) Other and unspecified carcinomas|60245835|2018
0-14|0.5|1.0|0.7|43|XII Other and unspecified malignant neoplasms|60245835|2018
0-14|0.2|0.5|0.3|17|XII(a) Other specified malignant tumors|60245835|2018
0-14|0.3|0.6|0.4|26|XII(b) Other unspecified malignant tumors|60245835|2018
0-19|183.5|189.5|186.5|15178|All ICCC Groups Combined|81129651|2018
0-19|47.2|50.3|48.7|3957|I Leukemias, myeloproliferative & myelodysplastic diseases|81129651|2018
0-19|34.4|37.0|35.7|2895|I(a) Lymphoid leukemias|81129651|2018
0-19|7.0|8.2|7.6|619|I(b) Acute myeloid leukemias|81129651|2018
0-19|1.9|2.6|2.2|182|I(c) Chronic myeloproliferative diseases|81129651|2018
0-19|0.8|1.3|1.0|83|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|81129651|2018
0-19|1.9|2.5|2.2|178|I(e) Unspecified and other specified leukemias|81129651|2018
0-19|27.8|30.2|29.0|2366|II Lymphomas and reticuloendothelial neoplasms|81129651|2018
0-19|11.6|13.1|12.3|1013|II(a) Hodgkin lymphomas|81129651|2018
0-19|9.1|10.5|9.8|797|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|81129651|2018
0-19|1.9|2.5|2.2|178|II(c) Burkitt lymphoma|81129651|2018
0-19|4.0|4.9|4.4|355|II(d) Miscellaneous lymphoreticular neoplasms|81129651|2018
0-19|0.2|0.4|0.3|23|II(e) Unspecified lymphomas|81129651|2018
0-19|25.9|28.1|27.0|2187|III CNS and misc intracranial and intraspinal neoplasms|81129651|2018
0-19|2.0|2.7|2.3|189|III(a) Ependymomas and choroid plexus tumor|81129651|2018
0-19|13.7|15.3|14.5|1177|III(b) Astrocytomas|81129651|2018
0-19|3.9|4.8|4.3|348|III(c) Intracranial and intraspinal embryonal tumors|81129651|2018
0-19|4.2|5.1|4.7|377|III(d) Other gliomas|81129651|2018
0-19|0.5|0.9|0.7|53|III(e) Other specified intracranial & intraspinal neoplasms|81129651|2018
0-19|0.4|0.7|0.5|43|III(f) Unspecified intracranial and intraspinal neoplasms|81129651|2018
0-19|8.0|9.3|8.6|695|IV Neuroblastoma and other peripheral nervous cell tumors|81129651|2018
0-19|7.8|9.1|8.4|675|IV(a) Neuroblastoma and ganglioneuroblastoma|81129651|2018
0-19|0.1|0.4|0.2|20|IV(b) Other peripheral nervous cell tumors|81129651|2018
0-19|10.8|12.3|11.5|935|IX Soft tissue and other extraosseous sarcomas|81129651|2018
0-19|4.0|4.9|4.4|359|IX(a) Rhabdomyosarcomas|81129651|2018
0-19|0.9|1.4|1.1|92|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|81129651|2018
0-19|~|~|~|~|IX(c) Kaposi sarcoma|81129651|2018
0-19|4.2|5.1|4.6|378|IX(d) Other specified soft tissue sarcomas|81129651|2018
0-19|1.0|1.5|1.3|104|IX(e) Unspecified soft tissue sarcomas|81129651|2018
0-19|2.8|3.6|3.2|255|Not classified by ICCC|81129651|2018
0-19|2.5|3.3|2.9|229|V Retinoblastoma|81129651|2018
0-19|6.3|7.5|6.9|559|VI Renal tumors|81129651|2018
0-19|5.6|6.7|6.1|496|VI(a) Nephroblastoma and other nonepithelial renal tumors|81129651|2018
0-19|0.5|0.9|0.7|59|VI(b) Renal carcinomas|81129651|2018
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|81129651|2018
0-19|2.3|3.0|2.6|210|VII Hepatic tumors|81129651|2018
0-19|1.6|2.2|1.9|153|VII(a) Hepatoblastoma|81129651|2018
0-19|0.5|0.9|0.7|54|VII(b) Hepatic carcinomas|81129651|2018
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|81129651|2018
0-19|8.9|10.2|9.5|776|VIII Malignant bone tumors|81129651|2018
0-19|4.7|5.8|5.2|427|VIII(a) Osteosarcomas|81129651|2018
0-19|0.3|0.6|0.4|33|VIII(b) Chondrosarcomas|81129651|2018
0-19|2.8|3.6|3.2|262|VIII(c) Ewing tumor and related sarcomas of bone|81129651|2018
0-19|0.3|0.6|0.4|35|VIII(d) Other specified malignant bone tumors|81129651|2018
0-19|0.1|0.4|0.2|19|VIII(e) Unspecified malignant bone tumors|81129651|2018
0-19|9.7|11.1|10.3|848|X Germ cell, trophoblastic tumors & neoplasms of gonads|81129651|2018
0-19|1.3|1.9|1.6|128|X(a) Intracranial & intraspinal germ cell tumors|81129651|2018
0-19|1.1|1.6|1.3|108|X(b) Malignant extracranial & extragonadal germ cell tumors|81129651|2018
0-19|6.1|7.3|6.7|550|X(c) Malignant gonadal germ cell tumors|81129651|2018
0-19|0.3|0.6|0.5|38|X(d) Gonadal carcinomas|81129651|2018
0-19|0.2|0.4|0.3|24|X(e) Other and unspecified malignant gonadal tumors|81129651|2018
0-19|24.3|26.5|25.3|2087|XI Other malignant epithelial neoplasms and malignant melanomas|81129651|2018
0-19|0.2|0.5|0.3|28|XI(a) Adrenocortical carcinomas|81129651|2018
0-19|11.4|12.9|12.1|1002|XI(b) Thyroid carcinomas|81129651|2018
0-19|0.3|0.6|0.4|35|XI(c) Nasopharyngeal carcinomas|81129651|2018
0-19|3.0|3.8|3.4|276|XI(d) Malignant melanomas|81129651|2018
0-19|~|~|~|~|XI(e) Skin carcinomas|81129651|2018
0-19|8.3|9.7|9.0|739|XI(f) Other and unspecified carcinomas|81129651|2018
0-19|0.7|1.1|0.9|74|XII Other and unspecified malignant neoplasms|81129651|2018
0-19|0.3|0.6|0.4|34|XII(a) Other specified malignant tumors|81129651|2018
0-19|0.4|0.7|0.5|40|XII(b) Other unspecified malignant tumors|81129651|2018
